[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "BS4018: Biology of Aging and Neurodegeneration",
    "section": "",
    "text": "This is a Quarto book.\nTo learn more about Quarto books visit https://quarto.org/docs/books.\n\n1 + 1\n\n[1] 2"
  },
  {
    "objectID": "chapters/week1.html",
    "href": "chapters/week1.html",
    "title": "1  Aging and Neurodegeneration",
    "section": "",
    "text": "Trends in Prolonging Human Life\nThe average human life expectancy has dramatically risen since the 1940s. The above figure suggests that there has been a three-month increase in the life expectancy for women per year for the past 160 years of history. A similar argument could also be said for men given the high \\(R^2\\) values (which describes how well a trend is being explained).\nNevertheless, the above trends have also altered the way that the world’s population pyramid is being shaped. Whereas the said curve looked more like a pyramid in the past, it is now starting to look more uniform (i.e., like a bottle).\nIn Singapore at least, at least 14.4% of Singaporeans are above 65 years old. This figure is expected to grow to about 28% by 2030 and to about 47% in 2050. With so many aging Singaporeans in the future, it’s not unrealistic to think that the government will soon start spending big bucks on healthcare-related expenses.\nThis course is relevant as aging is the biggest risk factor of multiple (chronic) diseases - including neurodegenerative ones like Alzheimer’s, cancer, diabetes, cardiovascular diseases, and much more.\nA healthspan is the number of years that a person in good health lives for. This metric is used to measure somebody’s quality of life as they age. A lifespan - on the contrary - refers to the number of years that a person lives from the time that they are born to the time that they die. In other terms, a lifespan is just how long somebody lives for - this metric is often used in demographic studies and life expectancy tables.\nRejuvenation is the idea that neurons and neural circuits (i.e., a bunch of neurons that are connected via synapses or gaps) can be restored via intervening, if not slowing down age-related degeneration processes and promoting neural cell regeneration.\nThe above graphic also depicts parabiosis: this is a surgical technique whereby the circulatory systems of two living animals are joined in such a way that they can exchange blood along with other proteins. In this example, parabiosis between a young and an old mouse is suggested to improve neural tissue regeneration, muscle function, cardiac function, and other bodily regulations in the old mouse, but have the reverse effect in the young mouse."
  },
  {
    "objectID": "chapters/week1.html#hallmarks-of-aging",
    "href": "chapters/week1.html#hallmarks-of-aging",
    "title": "1  Aging and Neurodegeneration",
    "section": "1.1 Hallmarks of Aging",
    "text": "1.1 Hallmarks of Aging\n\n\n\n\n\nSeveral Hallmarks of Aging\n\n\n\n\nThe above nine hallmarks or causes of aging will be explained upon in a future lesson. This week’s lecture only aims to provide a brief overview.\n\n1.1.1 Loss of Proteostasis\n\n\n\n\n\nLoss of Regulation of Proteostasis\n\n\n\n\nIn any living organism, outside or inside stressors such as heat, free radicals, something from the mitochondria may cause a normally-folded protein to unfold. The body typically has one of many ways to deal with the unfolded protein:\n\nAutophagy: the unfolded protein is uptaken by the lysosomes via an endosome (i.e., a container) or via means of a protein called Hsc70: a chaperone.\nDegradation: the unfolded protein could be ubiquinated and subsequently targeted for degradation by the ubiquitin-proteasome system.\nRefolding: the protein could just get refolded with the help of chaperone proteins.\n\nHowever, in the event that the cell is unable to perform any one of the above three functions, these unfolded proteins could aggregate and form plaques or tangles, hence leading to aging-related illnesses.\n\n\n1.1.2 Free Radical Theory of Aging\n\n\n\n\n\nOxidation Reactions on the Miotchondria\n\n\n\n\n\n\n\nOxidation Reactions on the Miotchondria\n\n\n\n\nThe free radical theory of aging suggests that the process of aging is partly caused by the damage that free radicals can inflict on our cells over time. Free radicals are unstable molecules that can harm our cells by causing oxidative stress, which can lead to various age-related diseases and the overall decline of our bodies as we get older.\nIn the late 1960s, scientists discovered an enzyme called superoxide dismutase (SOD). This enzyme plays a crucial role in our bodies by helping to neutralize free radicals and reduce the damage they can cause to our cells.\n\n\n\n\n\nMitochondria Degeneration Leading to Aging Effects\n\n\n\n\nNonetheless, when mitochondria age, a process called mitophagy occurs that engulfs damage mitochondria and remove them by degrading them. However, when an organism ages, mitophagy isn’t able to occur as readily and so, the damaged mitochondria accumulate and lead to the creation of reactive oxygen species (i.e., ROS) and age-related issues.\n\n\n1.1.3 Cell Senesence\n\n\n\n\n\nIllustration of Cell Senesence\n\n\n\n\nWhenever a cell divides, the ends of its chromosomes (i.e., its telomeres) shorten a little. These chromosomes are unable to be shortened past a certain point - because of this, cells can only divide so many times (which is shown by that graph on the left).\n\n\n1.1.4 Epigenetics\n\n\n\n\n\nHow Epigenetics Can Influence Aging\n\n\n\n\nThe above figure shows some processes that occur on the epigenetic-level that may contribute to aging-related health issues."
  },
  {
    "objectID": "chapters/week1.html#possible-interventions-to-expand-healthcare",
    "href": "chapters/week1.html#possible-interventions-to-expand-healthcare",
    "title": "1  Aging and Neurodegeneration",
    "section": "1.2 Possible Interventions to Expand Healthcare",
    "text": "1.2 Possible Interventions to Expand Healthcare\n\n\n\n\n\nPossible Ways to Prolong One’s Lifespan\n\n\n\n\nAll of the above will be explained in subsequent lectures."
  },
  {
    "objectID": "chapters/week2.html",
    "href": "chapters/week2.html",
    "title": "2  Ubiquitin Proteasome System",
    "section": "",
    "text": "Roles of the Ubiquitin Protein in the Cell\nAlthough ubiquitin is generally used to target proteins for degradation via the E3 ubiquitin ligase system, it also has roles in other cellular processes - for instance, the cell cycle, quality control, and metabolism."
  },
  {
    "objectID": "chapters/week2.html#e3-ligase-and-ubiquitylation",
    "href": "chapters/week2.html#e3-ligase-and-ubiquitylation",
    "title": "2  Ubiquitin Proteasome System",
    "section": "2.1 E3 Ligase and Ubiquitylation",
    "text": "2.1 E3 Ligase and Ubiquitylation\n\n\n\n\n\nE1, E2, and E3 Ubiquitination Cascade\n\n\n\n\nThis process is threefold and has the following steps - it is usually used to tag proteins for degradation within the cell and is important for maintaining homeostasis, cellular processes, and also protein levels:\n\nE1 Activation: The process begins with an enzyme called E1 (ubiquitin-activating enzyme). E1 activates ubiquitin, a small protein found in cells that serves as a tag for proteins destined for degradation. Activation involves the binding of ubiquitin to E1 in an ATP-dependent manner, forming a thioester bond between the ubiquitin molecule and E1.\nE2 Conjugation: Once activated, the ubiquitin molecule is transferred to a second enzyme called E2 (ubiquitin-conjugating enzyme). E2 works as a carrier for the ubiquitin molecule, shuttling it to the target protein.\nE3 Ligase: The E2 enzyme, now loaded with ubiquitin, interacts with a third enzyme called E3 ligase (ubiquitin-protein ligase). E3 ligase plays a crucial role in recognizing specific target proteins and facilitating the transfer of ubiquitin from E2 to the target protein.\nUbiquitination: The E3 ligase, along with the assistance of E2, transfers the ubiquitin molecule from the E2 enzyme to a lysine residue on the target protein, forming an isopeptide bond. This process can be repeated multiple times, resulting in the addition of multiple ubiquitin molecules to the target protein, forming a polyubiquitin chain.\nProteasomal Degradation: Once the target protein is tagged with ubiquitin chains, it is recognized and degraded by a large multi-subunit complex called the proteasome. The proteasome acts as the cell’s “garbage disposal,” breaking down tagged proteins into smaller peptides that can be recycled by the cell.\n\n\n2.1.1 Terminal Regions of Ubiquitin\n\n\n\n\n\nCys, Lys, and C-Termini of Ubiquitin\n\n\n\n\nUbiquitin is a small protein found in cells that plays a crucial role in tagging other proteins for degradation through the ubiquitin-proteasome system. Its structure consists of 76 amino acid residues and includes several key functional elements:\n\nCysteine (Cys): Ubiquitin contains a reactive thiol group (-SH) on its C-terminal glycine residue. This cysteine residue is where ubiquitin forms a thioester bond with the active site of the E1 ubiquitin-activating enzyme during the first step of the ubiquitination cascade. This thioester bond formation activates ubiquitin for conjugation to target proteins.\nLysine (Lys): Ubiquitin contains seven lysine residues (K6, K11, K27, K29, K33, K48, and K63), any of which can serve as attachment sites for additional ubiquitin molecules during the process of polyubiquitination. The type of polyubiquitin chain formed (e.g., K48-linked, K63-linked) determines the fate of the tagged protein, such as degradation by the proteasome or involvement in other cellular processes.\nC-Terminus: The C-terminus of ubiquitin is where its Gly76 residue is located. This glycine residue is crucial for the formation of the isopeptide bond between ubiquitin and the lysine residue of the target protein during ubiquitination. The C-terminus is also where the ubiquitin molecule is initially activated by the E1 enzyme, forming a thioester bond with the cysteine residue of E1.\n\n\n\n2.1.2 RING and HECT E3 Ligases\n\n\n\n\n\nIllustration of RING and HECT Ligases\n\n\n\n\nTwo primary classes of E3 ligases, known as RING (Really Interesting New Gene) ligases and HECT (Homologous to the E6-AP Carboxyl Terminus) ligases, operate distinctly within this ubiquitination process.\nFirstly, RING ligases function by directly mediating the transfer of ubiquitin from the E2 enzyme to the target protein without forming a covalent intermediate with ubiquitin. Although RING ligases lack intrinsic catalytic activity for ubiquitin transfer, they serve as scaffolds, bringing the E2 enzyme and the target protein into close proximity to facilitate efficient ubiquitin transfer. The RING domain, a characteristic feature of RING ligases, orchestrates the interaction between the E2 enzyme and the target protein, thereby enabling the ubiquitination process. Examples of RING ligases include Cullin-RING ligases (CRLs), which participate in the ubiquitination of diverse cellular proteins involved in crucial processes like cell cycle regulation and signal transduction.\nOn the other hand, HECT ligases operate differently by forming a thioester intermediate with ubiquitin prior to transferring it to the target protein. The HECT domain, distinctive to HECT ligases, contains a catalytic cysteine residue that forms a thioester bond with ubiquitin, facilitating its transfer to the target protein. Typically, HECT ligases exhibit a specific domain architecture, featuring an N-terminal domain responsible for substrate recognition and a C-terminal HECT domain accountable for ubiquitin transfer. Notable examples of HECT ligases include E6-AP (E6-associated protein) and NEDD4 (Neural Precursor Cell Expressed, Developmentally Down-Regulated 4), which respectively target specific proteins for ubiquitination and regulate the ubiquitination of membrane proteins and signaling molecules.\n\n2.1.2.1 Cullin-RING Ligases\n\n\n\n\n\nCullin-Ring Ligase Mechanisms\n\n\n\n\nThe Cullin-RING ubiquitin ligase (CRL) is a type of RING E3 ubiquitin ligase that plays a crucial role in the ubiquitination and subsequent degradation of specific target proteins within the cell. CRLs are part of a large family of multisubunit E3 ligases, and they are involved in the regulation of various cellular processes, including cell cycle progression, signal transduction, and response to environmental stimuli. Some key features of CRLs include:\n\nComposition: CRLs are modular complexes composed of multiple subunits. The core components include a cullin protein, a RING finger protein, an adaptor protein, and a substrate recognition module. The cullin protein acts as a scaffold, providing a platform for the assembly of the other components.\nCullin Family Members: Cullin proteins are a family of scaffold proteins, with Cul1, Cul2, Cul3, Cul4, Cul5, and Cul7 being the most well-known members. Each cullin family member associates with specific adaptor proteins and substrate recognition modules, conferring specificity to the CRL complex.\nRING Finger Protein: The RING finger protein, often referred to as Rbx1 or Rbx2, is responsible for binding to the E2 ubiquitin-conjugating enzyme and facilitating the transfer of ubiquitin from the E2 enzyme to the target protein.\nAdaptor Protein: The adaptor protein (e.g., Skp1, Elongin C) connects the cullin scaffold to the substrate recognition module, ensuring proper substrate recruitment.\nSubstrate Recognition Module: This module is responsible for recognizing and binding to specific target proteins marked for ubiquitination. Different CRLs have distinct substrate recognition modules, contributing to the specificity of ubiquitination events.\nUbiquitin Transfer: Once assembled, the CRL complex catalyzes the transfer of ubiquitin molecules from the E2 enzyme to the lysine residues on the target protein, leading to the formation of a polyubiquitin chain. This ubiquitin chain serves as a signal for the targeted protein to be recognized and degraded by the proteasome.\nRegulation of CRL Activity: The activity of CRLs is tightly regulated. Post-translational modifications, such as neddylation (attachment of the small ubiquitin-like modifier NEDD8 to cullin), are essential for CRL activation. Additionally, CRLs can be regulated by specific inhibitors and adaptors.\nCellular Functions: Due to their involvement in the ubiquitin-proteasome system, CRLs play critical roles in maintaining cellular homeostasis by controlling the levels of key regulatory proteins. Dysregulation of CRLs has been implicated in various diseases, including cancer.\n\n\n\n\n2.1.3 Marking Proteins by Ubiquitin\n\n\n\n\n\nProtein Marking by Ubiquitin\n\n\n\n\nThe marking of proteins by ubiquitin is a crucial process in cells, ensuring proper protein turnover and regulation. Ubiquitin is a small protein consisting of 76 amino acids. Its structure contains seven lysine residues (K6, K11, K27, K29, K33, K48, and K63) and an N-terminal methionine residue; each possible linkage leads to different cellular reactions.\n\n\n\n\n\nDifferent Linkage Types and Functions of Ubiquitin\n\n\n\n\n\n\n\nDifferent Linkage Types and Functions of Ubiquitin\n\n\n\n\nUbiquitin can attach to target proteins through its lysine residues or its N-terminal methionine residue, forming different types of ubiquitin chains. The most well-characterized ubiquitin chain types are formed through the linkage of ubiquitin molecules via one of its seven lysine residues or through the N-terminal methionine residue. These different linkages lead to diverse cellular outcomes:\n\nLinear Chains: Ubiquitin can also form linear chains where the C-terminal glycine of one ubiquitin molecule is linked to the N-terminal methionine of the next ubiquitin molecule. Linear chains are involved in various signaling pathways, including NF-κB activation and apoptosis."
  },
  {
    "objectID": "chapters/week2.html#n-end-rule-pathway",
    "href": "chapters/week2.html#n-end-rule-pathway",
    "title": "2  Ubiquitin Proteasome System",
    "section": "2.2 N-End Rule Pathway",
    "text": "2.2 N-End Rule Pathway\n\n\n\n\n\nVarious Roles of Deubiquitinase\n\n\n\n\nDeubiquitinases (DUBs) are enzymes that play a crucial role in the regulation of ubiquitin-mediated signaling pathways by removing ubiquitin molecules from proteins. While ubiquitination marks proteins for degradation or alters their function, deubiquitination mediated by DUBs reverses these modifications, allowing for precise control over protein stability, localization, and activity within the cell. They play some of the following roles in cells:\n\nRegulation of Protein Stability: DUBs counteract the activity of ubiquitin ligases by removing ubiquitin chains from proteins targeted for degradation. By deubiquitinating these proteins, DUBs can stabilize them and prevent their degradation by the proteasome. This process is crucial for maintaining the appropriate levels of key regulatory proteins involved in various cellular processes.\nControl of Signaling Pathways: Ubiquitination plays a central role in the regulation of signaling pathways involved in cell growth, differentiation, apoptosis, and immune responses. DUBs modulate these signaling pathways by removing ubiquitin chains from signaling molecules, thereby regulating their activity and localization. For example, DUBs can terminate signaling cascades by deubiquitinating and inactivating key signaling molecules.\nDNA Repair: DUBs are involved in the regulation of DNA repair pathways by controlling the ubiquitination status of proteins involved in DNA damage response and repair. By removing ubiquitin chains from DNA repair proteins, DUBs help maintain genomic integrity and prevent the accumulation of DNA damage.\nEndocytosis and Vesicular Trafficking: DUBs regulate the ubiquitination status of proteins involved in endocytosis, vesicular trafficking, and membrane protein turnover. By deubiquitinating membrane proteins, DUBs can control their internalization, recycling, and degradation, thereby regulating cellular processes such as receptor signaling and membrane protein turnover.\nMitochondrial Dynamics: DUBs play a role in regulating mitochondrial dynamics and function by modulating the ubiquitination status of proteins involved in mitochondrial quality control, fusion, fission, and mitophagy (selective autophagy of damaged mitochondria).\n\n\n2.2.1 What is the Rule?\n\n\n\n\n\nDepiction of the N-End Rule Pathway\n\n\n\n\nThe N-end rule pathway is a proteolytic system found in cells that targets proteins for degradation based on the identity of their N-terminal amino acid residue. This pathway was first proposed by Alexander Varshavsky in the late 1980s and has since been extensively studied in various organisms, including yeast, plants, and mammals. Key features of the N-end rule pathway include:\n\nRecognition of N-terminal Residues: The N-end rule pathway recognizes specific amino acids at the N-terminus of proteins. The identity of the N-terminal residue determines the fate of the protein. Certain amino acids, known as destabilizing residues, target proteins for degradation, while others are considered stabilizing residues.\nDegradation Signal: Proteins with destabilizing N-terminal residues are marked for degradation by the covalent attachment of ubiquitin molecules. This process involves the sequential action of enzymes known as N-terminal amino peptidases and E3 ubiquitin ligases, which recognize and ubiquitinate the target proteins, respectively.\nRecognition by the Proteasome: Ubiquitinated proteins are recognized and degraded by the proteasome, a large multi-subunit protease complex found in the cytoplasm and nucleus of eukaryotic cells. The proteasome cleaves ubiquitinated proteins into short peptides, which can then be further degraded into amino acids by cellular peptidases.\nFunction in Protein Quality Control: The N-end rule pathway serves as an important mechanism for maintaining protein quality control in cells. It targets misfolded or damaged proteins for degradation, thereby preventing the accumulation of potentially harmful protein aggregates and promoting cellular homeostasis.\nRegulation of Cellular Processes: The N-end rule pathway regulates various cellular processes, including cell cycle progression, DNA repair, apoptosis, and response to environmental stresses. By controlling the stability of key regulatory proteins, the N-end rule pathway helps orchestrate cellular responses to internal and external cues.\n\nExamples of destabilizing N-terminal residues include methionine (Met) followed by certain amino acids such as arginine (Arg), lysine (Lys), phenylalanine (Phe), and tryptophan (Trp). These residues are recognized by specific components of the N-end rule pathway and targeted for degradation.\n\n\n2.2.2 Substrates Produced\n\n\n\n\n\nPhysiological Substrates of the N-End Rule Pathway\n\n\n\n\nHere are some examples of physiological substrates of the N-end rule pathway:\n\nTranscription Factors: Certain transcription factors are targeted by the N-end rule pathway for degradation, regulating gene expression and cellular responses to environmental cues. For example, the transcription factor MATα2 in yeast and the transcription factor Pd in mammals are degraded by the N-end rule pathway.\nCell Cycle Regulators: Proteins involved in cell cycle regulation, such as cyclins and cyclin-dependent kinase inhibitors (CDKIs), are substrates of the N-end rule pathway. Degradation of these proteins by the N-end rule pathway helps control cell cycle progression and ensures proper cell division.\nDNA Repair Proteins: Components of DNA repair pathways, including proteins involved in base excision repair, nucleotide excision repair, and homologous recombination, can be targeted by the N-end rule pathway. Degradation of damaged or misfolded DNA repair proteins helps maintain genomic integrity and prevents the accumulation of DNA lesions.\nApoptotic Regulators: Proteins involved in apoptosis, or programmed cell death, are regulated by the N-end rule pathway. For example, certain pro-apoptotic proteins, such as Bid in mammals, are degraded by the N-end rule pathway, contributing to the control of apoptosis.\nCell Signaling Proteins: Components of cell signaling pathways, including kinases, phosphatases, and signaling adapters, can be targeted by the N-end rule pathway. Degradation of signaling proteins by the N-end rule pathway helps regulate cellular responses to extracellular signals and maintain signaling homeostasis.\nProteins with Misfolded or Damaged Domains: Proteins that become misfolded or damaged due to cellular stresses or mutations can be recognized and degraded by the N-end rule pathway. Degradation of misfolded or damaged proteins prevents the accumulation of toxic protein aggregates and promotes cellular health."
  },
  {
    "objectID": "chapters/week2.html#protein-quality-control-by-ups",
    "href": "chapters/week2.html#protein-quality-control-by-ups",
    "title": "2  Ubiquitin Proteasome System",
    "section": "2.3 Protein Quality Control by UPS",
    "text": "2.3 Protein Quality Control by UPS\n\n\n\n\n\nProtein Quality Control by the UPS\n\n\n\n\nThe above figure shows how denatured or misfolded proteins are targeted for destruction by the 26s proteasome. Ubiquitin conjugation marks structures for degradation as previously mentioned.\n\n2.3.1 Protein Secretory Pathway\n\n\n\n\n\nProtein Secretory Pathway\n\n\n\n\nThe protein secretory pathway is a fundamental cellular process responsible for the synthesis, modification, and transport of proteins destined for secretion or localization to various cellular compartments. It involves a series of highly coordinated steps that occur within different organelles and membrane-bound compartments of the cell. Here’s an overview of the protein secretory pathway:\n\nProtein Synthesis in the Cytoplasm: Protein synthesis begins on ribosomes in the cytoplasm, where messenger RNA (mRNA) molecules are translated into polypeptide chains. These polypeptide chains contain signal sequences, often located at the N-terminus, which direct them to the endoplasmic reticulum (ER) for further processing and secretion.\nTranslocation into the Endoplasmic Reticulum (ER): Proteins targeted for secretion or membrane insertion are co-translationally translocated into the lumen of the ER. This process involves the recognition of signal sequences by the signal recognition particle (SRP) and its receptor, which direct the ribosome-nascent chain complex to the ER membrane. Translocation occurs through proteinaceous channels called translocons.\nProtein Folding and Modification in the Endoplasmic Reticulum (ER): Once inside the ER lumen, newly synthesized proteins undergo folding, assembly, and post-translational modifications such as glycosylation, disulfide bond formation, and proteolytic cleavage. These processes ensure proper protein conformation and functionality.\nQuality Control in the Endoplasmic Reticulum (ER): The ER contains mechanisms for quality control to ensure that only properly folded and assembled proteins are transported further along the secretory pathway. Misfolded or unassembled proteins are recognized and targeted for degradation by the ER-associated degradation (ERAD) pathway.\nExport from the Endoplasmic Reticulum (ER): Proteins that pass quality control in the ER are packaged into transport vesicles derived from the ER membrane. These vesicles bud off and fuse with the Golgi apparatus, a central organelle in the secretory pathway.\nProcessing and Sorting in the Golgi Apparatus: Within the Golgi apparatus, proteins undergo further post-translational modifications, including glycosylation, sulfation, phosphorylation, and proteolytic cleavage. The Golgi also acts as a sorting station, directing proteins to their final destinations, such as the plasma membrane, lysosomes, or secretion outside the cell.\nSecretion and Exocytosis: Proteins destined for secretion are transported in vesicles from the trans-Golgi network to the cell surface. Upon reaching the plasma membrane, these vesicles fuse with the membrane through a process called exocytosis, releasing their contents into the extracellular space.\n\n\n\n2.3.2 ER-Associated Degradation\n\n\n\n\n\nDepiction of ERAD\n\n\n\n\n\n\n\n\n\nATPase in Protein Degradation\n\n\n\n\nERAD, or ER-associated degradation, is a quality control mechanism in eukaryotic cells responsible for identifying and targeting misfolded or unassembled proteins in the endoplasmic reticulum (ER) for degradation. The ERAD pathway ensures that only properly folded and functional proteins are allowed to proceed through the secretory pathway and reach their intended destinations within the cell. Here’s how ERAD works:\n\nRecognition of Misfolded Proteins: During protein synthesis, the ER serves as the primary site for the folding and maturation of secretory and membrane proteins. However, not all proteins fold correctly, and misfolded or improperly assembled proteins may accumulate in the ER lumen or membrane. These misfolded proteins are recognized by ER quality control systems, which include chaperone proteins and lectins that monitor protein folding status.\nUbiquitination: Upon recognition of misfolded proteins, they are targeted for degradation through the covalent attachment of ubiquitin molecules. Ubiquitination is mediated by a series of enzymes, including ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin ligases (E3s). In the case of ERAD, specific E3 ubiquitin ligases recognize misfolded proteins and facilitate their ubiquitination.\nExtraction from the ER Membrane: Misfolded membrane proteins must be extracted from the ER membrane before they can be degraded by the proteasome, a large proteolytic complex found in the cytoplasm. This extraction process involves the action of protein complexes such as the ATPase-containing Cdc48/p97 complex (also known as valosin-containing protein, VCP, in mammals), which extracts the misfolded proteins from the ER membrane into the cytoplasm.\nDegradation by the Proteasome: Once extracted from the ER membrane, ubiquitinated misfolded proteins are targeted to the proteasome for degradation. The proteasome recognizes polyubiquitinated proteins and proteolytically cleaves them into short peptides. These peptides can then be further degraded into amino acids by cytoplasmic peptidases.\nRegulation and Coordination: The ERAD pathway is tightly regulated to ensure efficient removal of misfolded proteins while minimizing the degradation of properly folded proteins. It involves coordination between various components, including chaperones, ubiquitin ligases, and the proteasome, as well as post-translational modifications and signaling pathways.\n\n\n2.3.2.1 Cdc48 / p97: AAA+ ATPase in Protein Degradation\n\n\n\n\n\nATPase Types in Organisms and Activities\n\n\n\n\n\n\n\nATPase Types in Organisms and Activities\n\n\n\n\n\n\n\n\n\nATPase Activities in ERAD\n\n\n\n\nThe AAA+ (ATPases Associated with diverse cellular Activities) family of proteins is a large and diverse group of ATPases found in all domains of life. These proteins share a common structural feature known as the AAA+ domain, which is characterized by conserved sequence motifs and is responsible for ATP binding and hydrolysis. AAA+ proteins participate in a wide range of cellular processes, including protein degradation, DNA replication, DNA repair, membrane fusion, and vesicle trafficking. Here’s an overview of the general mechanism of AAA+ family proteins:\n\nOligomerization: AAA+ proteins typically function as oligomers, forming complex structures composed of multiple subunits. These subunits may assemble into hexameric rings, double rings, or other higher-order oligomeric structures depending on the specific protein and its function.\nATP Binding and Hydrolysis: The AAA+ domain contains conserved Walker A and Walker B motifs, which are responsible for ATP binding and hydrolysis, respectively. Upon ATP binding, conformational changes occur within the AAA+ domain, resulting in the formation of a catalytically active ATPase site. ATP hydrolysis fuels the mechanical work performed by AAA+ proteins, driving conformational changes that are often essential for their biological functions.\nSubstrate Recognition and Binding: AAA+ proteins interact with specific substrate molecules through specialized substrate-binding domains or motifs located adjacent to the AAA+ domain. These substrate-binding domains recognize and bind to target proteins, nucleic acids, or other substrates, facilitating their processing, modification, or degradation.\nMechanical Work and Substrate Remodeling: ATP hydrolysis by AAA+ proteins generates mechanical force that drives conformational changes in the protein complex. These conformational changes can result in the remodeling, unfolding, or translocation of substrates, depending on the specific function of the AAA+ protein. For example, AAA+ proteins involved in protein degradation may unfold and translocate substrate proteins through a central pore formed by the AAA+ oligomer.\nRegulation and Coordination: The activity of AAA+ proteins is tightly regulated to ensure proper timing and coordination of cellular processes. Regulation may involve factors such as post-translational modifications, cofactors, allosteric regulators, and interactions with other proteins or cellular components. For example, ATP binding and hydrolysis kinetics, as well as interactions with regulatory proteins, can modulate the activity of AAA+ proteins involved in DNA replication or protein degradation.\n\n\n\n\n2.3.3 Cdc48 / p97 Function in UBS\n\n\n\n\n\nRole of Cdc48 / p97 in the UBS\n\n\n\n\nCdc48, also known as p97 in mammals, is a highly conserved AAA+ (ATPases Associated with diverse cellular Activities) ATPase protein that plays a crucial role in various cellular processes, including the ubiquitin-proteasome system (UPS). Its function in the UPS is diverse and multifaceted, contributing to protein quality control, protein degradation, and various cellular pathways. Here’s an overview of the functions of Cdc48/p97 in the ubiquitin-proteasome system:\n\nProtein Degradation and ERAD (ER-Associated Degradation): Cdc48/p97 is a central player in ERAD, a quality control mechanism responsible for identifying and targeting misfolded or unassembled proteins in the endoplasmic reticulum (ER) for degradation by the proteasome. Cdc48/p97 extracts ubiquitinated substrates from the ER membrane and facilitates their delivery to the proteasome for degradation. It collaborates with other ERAD components, including E3 ubiquitin ligases and ubiquitin-conjugating enzymes, to ensure efficient protein degradation and maintain ER homeostasis.\nUbiquitin-Dependent Protein Degradation: Cdc48/p97 participates in the degradation of ubiquitinated proteins in the cytoplasm and nucleus. It collaborates with specific ubiquitin ligases to extract ubiquitinated proteins from cellular structures, protein complexes, or membranes, facilitating their degradation by the proteasome. Cdc48/p97 also plays a role in disassembling protein complexes or aggregates targeted for degradation, promoting the recycling of ubiquitin and preventing the accumulation of toxic protein aggregates.\nCell Cycle Regulation: Cdc48/p97 is involved in various aspects of cell cycle regulation, including mitotic progression, DNA replication, and DNA repair. It participates in the turnover of cell cycle regulators, DNA replication factors, and checkpoint proteins by facilitating their ubiquitin-dependent degradation. Cdc48/p97-mediated protein degradation ensures proper cell cycle progression and maintenance of genomic integrity.\nProtein Quality Control and Stress Response: Cdc48/p97 contributes to protein quality control and stress response pathways by eliminating misfolded, damaged, or aggregated proteins. It collaborates with molecular chaperones, proteases, and other protein quality control factors to recognize, extract, and degrade aberrant proteins, thereby maintaining cellular homeostasis and viability under stress conditions.\nMembrane Dynamics and Vesicle Trafficking: Cdc48/p97 participates in membrane dynamics, vesicle trafficking, and organelle biogenesis by regulating the turnover of membrane-associated proteins and lipid-modifying enzymes. It mediates the extraction and degradation of membrane proteins involved in membrane fusion, vesicle formation, and organelle assembly, contributing to the maintenance of cellular membrane integrity and function."
  },
  {
    "objectID": "chapters/week2.html#degradation-by-the-proteasome",
    "href": "chapters/week2.html#degradation-by-the-proteasome",
    "title": "2  Ubiquitin Proteasome System",
    "section": "2.4 Degradation by the Proteasome",
    "text": "2.4 Degradation by the Proteasome\n\n\n\n\n\nStructure of the Proteasome\n\n\n\n\nThe proteasome, a critical component of cellular protein degradation machinery, is a large, multi-subunit protease complex found within eukaryotic cells. It plays a fundamental role in maintaining cellular homeostasis by selectively degrading proteins marked for destruction by ubiquitin. Structurally, the proteasome consists of a core particle, known as the 20S proteasome, which serves as the central catalytic unit responsible for protein degradation. This cylindrical core particle comprises four stacked rings, with two outer rings composed of seven α subunits each and two inner rings made up of seven β subunits each.\nEach β subunit within the 20S proteasome possesses catalytic activity, allowing the proteasome to cleave peptide bonds within target proteins. The β subunits are categorized into three distinct types: β1, β2, and β5, each exhibiting specific peptidase activities. The β1 subunits display caspase-like activity, cleaving after acidic residues; the β2 subunits exhibit trypsin-like activity, cleaving after basic residues; and the β5 subunits demonstrate chymotrypsin-like activity, cleaving after hydrophobic residues.\nProteins targeted for degradation are tagged with a small protein called ubiquitin, marking them for recognition and processing by the proteasome. The recognition and degradation of ubiquitinated proteins involve a complex series of events coordinated by various cellular components, including E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases. Once recognized, ubiquitinated proteins are unfolded and translocated into the central chamber of the 20S proteasome, where they undergo proteolytic degradation into short peptide fragments.\n\n2.4.1 Multiple Myeloma and Proteasome Inhibitor\n\n\n\n\n\nInhibitors of the Proteasome and Multiple Myeloma\n\n\n\n\nMultiple myeloma is a kind of cancer of the plasma cells. One’s risk of developing multiple myeloma increases as they become older - most people who have this kind of cancer get diagnosed in their mid-60s.\n\n\n\n\n\nComparison Between a B Cell and a Plasma Cell\n\n\n\n\nSome symptoms of this cancer include:\n\nAnemia (i.e., a shortage of red blood cells) resulting in fatigue\nThrombocytopenia (i.e., a lack of platelets) resulting in easy bleeding and bruising\nLeukopenia (i.e., a lack of white blood cells) resulting in frequent infections\n\n\n\n2.4.2 Aneuploidy and Toxic Stress\n\n\n\n\n\nAneuploidy and Toxic Stress\n\n\n\n\nAneuploidy refers to an abnormal number of chromosomes in a cell, typically resulting from errors in cell division processes such as mitosis or meiosis. This condition leads to cells having either fewer or more chromosomes than the normal diploid number characteristic of the species. Aneuploidy can occur in various organisms, including humans, and it is associated with several health conditions, including developmental disorders and cancer.\nProteotoxic stress, on the other hand, refers to the cellular stress caused by an imbalance in protein homeostasis, leading to the accumulation of misfolded or aggregated proteins. Proteotoxic stress can result from various factors such as environmental stressors, genetic mutations, or disruptions in protein quality control mechanisms. The accumulation of misfolded proteins can overwhelm the cellular protein degradation systems, including the ubiquitin-proteasome system and autophagy pathways, leading to cellular dysfunction and disease.\nAneuploid cells often experience proteotoxic stress due to alterations in gene dosage and expression resulting from chromosome imbalances. The abnormal expression levels of genes encoding chaperones, proteases, and components of the protein degradation machinery can disrupt protein folding, assembly, and turnover processes, contributing to proteotoxic stress in aneuploid cells.\nConversely, proteotoxic stress can also promote aneuploidy by inducing genomic instability and impairing cell division processes. Misfolded or aggregated proteins can interfere with the function of key cellular pathways involved in DNA replication, repair, and chromosome segregation, leading to the accumulation of genetic abnormalities and aneuploidy over time.\n\n\n2.4.3 Problems with Proteasomal Degradation\n\n\n\n\n\nProblems Associated with Proteasomal Degradation\n\n\n\n\n\n\n\nProblems Associated with Proteasomal Degradation\n\n\n\n\nSeveral problems can arise when proteasomal degradation is impaired or dysregulated:\n\nAccumulation of Misfolded or Damaged Proteins: Impaired proteasomal degradation can lead to the accumulation of misfolded or damaged proteins within cells. These proteins may form aggregates or toxic oligomers, disrupting cellular function and contributing to the pathogenesis of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s disease.\nDysregulation of Protein Turnover: Proper protein turnover is essential for maintaining cellular function and responding to dynamic changes in cellular environments. Dysregulation of proteasomal degradation can disrupt protein turnover rates, leading to the accumulation of specific proteins that are not degraded when they should be, or the premature degradation of proteins essential for cellular processes.\nProtein Aggregation and Neurodegeneration: Impaired proteasomal degradation is implicated in the pathogenesis of neurodegenerative diseases characterized by the accumulation of protein aggregates, such as tau tangles in Alzheimer’s disease and α-synuclein aggregates in Parkinson’s disease. The failure to clear these aggregates can lead to neuronal dysfunction and cell death.\nCell Cycle Dysregulation: The proteasome plays a crucial role in regulating cell cycle progression by degrading key cell cycle regulators, such as cyclins and cyclin-dependent kinase inhibitors. Dysregulation of proteasomal degradation can lead to aberrant cell cycle progression, uncontrolled cell proliferation, and genomic instability, contributing to cancer development and progression.\nImmune System Dysfunction: The proteasome is involved in the processing of antigens for presentation on major histocompatibility complex (MHC) molecules, a critical step in the activation of the immune response. Impaired proteasomal degradation can lead to defects in antigen presentation, compromising immune surveillance and response to pathogens.\nDrug Resistance in Cancer: Cancer cells often develop resistance to chemotherapy drugs by upregulating proteasomal activity, leading to increased degradation of anti-cancer proteins. Targeting the proteasome with proteasome inhibitors can overcome drug resistance in some cases by inducing apoptosis in cancer cells.\nAging and Age-Related Diseases: Dysregulation of proteasomal degradation is associated with aging and age-related diseases. As cells age, the efficiency of proteasomal degradation declines, leading to the accumulation of damaged proteins and contributing to the aging process and age-related diseases."
  },
  {
    "objectID": "chapters/week2.html#ups-and-neurodegeneration",
    "href": "chapters/week2.html#ups-and-neurodegeneration",
    "title": "2  Ubiquitin Proteasome System",
    "section": "2.5 UPS and Neurodegeneration",
    "text": "2.5 UPS and Neurodegeneration\n\n\n\n\n\nImpact of Protein Aggregates on the UPS\n\n\n\n\nProtein aggregates, which result from the misfolding and aggregation of proteins, can have significant impacts on the Ubiquitin-Proteasome System (UPS), the primary mechanism responsible for protein degradation in eukaryotic cells. Here are some key impacts of protein aggregates on the UPS:\n\nOverload of the UPS: Protein aggregates can overwhelm the capacity of the UPS, leading to a backlog of ubiquitinated proteins awaiting degradation. The UPS relies on the coordinated action of E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases to tag proteins with ubiquitin for degradation by the proteasome. However, the excessive accumulation of misfolded or aggregated proteins can saturate the UPS, impairing its ability to degrade other cellular proteins.\nInhibition of Proteasomal Activity: Protein aggregates can directly inhibit proteasomal activity by physically obstructing the proteasome’s access to substrate proteins or by interfering with the unfolding and translocation of substrates into the proteasomal core particle. Additionally, certain types of protein aggregates, such as amyloid fibrils, can bind to and sequester proteasomal subunits, further impairing proteasome function.\nInduction of Proteasome Stress: The presence of protein aggregates within cells can induce a cellular stress response known as proteasome stress. Proteasome stress is characterized by the upregulation of genes encoding proteasome subunits, as well as components of the UPS and protein quality control machinery. While proteasome stress initially serves to enhance the cell’s capacity to degrade misfolded proteins, chronic or severe proteasome stress can lead to cellular dysfunction and apoptosis.\nFormation of Resistant Aggregates: Some protein aggregates, particularly those associated with neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, are highly stable and resistant to degradation by the UPS. These aggregates may contain cross-linked or ubiquitinated proteins that are difficult for the proteasome to recognize and process. As a result, the accumulation of resistant protein aggregates can exacerbate proteotoxicity and contribute to disease progression.\nImpairment of Protein Quality Control Pathways: The presence of protein aggregates can impair other protein quality control pathways, such as chaperone-mediated autophagy (CMA) and macroautophagy. While the UPS primarily degrades short-lived and soluble proteins, autophagy pathways are responsible for the degradation of larger protein aggregates and damaged organelles. However, the chronic accumulation of protein aggregates can overwhelm autophagy pathways, further exacerbating proteotoxicity and cellular dysfunction."
  },
  {
    "objectID": "chapters/week3.html",
    "href": "chapters/week3.html",
    "title": "3  Regulating Protein Synthesis",
    "section": "",
    "text": "Outline of the Central Dogma\nThe central dogma of molecular biology is a fundamental principle that describes the flow of genetic information within a biological system, particularly in cells. Proposed by Francis Crick in 1958, the central dogma outlines the sequential processes by which genetic information encoded in DNA is transferred to RNA and eventually translated into proteins. The central dogma can be summarized in three main steps:"
  },
  {
    "objectID": "chapters/week3.html#structure-and-synthesis-of-the-ribosome",
    "href": "chapters/week3.html#structure-and-synthesis-of-the-ribosome",
    "title": "3  Regulating Protein Synthesis",
    "section": "3.1 Structure and Synthesis of the Ribosome",
    "text": "3.1 Structure and Synthesis of the Ribosome\n\n\n\n\n\nDifferences Between Eukaryotic and Prokaryotic Ribosomes\n\n\n\n\nProkaryotic ribosomes are composed of two subunits: a large 50S subunit and a small 30S subunit, which together form the 70S ribosome. The 70S ribosome is the site of protein synthesis in prokaryotic cells. Prokaryotic ribosomes are smaller than eukaryotic ribosomes, with the 50S subunit having a sedimentation coefficient of 50S and the 30S subunit having a sedimentation coefficient of 30S. They contain ribosomal RNA (rRNA) and protein components, with the 50S subunit containing 23S and 5S rRNA molecules, and the 30S subunit containing 16S rRNA.\nEukaryotic ribosomes are larger and more complex than prokaryotic ribosomes, consisting of a large 60S subunit and a small 40S subunit, which together form the 80S ribosome. The 80S ribosome is the site of protein synthesis in eukaryotic cells. Eukaryotic ribosomes are larger than prokaryotic ribosomes, with the 60S subunit having a sedimentation coefficient of 60S and the 40S subunit having a sedimentation coefficient of 40S. They also contain rRNA and protein components, with the 60S subunit containing 28S, 5.8S, and 5S rRNA molecules, and the 40S subunit containing 18S rRNA.\n\n3.1.1 Ribosome Synthesis\n\n\n\n\n\nRibosome Synthesis Outline\n\n\n\n\nRibosome synthesis primarily occurs within the nucleolus, a distinct subcompartment of the cell nucleus responsible for ribosome biogenesis. The nucleolus is the site where ribosomal RNA (rRNA) transcription, processing, and assembly with ribosomal proteins take place, leading to the formation of functional ribosomes. Here’s an overview of ribosome synthesis in the nucleolus:\n\nrRNA Transcription: The process of ribosome synthesis begins with the transcription of rRNA genes by RNA polymerase I (Pol I) within the nucleolus. These rRNA genes are organized into tandem repeats known as nucleolar organizer regions (NORs) located on specific chromosomes. The transcription of rRNA genes generates a large precursor molecule called pre-rRNA.\nPre-rRNA Processing: The pre-rRNA transcript undergoes extensive processing to generate mature rRNAs, including the 18S, 5.8S, and 28S rRNAs found in eukaryotic ribosomes. Processing involves the removal of spacer sequences and the cleavage of pre-rRNA intermediates by a complex machinery of small nucleolar ribonucleoproteins (snoRNPs) and endonucleases. This processing occurs in distinct subcompartments of the nucleolus, known as the fibrillar center and the dense fibrillar component.\nAssembly of Ribosomal Subunits: Once processed, the mature rRNAs associate with ribosomal proteins to form the small (40S) and large (60S) ribosomal subunits. The assembly of ribosomal subunits occurs in a stepwise manner, involving the coordinated binding of ribosomal proteins to specific regions of the rRNA molecules. The nucleolus provides the necessary environment and factors for efficient assembly, ensuring the proper folding and stability of the ribosomal subunits.\nExport of Ribosomal Subunits: After assembly, the mature ribosomal subunits are exported from the nucleolus to the cytoplasm, where they participate in protein synthesis. This export process involves the recognition of specific export signals within the ribosomal subunits by nuclear export receptors and the translocation of ribosomal subunits through nuclear pores. Once in the cytoplasm, the small and large ribosomal subunits associate with messenger RNA (mRNA) and transfer RNA (tRNA) molecules to form functional ribosomes capable of protein synthesis.\n\n\n\n3.1.2 RNA Binding Sites\n\n\n\n\n\nThe Four RNA Binding Sites\n\n\n\n\nRibosomes possess three primary binding sites crucial for the translation process: the A (Aminoacyl) site, the P (Peptidyl) site, and the E (Exit) site. These sites facilitate the interaction between mRNA, tRNA, and ribosomal subunits during protein synthesis. In the A site, incoming aminoacyl-tRNA molecules bearing amino acids align with the mRNA codon, ensuring the correct addition of amino acids to the growing polypeptide chain. The P site harbors the peptidyl-tRNA, where the nascent polypeptide chain is elongated by the addition of amino acids. Finally, the E site accommodates the exit of deacylated tRNA molecules following peptide bond formation, enabling the recycling of tRNA for subsequent rounds of translation.\nTranslation proceeds through four main steps: initiation, elongation, termination, and ribosome recycling. During initiation, the small ribosomal subunit binds to the mRNA molecule at the start codon, guided by initiation factors and the initiator tRNA. Following initiation, the large ribosomal subunit joins the complex, forming the functional ribosome ready for protein synthesis. In the elongation phase, aminoacyl-tRNA molecules enter the A site, and peptide bond formation occurs between the amino acids carried by the tRNAs in the A and P sites. The ribosome moves along the mRNA in a 5’ to 3’ direction, synthesizing the polypeptide chain one amino acid at a time.\nTermination occurs when the ribosome encounters a stop codon (UAA, UAG, or UGA) on the mRNA. Release factors bind to the A site, promoting the hydrolysis of the bond between the completed polypeptide chain and the tRNA in the P site. This leads to the release of the polypeptide chain from the ribosome and the dissociation of the ribosomal subunits from the mRNA. Finally, in the ribosome recycling phase, ribosome recycling factors facilitate the disassembly of the ribosome complex, allowing the small and large subunits to be reused for subsequent rounds of translation. This cycle ensures the continuous synthesis of proteins in the cell, crucial for various cellular functions and processes."
  },
  {
    "objectID": "chapters/week3.html#initiating-translation",
    "href": "chapters/week3.html#initiating-translation",
    "title": "3  Regulating Protein Synthesis",
    "section": "3.2 Initiating Translation",
    "text": "3.2 Initiating Translation\n\n\n\n\n\nDepiction of the Shine-Dalgarno Sequence\n\n\n\n\nIn prokaryotes, the Shine-Dalgarno sequence is a conserved nucleotide sequence found in the mRNA, typically positioned upstream of the start codon (AUG) within the ribosome binding site (RBS). The Shine-Dalgarno sequence facilitates the recognition and binding of the mRNA by the small ribosomal subunit during the initiation of translation.\nThe Shine-Dalgarno sequence is characterized by the presence of a purine-rich region, often containing the consensus sequence AGGAGG. This sequence is complementary to a region of the 16S ribosomal RNA (rRNA) found in the small ribosomal subunit. The interaction between the Shine-Dalgarno sequence in the mRNA and the complementary sequence in the 16S rRNA helps position the ribosome correctly on the mRNA, ensuring accurate initiation of protein synthesis.\nDuring translation initiation in prokaryotes, the small ribosomal subunit, along with initiation factors, recognizes and binds to the Shine-Dalgarno sequence on the mRNA. This binding facilitates the scanning of the mRNA by the ribosome until it reaches the start codon (usually AUG). Once the start codon is encountered, the large ribosomal subunit joins the complex, and protein synthesis proceeds along the mRNA.\n\n3.2.1 Initiation Factors in Bacteria\n\n\n\n\n\nSome Bacterial Initiation Factors\n\n\n\n\nIn bacterial translation initiation, several initiation factors play critical roles in orchestrating the assembly of the translation initiation complex and ensuring accurate start codon recognition. Two key initiation factors in bacteria are IF1 and IF3, which prevent premature association of the large 50S ribosomal subunit with the small 30S subunit, thereby promoting the formation of the initiation complex on the mRNA.\n\nIF1: IF1 is an initiation factor that helps prevent the premature binding of the 50S ribosomal subunit to the 30S subunit, ensuring that translation initiation occurs accurately at the start codon. IF1 also stabilizes the 30S subunit and helps maintain its integrity during the initiation process.\nIF3: IF3 is another initiation factor that contributes to the fidelity of translation initiation by preventing the association of the 50S subunit with the 30S subunit until the initiation complex is properly assembled on the mRNA. IF3 also helps dissociate ribosomes at the termination of translation.\n\nIn addition to IF1 and IF3, IF2 is a critical initiation factor responsible for delivering the initiator tRNA (fMet-tRNAfMet) to the ribosomal complex during translation initiation. IF2 is a GTPase, meaning it hydrolyzes GTP to GDP during its function in the initiation process. The binding of IF2-GTP to the initiator tRNA stabilizes its interaction with the 30S ribosomal subunit and helps position it correctly within the ribosomal P site, ensuring accurate start codon recognition and initiation of protein synthesis.\n\n\n3.2.2 In Eukaryotes\n\n\n\n\n\nInitiating Translation in Eukaryotes\n\n\n\n\nHere’s an overview of the key steps involved in translation initiation in eukaryotic cells:\n\nRecognition of the 5’ Cap Structure: Translation initiation in eukaryotes begins with the recognition of the 5’ cap structure present at the 5’ end of the mRNA molecule. The 5’ cap is recognized by the eukaryotic initiation factor 4E (eIF4E), which forms part of the eIF4F complex along with eIF4A (helicase) and eIF4G (scaffolding protein).\nRecruitment of the 40S Ribosomal Subunit: The eIF4F complex, bound to the 5’ cap structure, recruits the 40S small ribosomal subunit. This recruitment is facilitated by the interaction between eIF4G and the poly(A)-binding protein (PABP) bound to the poly(A) tail of the mRNA, forming a closed-loop structure that enhances translation efficiency.\nScanning for the Start Codon: The 40S subunit, together with initiation factors (eIF1, eIF1A, and eIF3), scans along the mRNA in a 5’ to 3’ direction until it encounters the start codon (AUG) within a favorable Kozak sequence context. The Kozak sequence (consensus sequence: GCCRCCAUGG) surrounding the start codon helps ensure accurate start codon recognition.\nInitiator tRNA Binding: Upon recognition of the start codon, the initiator tRNA (Met-tRNAiMet) bound to eukaryotic initiation factor 2 (eIF2) and GTP forms a ternary complex. This ternary complex is then recruited to the ribosome, where it base pairs with the start codon in the mRNA.\nAssembly of the 80S Initiation Complex: Once the initiator tRNA is properly positioned at the start codon, GTP bound to eIF2 is hydrolyzed to GDP and Pi, resulting in the release of eIF2-GDP from the ribosome. The 60S large ribosomal subunit then joins the 40S subunit to form the 80S initiation complex, with the initiator tRNA occupying the P site of the ribosome.\nInitiation Factor Dissociation and Start of Elongation: Following the assembly of the 80S initiation complex, initiation factors eIF1, eIF1A, and eIF3 are released from the ribosome, allowing for the start of elongation. Elongation factors, along with charged tRNAs and GTP, facilitate the stepwise addition of amino acids to the growing polypeptide chain.\n\n\n\n3.2.3 5’ UTR in Eukaryotes\n\n\n\n\n\nIllustration of the 5’ UTR in Eukaryotes\n\n\n\n\nIn eukaryotic translation initiation, the 5’ untranslated region (5’ UTR) of mRNA plays a crucial role in directing ribosomes to the correct start codon for protein synthesis. The process of 5’ UTR scanning involves the stepwise movement of ribosomes along the 5’ UTR until they identify and initiate translation at the appropriate start codon. Here’s how 5’ UTR scanning occurs in eukaryotes:\n\nRecognition of the 5’ Cap Structure: Translation initiation begins with the recognition of the 5’ cap structure present at the 5’ end of the mRNA molecule. The 5’ cap consists of a modified guanosine nucleotide (7-methylguanosine) added during mRNA transcription. The cap structure is recognized by eukaryotic initiation factors (eIFs), particularly eIF4E, which is a component of the eIF4F complex.\nRecruitment of the 43S Pre-initiation Complex: The eIF4F complex, bound to the 5’ cap structure, recruits the 43S pre-initiation complex, which comprises the 40S small ribosomal subunit, eIF3, eIF1, eIF1A, and the ternary complex consisting of initiator tRNA (Met-tRNAiMet) and eIF2-GTP (eukaryotic initiation factor 2 bound to guanosine triphosphate).\nScanning of the 5’ UTR: The 43S pre-initiation complex, guided by eIF4F, scans along the 5’ UTR of the mRNA in a 5’ to 3’ direction. The scanning process is facilitated by the interaction between eIF4G, a component of the eIF4F complex, and the poly(A)-binding protein (PABP) bound to the poly(A) tail of the mRNA. This interaction helps maintain the circular structure of the mRNA, allowing the ribosome to scan efficiently.\nRecognition of the Start Codon: As the 43S pre-initiation complex scans along the 5’ UTR, it encounters the start codon (AUG) embedded within the Kozak consensus sequence. The Kozak sequence (GCC(A/G)CCAUGG) surrounding the start codon helps facilitate accurate start codon recognition by the ribosome.\nFormation of the 48S Initiation Complex: Upon recognition of the start codon, base pairing occurs between the initiator tRNA (Met-tRNAiMet) and the start codon. GTP bound to eIF2 is hydrolyzed to GDP and Pi, leading to the release of eIF2-GDP and other initiation factors. The 60S large ribosomal subunit then joins the 40S subunit to form the 80S initiation complex, ready for translation elongation.\n\n\n\n3.2.4 Prokaryotic and Eukaryotic mRNA\n\n\n\n\n\nDifferent Kinds of mRNA\n\n\n\n\nProkaryotic and eukaryotic mRNA serve as intermediaries between DNA and protein synthesis, yet they exhibit notable differences in structure, processing, and regulation. Prokaryotic mRNA tends to have a simpler structure, lacking extensive post-transcriptional modifications commonly found in eukaryotic mRNA. In prokaryotes, mRNA molecules are often polycistronic, capable of encoding multiple proteins within a single transcript. Conversely, eukaryotic mRNA is typically monocistronic, encoding only one protein per transcript, adding to the complexity of gene expression regulation.\nEukaryotic mRNA undergoes comprehensive post-transcriptional processing, including 5’ capping, splicing, and polyadenylation, which stabilize the molecule and optimize translation initiation. This processing ensures the production of mature mRNA molecules ready for efficient translation. In contrast, prokaryotic mRNA generally lacks such extensive post-transcriptional modifications, being synthesized as mature transcripts directly by RNA polymerase.\nRegulatory mechanisms governing mRNA expression differ significantly between prokaryotes and eukaryotes. In eukaryotic cells, gene expression is tightly regulated at various levels, including chromatin remodeling, transcription initiation, mRNA processing, nuclear export, and mRNA stability. Prokaryotic gene expression, on the other hand, primarily occurs at the transcriptional level, although regulatory RNA elements and proteins can also modulate mRNA stability and translation efficiency.\nProkaryotic mRNA features a Shine-Dalgarno sequence upstream of the start codon, facilitating ribosome binding and translation initiation. In contrast, eukaryotic mRNA lacks a Shine-Dalgarno sequence and relies on the recognition of the 5’ cap structure by initiation factors to initiate translation. The ribosome then scans along the 5’ untranslated region until it encounters the start codon."
  },
  {
    "objectID": "chapters/week3.html#regulating-translation-initiation",
    "href": "chapters/week3.html#regulating-translation-initiation",
    "title": "3  Regulating Protein Synthesis",
    "section": "3.3 Regulating Translation Initiation",
    "text": "3.3 Regulating Translation Initiation\n\n\n\n\n\nmTORC1 Phosphorylating eIF4E-Binding Protein\n\n\n\n\nThe phosphorylation of eIF4E-binding proteins (4E-BPs) by the mechanistic target of rapamycin complex 1 (mTORC1) is a critical regulatory event in the control of protein synthesis in eukaryotic cells. 4E-BPs are a family of proteins that bind to eIF4E, preventing its interaction with the mRNA 5’ cap structure and thereby inhibiting translation initiation. Here’s an overview of how mTORC1 regulates protein synthesis through the phosphorylation of 4E-BPs:\n\nmTORC1 Activation: The mechanistic target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth and metabolism that integrates various signals, including growth factors, nutrients, energy status, and stress, to control protein synthesis and cell proliferation. When activated, mTORC1 phosphorylates downstream targets involved in protein synthesis, including 4E-BPs.\nPhosphorylation of 4E-BPs: In response to favorable growth conditions and signaling cues, mTORC1 phosphorylates 4E-BPs at multiple serine and threonine residues. Phosphorylation of 4E-BPs induces a conformational change that reduces their affinity for eIF4E, allowing eIF4E to interact with eIF4G and other initiation factors to form the eIF4F complex. The eIF4F complex then associates with the mRNA 5’ cap structure, promoting translation initiation.\nRelease of eIF4E: Upon phosphorylation by mTORC1, 4E-BPs dissociate from eIF4E, freeing eIF4E to participate in the assembly of the translation initiation complex. By releasing eIF4E from its inhibitory interaction with 4E-BPs, mTORC1 activation promotes the recruitment of ribosomes to mRNA transcripts and enhances protein synthesis rates.\nRegulation of Gene Expression: The phosphorylation of 4E-BPs by mTORC1 represents a key regulatory mechanism that controls the translation of specific mRNAs involved in cell growth, proliferation, and metabolism. By modulating the activity of 4E-BPs, mTORC1 fine-tunes the translational output of cells in response to extracellular signals and nutrient availability, ensuring efficient protein synthesis under conditions favorable for cell growth and survival.\n\n\n3.3.1 eIF2 Cycle\n\n\n\n\n\nCycle of eIF2\n\n\n\n\nThe eukaryotic translation initiation factor 2 (eIF2) cycle is a fundamental process in protein synthesis regulation, controlling the initiation of translation in response to various cellular stresses and environmental cues. Here’s an overview of the eIF2 cycle:\n\nGTP-bound eIF2 Complex Formation: In its inactive state, eIF2 is bound to guanosine triphosphate (GTP) and forms a complex with initiator tRNA (Met-tRNAiMet), termed the ternary complex (eIF2-GTP-Met-tRNAiMet). This ternary complex plays a crucial role in delivering the initiator tRNA to the ribosome during translation initiation.\nRecognition of Start Codon: The eIF2-GTP-Met-tRNAiMet complex associates with the small ribosomal subunit (40S) and scans the mRNA transcript for the start codon (AUG). Once the start codon is recognized, the ternary complex positions the initiator tRNA at the ribosomal P site, ready to initiate translation.\nGTP Hydrolysis: Upon accurate recognition of the start codon, GTP bound to eIF2 is hydrolyzed to guanosine diphosphate (GDP) and inorganic phosphate (Pi) by the GTPase activity of eIF2. This hydrolysis reaction is facilitated by eIF5, a GTPase-activating protein (GAP) that stimulates the intrinsic GTPase activity of eIF2.\nRelease of eIF2-GDP: Following GTP hydrolysis, eIF2-GDP is released from the ribosome and recycled back to its active form through the exchange of GDP for GTP. This exchange is catalyzed by eIF2B, a guanine nucleotide exchange factor (GEF) that promotes the reactivation of eIF2 by loading GTP onto eIF2, allowing it to participate in subsequent rounds of translation initiation.\nRegulation by Phosphorylation: The activity of eIF2 is tightly regulated by phosphorylation of its α-subunit at a conserved serine residue (Ser51) by specific kinases in response to various stress signals. Phosphorylation of eIF2α inhibits the guanine nucleotide exchange activity of eIF2B, leading to a decrease in the formation of active eIF2-GTP complexes and a consequent reduction in global protein synthesis rates. This integrated stress response (ISR) helps cells adapt to adverse conditions by conserving energy and resources.\n\n\n3.3.1.1 Inactivating eIF2\n\n\n\n\n\nHow eIF2 Can be Inactivated\n\n\n\n\nThe inactivation of eukaryotic translation initiation factor 2B (eIF2B) by phosphorylated eIF2 is a key regulatory mechanism in the integrated stress response (ISR) pathway. eIF2B is a guanine nucleotide exchange factor (GEF) responsible for catalyzing the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) on eukaryotic translation initiation factor 2 (eIF2), thereby promoting the formation of the active eIF2-GTP ternary complex essential for translation initiation. Here’s how the inactivation process occurs:\n\nPhosphorylation of eIF2: In response to various stress stimuli such as amino acid deprivation, viral infection, endoplasmic reticulum (ER) stress, or oxidative stress, specific kinases phosphorylate the alpha subunit of eIF2 (eIF2α) at a conserved serine residue (Ser51). These kinases include protein kinase R (PKR), heme-regulated inhibitor kinase (HRI), PKR-like endoplasmic reticulum kinase (PERK), and general control non-derepressible 2 (GCN2). Phosphorylation of eIF2α at Ser51 inhibits the GDP-GTP exchange activity of eIF2B, leading to the sequestration of eIF2 in its inactive GDP-bound form.\nAttenuation of Guanine Nucleotide Exchange Activity: Phosphorylated eIF2 (eIF2α-P) binds tightly to eIF2B, resulting in the sequestration and inhibition of eIF2B’s guanine nucleotide exchange activity. As a consequence, the recycling of eIF2-GDP to its active GTP-bound form is impaired, leading to a reduction in the levels of the active eIF2-GTP ternary complex available for translation initiation.\nGlobal Attenuation of Protein Synthesis: The inhibition of eIF2B by phosphorylated eIF2 results in a general attenuation of protein synthesis rates in the cell. Translation initiation is hindered due to the reduced availability of the active eIF2-GTP ternary complex, which is essential for the formation of the pre-initiation complex and the recruitment of ribosomes to mRNA transcripts.\nInduction of Stress-Responsive Gene Expression: The reduction in global protein synthesis rates during the ISR is coupled with the selective translation of specific stress-responsive mRNAs encoding proteins involved in adaptive cellular processes. This selective translational control allows cells to conserve energy and resources while prioritizing the synthesis of proteins required for stress adaptation and survival.\n\n\n\n\n3.3.2 Integrated Stress Response\n\n\n\n\n\nIntegrated Stress Response Depictions\n\n\n\n\nThe integrated stress response (ISR) is a conserved cellular signaling pathway that coordinates adaptive responses to various environmental stresses and perturbations. It serves as a crucial mechanism for maintaining cellular homeostasis and promoting cell survival under adverse conditions. Here’s an overview of the integrated stress response:\n\nInitiation of the Integrated Stress Response: The ISR is initiated by the phosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α) at a conserved serine residue (Ser51) in response to diverse stress stimuli. Several stress-responsive protein kinases, including protein kinase R (PKR), heme-regulated inhibitor kinase (HRI), PKR-like endoplasmic reticulum kinase (PERK), and general control non-derepressible 2 (GCN2), phosphorylate eIF2α in a context-specific manner.\nGlobal Attenuation of Protein Synthesis: Phosphorylation of eIF2α inhibits the guanine nucleotide exchange activity of eIF2B, leading to a reduction in the formation of the active eIF2-GTP ternary complex required for translation initiation. As a result, global protein synthesis rates are attenuated, conserving cellular resources and energy during stress conditions.\nSelective Translation of Stress-Responsive mRNAs: Despite the general inhibition of protein synthesis, the ISR promotes the selective translation of a subset of mRNAs encoding stress-responsive proteins involved in adaptive cellular processes. These mRNAs often contain upstream open reading frames (uORFs) or specific regulatory elements in their untranslated regions (UTRs) that confer sensitivity to eIF2α phosphorylation and enable preferential translation under stress conditions.\nInduction of Stress-Responsive Genes: Activation of the ISR leads to the transcriptional upregulation of stress-responsive genes through the activation of transcription factors such as ATF4 (activating transcription factor 4). ATF4 induces the expression of genes involved in amino acid metabolism, redox regulation, autophagy, and apoptosis, facilitating cellular adaptation and survival in response to stress.\nIntegration with Other Signaling Pathways: The ISR is integrated with other stress signaling pathways, including the unfolded protein response (UPR), oxidative stress response, and DNA damage response, to coordinate cellular stress responses and maintain homeostasis. Crosstalk between these pathways allows cells to mount appropriate adaptive responses tailored to specific stressors and environmental cues."
  },
  {
    "objectID": "chapters/week3.html#elongating-translation",
    "href": "chapters/week3.html#elongating-translation",
    "title": "3  Regulating Protein Synthesis",
    "section": "3.4 Elongating Translation",
    "text": "3.4 Elongating Translation\n\n\n\n\n\nElongating Translation via Eukaryotes\n\n\n\n\nEukaryotic translation elongation is the stage of protein synthesis where amino acids are added to the growing polypeptide chain according to the sequence encoded by the mRNA. It involves the movement of ribosomes along the mRNA template, decoding successive codons, and facilitating the transfer of amino acids from charged tRNAs to the growing peptide chain. Here’s an overview of eukaryotic translation elongation:\n\nRibosome Movement: Once the ribosome is assembled on the mRNA and the initiator tRNA is positioned at the start codon (AUG), elongation begins with the binding of the second aminoacyl-tRNA to the A site of the ribosome. The ribosome then translocates along the mRNA in a 5’ to 3’ direction, shifting the peptidyl-tRNA from the A site to the P site and making space for the next incoming aminoacyl-tRNA.\nCodon Recognition and Peptide Bond Formation: During each cycle of elongation, the ribosome decodes the mRNA by recognizing the next codon in the A site. Aminoacyl-tRNAs carrying the corresponding amino acids bind to the A site through complementary base pairing between the anticodon of the tRNA and the mRNA codon. Peptide bond formation then occurs between the amino acid carried by the peptidyl-tRNA in the P site and the amino acid carried by the aminoacyl-tRNA in the A site, catalyzed by peptidyl transferase activity in the ribosome.\nTranslocation: After peptide bond formation (which is formed via a nucleophilic attack by the N-terminus of an amino acid to the center carbon), the ribosome undergoes a translocation step, facilitated by elongation factor EF-G (eEF2 in eukaryotes) and GTP hydrolysis. This translocation process moves the ribosome along the mRNA by one codon, shifting the peptidyl-tRNA from the A site to the P site and the deacylated tRNA from the P site to the E (exit) site. The mRNA and the newly formed peptidyl-tRNA now occupy the A site, ready for the next cycle of elongation.\nElongation Factors: Elongation factors play critical roles in facilitating the elongation process. In addition to EF-G, eukaryotic elongation factors include eEF1A, which delivers aminoacyl-tRNAs to the ribosome, and eEF1B, which promotes the binding of aminoacyl-tRNAs to eEF1A. These factors help ensure the accurate and efficient addition of amino acids to the growing polypeptide chain.\nTermination: Elongation continues until a stop codon (UAA, UAG, or UGA) is encountered in the A site of the ribosome. Termination factors, such as eRF1 and eRF3 in eukaryotes, recognize the stop codon and promote the release of the completed polypeptide chain from the ribosome. The ribosome dissociates into its subunits, and the newly synthesized protein is released into the cytoplasm for further processing or folding.\n\n\n3.4.1 tRNA Charging\n\n\n\n\n\ntRNA Charging\n\n\n\n\ntRNA charging, also known as tRNA aminoacylation, is a crucial step in protein synthesis where specific amino acids are covalently attached to their corresponding transfer RNA (tRNA) molecules by aminoacyl-tRNA synthetases (aaRSs). This process ensures that the correct amino acid is delivered to the ribosome during translation. Here’s an overview of tRNA charging by aminoacyl-tRNA synthetases:\n\nRecognition of Amino Acids: Each aminoacyl-tRNA synthetase is specific to a particular amino acid. Before aminoacylation, the amino acid to be attached to the tRNA is first recognized and selected by the corresponding aminoacyl-tRNA synthetase. This recognition process involves the binding of the amino acid to a specific binding pocket within the active site of the synthetase enzyme.\nAminoacylation Reaction: Once the correct amino acid is bound to the synthetase enzyme, the aminoacylation reaction occurs. The enzyme catalyzes the transfer of the amino acid to the 3’ end of the appropriate tRNA molecule, forming an aminoacyl-tRNA complex. This reaction is driven by the hydrolysis of ATP, which provides the energy required for the formation of the high-energy aminoacyl-AMP intermediate.\nSpecificity Determinants: Aminoacyl-tRNA synthetases possess mechanisms to ensure the fidelity and accuracy of tRNA charging. These enzymes contain specific recognition sites that interact with both the amino acid and the tRNA molecule, allowing them to distinguish between correct and incorrect substrates. The accuracy of tRNA charging is critical for maintaining the fidelity of protein synthesis and preventing errors in translation.\nProofreading and Editing: Despite the high specificity of aminoacyl-tRNA synthetases, errors in tRNA charging can still occur. To minimize errors, some synthetases have proofreading or editing mechanisms that hydrolyze incorrectly charged aminoacyl-tRNA complexes. These editing activities help to correct mischarged tRNAs and maintain the integrity of the translation process.\nRole in Protein Synthesis: Once aminoacylated, the charged tRNA molecules serve as adapters between the mRNA codons and the corresponding amino acids during translation elongation. Each tRNA molecule carries a specific amino acid attached to its 3’ end and contains an anticodon sequence that base-pairs with the complementary mRNA codon. This ensures that the correct amino acid is incorporated into the growing polypeptide chain according to the genetic code.\n\n\n3.4.1.1 eEF1A\n\n\n\n\n\neEF1A Delivering Aminoacyl-tRNAs\n\n\n\n\nEukaryotic elongation factor 1A (eEF1A) plays a crucial role in protein synthesis by delivering aminoacyl-tRNA (aa-tRNA) molecules to the ribosome during the elongation phase of translation. Here’s how eEF1A facilitates the delivery of aminoacyl-tRNAs:\n\nBinding to Aminoacyl-tRNA (aa-tRNA): eEF1A binds to aminoacyl-tRNA molecules in a GTP-dependent manner. Each eEF1A molecule forms a complex with a single aa-tRNA, where the amino acid is attached to the 3’ end of the tRNA molecule. This binding occurs at the ribosomal A (aminoacyl) site during the elongation phase of translation.\nGTP Hydrolysis: The binding of eEF1A to aa-tRNA is accompanied by the hydrolysis of GTP bound to eEF1A. GTP hydrolysis triggers a conformational change in eEF1A, promoting the release of GDP and inorganic phosphate (Pi) from the protein. This conformational change is essential for the efficient delivery of aa-tRNA to the ribosome.\nDelivery to the Ribosome: Once eEF1A is bound to aa-tRNA and GTP is hydrolyzed, the eEF1A-aa-tRNA complex undergoes a structural rearrangement that allows it to interact with the ribosome. eEF1A delivers the aa-tRNA to the ribosomal A site, where the anticodon of the tRNA base-pairs with the complementary mRNA codon.\nTranslocation and Peptide Bond Formation: After the aa-tRNA is delivered to the ribosome, the ribosome catalyzes the formation of a peptide bond between the amino acid carried by the aa-tRNA in the A site and the growing polypeptide chain attached to the peptidyl-tRNA in the P (peptidyl) site. This process is facilitated by elongation factors and ribosomal RNA (rRNA) within the ribosomal complex.\nGDP Dissociation and Recycling: Following peptide bond formation, eEF1A dissociates from the ribosome, releasing GDP from its active site. The released GDP is then exchanged for GTP by guanine nucleotide exchange factors (GEFs), such as eEF1B, regenerating the active form of eEF1A and allowing it to participate in subsequent rounds of aa-tRNA delivery.\n\n\n\n\n3.4.2 Elongation by eEF2\n\n\n\n\n\neEF2 Promoting Translation Elongation\n\n\n\n\nEukaryotic elongation factor 2 (eEF2) is a GTPase protein that facilitates translocation by promoting the movement of the ribosome along the mRNA template. Here’s how eEF2 mediates translocation:\n\nRibosome Movement: After the formation of the peptide bond between the amino acid attached to the tRNA in the A site and the growing polypeptide chain on the tRNA in the P site, the ribosome needs to shift to the next codon on the mRNA template to continue elongation.\nGTP Binding and Hydrolysis: eEF2 binds to the ribosome in a GTP-bound form. GTP hydrolysis by eEF2 is coupled with the translocation process. The hydrolysis of GTP into GDP and inorganic phosphate (Pi) provides the energy necessary for ribosome movement along the mRNA.\nRibosome Translocation: Upon GTP hydrolysis, eEF2 undergoes a conformational change, which results in the movement of the ribosome along the mRNA in a 5’ to 3’ direction. This translocation step shifts the peptidyl-tRNA from the A site to the P site, and the deacylated tRNA from the P site to the E (exit) site of the ribosome.\nGDP Release and Recycling: After translocation, eEF2-GDP is released from the ribosome, and GDP is exchanged for GTP by guanine nucleotide exchange factors (GEFs), such as eEF2B. The recycling of eEF2 to its active GTP-bound form allows it to participate in subsequent rounds of translocation during translation elongation.\nAccuracy and Efficiency: The translocation process facilitated by eEF2 is essential for the accurate and efficient synthesis of proteins. It ensures that the ribosome moves along the mRNA in a stepwise manner, decoding each codon and adding the corresponding amino acid to the growing polypeptide chain.\n\n\n\n3.4.3 Profiling\n\n3.4.3.1 Polysomes\n\n\n\n\n\nSteps Involved in Polysome Profiling\n\n\n\n\nPolysome profiling is a technique used to analyze the translational activity of mRNA molecules within cells. It involves subjecting cell lysates to centrifugation in a sucrose density gradient, which separates ribosomes and associated mRNA molecules based on their sedimentation rates. Polysomes, which consist of multiple ribosomes translating a single mRNA molecule, sediment at higher sucrose densities, while free ribosomes and untranslated mRNA sediment at lower densities.\nBy analyzing the distribution of ribosomes and mRNA along the gradient, polysome profiling provides valuable information about the efficiency of translation and the regulation of gene expression at the level of mRNA translation. This technique is widely used in molecular biology and cell biology research to study translational control mechanisms, cellular responses to stress, and changes in gene expression under different physiological conditions.\n\n\n3.4.3.2 Ribosome Profiling\n\n\n\n\n\nSteps Involved in Ribosome Profiling\n\n\n\n\nRibosome profiling, also known as ribosome footprinting or ribo-seq, is a powerful technique used to study the global landscape of translation at a genome-wide level. It involves the deep sequencing of ribosome-protected mRNA fragments (ribosome footprints) to identify the positions of ribosomes along mRNA molecules. The technique begins by treating cells with a translation inhibitor to arrest ribosomes at specific positions on mRNA transcripts. Subsequently, ribosomes are digested away, leaving behind ribosome-protected mRNA fragments. These fragments are then isolated, converted into cDNA libraries, and sequenced using high-throughput sequencing technologies.\nRibosome profiling provides detailed information about the density and position of ribosomes on mRNAs, allowing researchers to determine which mRNAs are actively translated, the efficiency of translation, and the locations of translation initiation and termination."
  },
  {
    "objectID": "chapters/week3.html#terminating-translation",
    "href": "chapters/week3.html#terminating-translation",
    "title": "3  Regulating Protein Synthesis",
    "section": "3.5 Terminating Translation",
    "text": "3.5 Terminating Translation\n\n\n\n\n\neRF1 and eRF3 Terminating Translation\n\n\n\n\nAt the termination stage of translation, eukaryotic release factor 1 (eRF1) and eukaryotic release factor 3 (eRF3) play crucial roles in recognizing and facilitating the termination of protein synthesis at stop codons. Here’s how they function at the stop codon:\n\nRecognition of Stop Codon: As the ribosome moves along the mRNA during translation elongation, it encounters stop codons (UAA, UAG, or UGA) that signal the end of protein synthesis. When a stop codon enters the ribosomal A (aminoacyl) site, it does not code for an amino acid but instead signals the termination of translation.\nRole of eRF1: eRF1 is responsible for recognizing stop codons and promoting the release of the nascent polypeptide chain from the ribosome. It binds to the stop codon in the A site of the ribosome, mimicking the structure of a tRNA molecule. However, instead of carrying an amino acid, eRF1 triggers the hydrolysis of the ester bond between the nascent polypeptide chain and the tRNA molecule in the P (peptidyl) site, resulting in the release of the polypeptide from the ribosome.\nInteraction with eRF3: eRF3 is a GTPase protein that interacts with eRF1 during translation termination. It enhances the efficiency of termination by stimulating the activity of eRF1 and promoting its release of the polypeptide chain. eRF3 also helps to recycle eRF1 by facilitating the dissociation of eRF1 from the ribosome after termination.\nGTP Hydrolysis: The interaction between eRF1 and eRF3 is GTP-dependent. eRF3 binds to GTP, and upon interaction with eRF1 at the ribosome, GTP hydrolysis occurs. This hydrolysis event is coupled with the termination process and facilitates the dissociation of eRF1 and eRF3 from the ribosome, allowing the ribosome to be recycled for another round of translation.\n\n\n3.5.1 Recycling Ribosomes\n\n\n\n\n\nRibosomes are Recycled After Translation\n\n\n\n\nRibosome recycling is a critical process in protein synthesis that ensures the efficient reuse of ribosomes after the termination of translation. It involves the dissociation of ribosomes from mRNA and the recycling of ribosomal subunits for subsequent rounds of translation. Here’s how ribosome recycling occurs:\n\nTermination of Translation: Ribosome recycling begins after the termination of translation, when a stop codon is encountered on the mRNA template. Release factors, such as eukaryotic release factor 1 (eRF1) and eukaryotic release factor 3 (eRF3), facilitate the release of the synthesized polypeptide chain from the ribosome.\nDissociation of Ribosomes: Once translation is terminated, the ribosome complex consisting of the large and small subunits needs to be disassembled from the mRNA molecule. This dissociation is facilitated by ribosome recycling factors, such as ribosome recycling factor (RRF) and elongation factor G (EF-G) in bacteria, and Rli1/ABCE1 in eukaryotes. These factors promote the separation of the ribosomal subunits and disengage the ribosome from mRNA.\nRibosome Splitting: In bacteria, RRF and EF-G work together to split the ribosome into its large and small subunits. RRF binds to the ribosomal A site, while EF-G hydrolyzes GTP and promotes the splitting of the ribosome complex. In eukaryotes, Rli1/ABCE1 acts as a ribosome-splitting factor by hydrolyzing ATP and disrupting the intersubunit bridges between the large and small ribosomal subunits.\nRecycling of Ribosomal Subunits: After the ribosome is split into its subunits, both bacterial and eukaryotic ribosomal subunits are recycled for further rounds of translation. The small ribosomal subunit is particularly important, as it recognizes the mRNA start codon and initiates translation. The recycling process ensures the efficient utilization of ribosomal components and enables the cell to maintain high rates of protein synthesis."
  },
  {
    "objectID": "chapters/week4.html",
    "href": "chapters/week4.html",
    "title": "4  Chaperones and Protein Homeostasis",
    "section": "",
    "text": "Christian Anfinsen, winner of the 1972 Nobel Prize in Chemistry, once pondered the questions of who is right and what is true. These questions are fundamental to understanding the world around us. In his research, Anfinsen explored how proteins fold, a process essential for their function. His work shed light on the complex mechanisms governing life at a molecular level.\nSimilarly, scientists F. Ulrich Hartl and Arthur Horwich have made significant contributions to our understanding of biology. Their research delves into the intricate world of protein folding, unraveling the mysteries of how cells function and how diseases like Alzheimer’s and Parkinson’s develop.\nProtein folding, the process by which proteins assume their functional three-dimensional shapes, is crucial for their proper functioning within living organisms. Imagine a bustling city with crowded streets; similarly, within our cells, proteins fold in a crowded environment filled with other molecules.\nThis crowded environment presents challenges for proteins as they fold. They must navigate through a sea of other molecules, jostling and interacting with them along the way. Sometimes, this crowded space can hinder the folding process, leading to misfolded proteins that may not function correctly.\nScientists like F. Ulrich Hartl and Arthur Horwich have dedicated their research to understanding how proteins fold in such crowded conditions. By studying the intricate dance of molecules within cells, they have uncovered mechanisms that assist proteins in folding properly despite the crowded environment.\nChaperones play vital roles in the proteostasis network, which is the cellular system responsible for maintaining the proper balance of proteins. Think of chaperones as the guardians of protein health within our cells.\nOne of the primary functions of chaperones is to assist proteins in folding correctly. Proteins start as long chains of amino acids and need to fold into specific shapes to perform their functions effectively. Chaperones help guide this folding process, ensuring that proteins adopt their proper three-dimensional structures.\nAdditionally, chaperones prevent protein misfolding and aggregation. Sometimes, proteins can misfold or clump together, which can be harmful to the cell. Chaperones act as quality control agents, identifying misfolded or aggregated proteins and either refolding them into their correct shapes or targeting them for degradation.\nChaperones also play a role in protein transport within the cell. They help ferry proteins to their designated locations, ensuring they reach the right organelles or compartments where they are needed.\nFurthermore, chaperones assist in protein degradation. When proteins are damaged or no longer needed, they must be broken down and recycled. Chaperones help facilitate this process by guiding proteins to degradation machinery where they can be dismantled into their component parts for reuse."
  },
  {
    "objectID": "chapters/week4.html#protein-folding-pathways-in-bacteria",
    "href": "chapters/week4.html#protein-folding-pathways-in-bacteria",
    "title": "4  Chaperones and Protein Homeostasis",
    "section": "4.1 Protein Folding Pathways in Bacteria",
    "text": "4.1 Protein Folding Pathways in Bacteria\n\n\n\n\n\nProtein Folding Pathway in Bacteria\n\n\n\n\nOne of the primary pathways involved in protein folding in bacteria is the chaperone-mediated folding pathway. Chaperones are specialized proteins that assist other proteins in folding correctly. Within this pathway, chaperones interact with newly synthesized proteins as they emerge from ribosomes, guiding them through the folding process to ensure they attain their functional shapes.\nAnother important pathway in bacterial protein folding is the co-translational folding pathway. In this pathway, proteins begin to fold even as they are being synthesized by ribosomes. As the protein chain emerges from the ribosome, it starts to fold into its native structure with the help of chaperones and other folding factors. This simultaneous folding and synthesis process ensure that the protein is properly folded as soon as it is synthesized.\nFurthermore, bacteria utilize protein degradation pathways to maintain protein homeostasis. If a protein fails to fold correctly despite chaperone assistance or becomes damaged or obsolete, it may be targeted for degradation. Bacterial cells have proteases, enzymes specialized in breaking down proteins, which dismantle misfolded or unwanted proteins into smaller peptides or amino acids for recycling.\n\n4.1.0.1 Hsp70-Hsp40 System\n\n\n\n\n\nIllustration of the Hsp70-Hsp40 System\n\n\n\n\nThe Hsp70-Hsp40 system is a critical molecular machinery found in cells, including bacteria, that helps in protein folding and quality control. These components are often referred to as chaperones because they assist other proteins in folding correctly and prevent misfolding.\nAt the heart of this system is the Hsp70 protein, which acts as a molecular chaperone. Hsp70 binds to exposed hydrophobic regions on proteins, which are common during the folding process. By doing so, Hsp70 prevents these regions from sticking together inappropriately, thus helping the protein fold properly into its functional shape. However, Hsp70 alone can be slow in its action.\nThis is where the Hsp40 co-chaperone comes into play. Hsp40 interacts with Hsp70 and helps accelerate its activity. It does this by stimulating the ATPase activity of Hsp70, which is crucial for its chaperone function. By enhancing the ATPase activity, Hsp40 increases the efficiency of Hsp70 in binding to and releasing its client proteins, thereby facilitating the protein folding process.\nTogether, the Hsp70-Hsp40 system forms a dynamic duo in the cell, working hand in hand to ensure that proteins fold correctly and maintain their proper structures. This system is essential for cellular health and is involved in various cellular processes, including protein synthesis, protein trafficking, and response to stress.\n\n\n4.1.1 Chaperonin\n\n\n\n\n\nIllustration of Chaperonin\n\n\n\n\nChaperonins are like tiny cages within the cell that provide a protected environment for protein folding. These remarkable structures play a crucial role in ensuring that proteins fold correctly, without interference from other molecules in the crowded cellular environment.\nThe key feature of chaperonins is their hollow, barrel-like structure, which forms a chamber where proteins can fold undisturbed. One of the most well-known types of chaperonins is called GroEL-GroES, found in bacteria.\nWhen a protein needs to fold, it enters the central cavity of the chaperonin. Once inside, the chaperonin closes like a lid, encapsulating the protein within its chamber. This isolation shields the folding protein from potential disruptions by other cellular components, allowing it to fold properly.\nInside the chaperonin chamber, the folding protein is provided with the ideal conditions for folding. The enclosed space allows the protein to explore different conformations without interference, helping it find its correct three-dimensional structure.\nTo further assist in the folding process, chaperonins often work in conjunction with co-chaperones, such as GroES in the case of GroEL. GroES acts as a lid, sealing the top of the chaperonin chamber and creating an even more secluded environment for protein folding.\nOnce the folding process is complete, the chaperonin releases the folded protein, which can then go on to perform its specific function within the cell."
  },
  {
    "objectID": "chapters/week4.html#chaperone-families-in-eukaryotes-and-their-functions",
    "href": "chapters/week4.html#chaperone-families-in-eukaryotes-and-their-functions",
    "title": "4  Chaperones and Protein Homeostasis",
    "section": "4.2 Chaperone Families in Eukaryotes and Their Functions",
    "text": "4.2 Chaperone Families in Eukaryotes and Their Functions\n\n\n\n\n\nNAC and RAC\n\n\n\n\nIn eukaryotic cells, there are specialized chaperones that assist in protein folding as soon as the proteins are synthesized by ribosomes. Two prominent examples of these ribosome-binding chaperones are RAC (Ribosome-associated complex) and NAC (Nascent polypeptide-associated complex).\n\n\n\n\n\nIllustration of NAC and RAC Mechanism\n\n\n\n\nRAC serves as a cofactor of Hsp70, another important chaperone protein, facilitating its activity in protein folding. As proteins are being synthesized by ribosomes, RAC interacts with the ribosome and recruits Hsp70 to the nascent polypeptide chain as it emerges from the ribosome. This interaction helps to prevent premature folding or aggregation of the nascent protein, ensuring that it attains its proper three-dimensional structure.\nNAC, on the other hand, directly binds to the nascent polypeptide chain as it emerges from the ribosome. This association helps to shield the newly synthesized protein from interactions with other cellular components and provides a conducive environment for proper folding. NAC also assists in targeting the nascent protein to its correct cellular location, ensuring that it reaches its designated organelle or compartment.\n\n4.2.1 Functions of Hsp70\n\n\n\n\n\nCellular Functions of Hsp70\n\n\n\n\nFirstly, Hsp70 assists in protein folding. It interacts with newly synthesized or misfolded proteins, preventing them from aggregating and guiding them along the correct folding pathways. By doing so, Hsp70 ensures that proteins adopt their proper three-dimensional structures, which is essential for their biological activity.\nSecondly, Hsp70 plays a role in protein transport within the cell. It helps to ferry proteins across membranes or guide them to specific cellular compartments where they are needed for various functions. This transport function ensures that proteins reach their correct destinations within the cell, allowing them to perform their designated roles.\nAdditionally, Hsp70 is involved in protein degradation. It interacts with misfolded or damaged proteins, targeting them for degradation by cellular machinery such as proteasomes. This process helps to remove aberrant proteins from the cell, preventing them from interfering with normal cellular processes and maintaining protein quality control.\nMoreover, Hsp70 plays a crucial role in cellular stress responses. When cells are exposed to stressful conditions such as heat, oxidative stress, or nutrient deprivation, the expression of Hsp70 is often upregulated. Hsp70 helps cells cope with these stresses by stabilizing proteins, preventing their denaturation, and promoting cell survival under adverse conditions.\n\n\n4.2.2 TRiC\n\n\n\n\n\nTRiC Illustration\n\n\n\n\nTRiC, also known as TCP-1 Ring Complex, is a type II chaperonin found in the cytosol of eukaryotic cells. It is composed of two stacked rings, each containing eight different subunits. TRiC plays a crucial role in facilitating the folding of diverse cytosolic proteins, ensuring their proper structure and function.\nOne of the key functions of TRiC is to assist in the folding of newly synthesized proteins as they emerge from ribosomes. As proteins are synthesized, they often require assistance to attain their correct three-dimensional shapes. TRiC provides a protected environment within its chamber-like structure, allowing proteins to fold properly without interference from other cellular components. This function is particularly important for proteins with complex folding patterns or those prone to misfolding.\nAdditionally, TRiC is involved in the folding of proteins that are crucial for cellular processes such as cell cycle regulation, cytoskeletal dynamics, and signal transduction. By facilitating the folding of these essential proteins, TRiC contributes to the proper functioning of the cell.\nMoreover, TRiC is implicated in the maintenance of protein homeostasis and cellular integrity under stress conditions. When cells are exposed to environmental stressors such as heat or toxins, TRiC helps to prevent protein misfolding and aggregation, thereby promoting cell survival.\n\n\n4.2.3 Protein Folding in Eukaryotes\n\n\n\n\n\nProtein Folding in Eukaryotes\n\n\n\n\nIn eukaryotic cells, cytosolic protein folding involves a series of coordinated pathways and molecular chaperones that ensure newly synthesized proteins attain their correct three-dimensional structures. Here’s an overview of the key players and steps involved in cytosolic protein folding:\n\nRAC (Ribosome-associated complex) and NAC (Nascent polypeptide-associated complex): These complexes interact with ribosomes and nascent polypeptide chains emerging from ribosomes, respectively. RAC recruits Hsp70 to the nascent chain, while NAC directly binds to the nascent polypeptide, protecting it and facilitating its proper folding.\nHsp70: Heat Shock Protein 70 is a major molecular chaperone involved in protein folding. It interacts with exposed hydrophobic regions on proteins, preventing misfolding and aggregation. Hsp70’s activity is regulated by ATP and co-chaperones such as Hsp40 (also known as DnaJ).\nHsp40 (DnaJ): Hsp40 acts as a co-chaperone to Hsp70, stimulating its ATPase activity and enhancing its chaperone function. It helps to deliver substrate proteins to Hsp70 and stabilize their binding.\nNEF (Nucleotide Exchange Factor): NEF assists in the dissociation of ADP from Hsp70, allowing for the binding of fresh ATP. This ATP hydrolysis and exchange cycle is essential for the chaperone activity of Hsp70.\nHOP (Hsp70-Hsp90 Organizing Protein): HOP acts as a co-chaperone that bridges the interaction between Hsp70 and Hsp90. This interaction is crucial for the transfer of client proteins from Hsp70 to Hsp90 during their folding process.\nHsp90: Heat Shock Protein 90 is another important molecular chaperone involved in protein folding. It acts downstream of Hsp70 and plays a role in the maturation and stabilization of client proteins. Hsp90’s activity is also ATP-dependent.\nTRiC (TCP-1 Ring Complex): TRiC is a large multi-subunit chaperonin complex that provides a protected environment for the folding of diverse cytosolic proteins. It assists in the folding of a wide range of substrates, particularly those with complex folding patterns.\n\n\n\n4.2.4 Polyribosomes\n\n\n\n\n\nIllustration of Polyribosomes\n\n\n\n\nPolyribosomes, also known as polysomes, are clusters of ribosomes found within eukaryotic cells that are actively translating mRNA molecules into proteins. These structures play a crucial role in protein synthesis, allowing multiple ribosomes to simultaneously translate a single mRNA strand. Within eukaryotic cells, polyribosomes can exist in two primary forms: free polyribosomes and membrane-bound polyribosomes.\nFree polyribosomes are dispersed throughout the cytoplasm, existing independently of any membrane-bound structures such as the endoplasmic reticulum (ER). They are responsible for synthesizing proteins that are intended to remain within the cytosol or to be transported to various organelles such as the nucleus or mitochondria. Proteins synthesized by free polyribosomes often fulfill essential cellular functions related to metabolism, cytoskeletal organization, and signaling pathways.\nOn the other hand, membrane-bound polyribosomes are attached to the endoplasmic reticulum (ER) membrane. These polyribosomes are typically found in close association with the rough ER, contributing to its characteristic rough appearance observed under electron microscopy. Proteins synthesized by membrane-bound polyribosomes are translocated into the lumen of the ER as they are being synthesized. These proteins undergo further processing, such as folding and glycosylation, within the ER before being transported to their final destinations. Membrane-bound polyribosomes primarily synthesize proteins that are destined for secretion, incorporation into the plasma membrane, or localization within the endomembrane system, including lysosomes and the Golgi apparatus.\n\n\n4.2.5 Secretory Protein Binding\n\n\n\n\n\nSecretory Protein Binding Illustration\n\n\n\n\nSecretory protein folding is a complex process that occurs within the endoplasmic reticulum (ER) of eukaryotic cells. As proteins destined for secretion are synthesized by ribosomes attached to the rough ER, they undergo a series of folding and modification steps to attain their native conformations. Several key molecular players are involved in this process, including BiP (binding protein), Hsp70 chaperone, and Protein disulfide isomerase (PDI).\nBiP, also known as GRP78, is an ER-resident chaperone protein that plays a central role in protein folding and quality control within the ER lumen. It interacts with newly synthesized polypeptide chains to prevent misfolding and aggregation, guiding them along the folding pathway. BiP also assists in the translocation of proteins across the ER membrane and facilitates the assembly of multiprotein complexes.\nHsp70 chaperone, similar to BiP, is involved in the folding of secretory proteins within the ER. It interacts with exposed hydrophobic regions on nascent polypeptide chains, preventing nonproductive interactions and promoting correct folding. Hsp70’s activity is regulated by ATP hydrolysis and is coordinated with other ER-resident chaperones to ensure efficient protein folding.\nProtein disulfide isomerase (PDI) is an enzyme that catalyzes the formation and breakage of disulfide (S-S) bonds within secretory proteins. Disulfide bonds play a crucial role in stabilizing protein structures, particularly in secretory and membrane proteins. PDI helps to ensure the proper formation of disulfide bonds, which are essential for protein stability and function. Additionally, PDI can catalyze the rearrangement of incorrect disulfide bonds, ensuring that secretory proteins attain their correct native conformations.\n\n\n4.2.6 Protein Glycosylation\n\n\n\n\n\nProtein Glycosylation\n\n\n\n\nProtein glycosylation is a common post-translational modification that occurs in the endoplasmic reticulum (ER) of eukaryotic cells. This process involves the addition of sugar molecules, such as glucose, mannose, and N-acetylglucosamine, to specific amino acid residues on nascent polypeptide chains as they are being synthesized by ribosomes attached to the ER membrane. The process of protein glycosylation in the ER involves several steps:\n\nEnzymatic addition of a pre-formed oligosaccharide: The initial step of protein glycosylation involves the transfer of a pre-formed oligosaccharide (a short sugar chain) from a lipid carrier molecule to specific asparagine residues on the nascent polypeptide chain. This process is catalyzed by an enzyme complex known as the oligosaccharyltransferase (OST) complex, which is embedded in the ER membrane.\nModification and processing of the glycan chain: After the oligosaccharide is transferred to the protein, it undergoes further modifications and processing steps within the ER lumen. These modifications include trimming of the sugar chain by specific enzymes and the addition of additional sugar residues to form complex glycan structures.\nQuality control and protein folding: During or after glycosylation, the newly synthesized protein undergoes quality control checks to ensure proper folding and assembly. Chaperone proteins such as BiP and lectin-like chaperones assist in protein folding and recognize misfolded or improperly glycosylated proteins, targeting them for degradation if necessary.\nGlycoprotein trafficking: Once properly folded and glycosylated, the glycoproteins are transported from the ER to the Golgi apparatus for further processing and sorting. In the Golgi, additional modifications may occur, and glycoproteins are sorted for secretion or delivery to specific cellular compartments.\n\n\n4.2.6.1 Role of Glycosylation During ER Protein Folding\n\n\n\n\n\nRole of Glycosylation in ER Protein Folding\n\n\n\n\nGlycosylation plays a crucial role in protein folding within the endoplasmic reticulum (ER), and calnexin is a key player in this process. Calnexin is a type I integral membrane protein located in the ER membrane and functions as a lectin, specifically a carbohydrate-binding protein.\nDuring protein synthesis, nascent polypeptide chains are co-translationally glycosylated by the addition of a pre-formed oligosaccharide chain. This glycosylation is essential for proper protein folding and quality control. Calnexin recognizes specific monosaccharides, such as glucose and mannose, present on the glycosylated proteins.\nCalnexin interacts with newly synthesized glycoproteins that have not yet folded correctly. By binding to the oligosaccharide chains on these proteins, calnexin helps to stabilize them and prevent premature degradation. This interaction provides a quality control mechanism, allowing the glycoproteins to undergo proper folding and assembly.\nFurthermore, calnexin collaborates with other chaperones and folding enzymes within the ER, such as BiP (binding immunoglobulin protein) and protein disulfide isomerase (PDI), to facilitate protein folding. Together, these ER-resident proteins ensure that glycosylated proteins attain their native conformations and are properly folded before being transported to their final destinations within the cell.\n\n\n\n4.2.7 ERAD Substrate Recognition\n\n\n\n\n\nERAD Pathway Mechanism\n\n\n\n\nERAD (Endoplasmic Reticulum-Associated Degradation) is a cellular quality control mechanism responsible for identifying and targeting misfolded or unassembled proteins in the endoplasmic reticulum (ER) for degradation. Substrate recognition is a crucial step in the ERAD process, ensuring that only aberrant proteins are targeted for degradation while properly folded proteins are spared.\nThe recognition of ERAD substrates involves multiple checkpoints and mechanisms:\n\nQuality control during protein folding: The ER contains a network of chaperones and folding enzymes that assist in the folding of nascent proteins. Properly folded proteins are able to escape recognition by ERAD machinery and proceed to their intended destinations. However, misfolded or unassembled proteins are retained in the ER and subjected to further scrutiny.\nGlycan-dependent recognition: Many ERAD substrates bear characteristic glycan modifications that serve as signals for recognition by ERAD machinery. Lectins, such as calnexin and calreticulin, recognize these glycan structures and facilitate the interaction between misfolded proteins and ERAD components.\nUbiquitin-dependent recognition: Misfolded or unassembled proteins are tagged with ubiquitin, a small protein that serves as a signal for degradation by the proteasome. This ubiquitination process is mediated by ER-resident E3 ubiquitin ligases, which specifically recognize and target ERAD substrates for ubiquitination.\nERAD receptors: ERAD substrates are recognized and bound by ER-resident receptors that bridge the interaction between the misfolded protein and the ERAD machinery. These receptors contain specific domains that recognize either the glycan modifications or the ubiquitin chains on ERAD substrates. Examples of ERAD receptors include Derlin proteins and Hrd1 complex components.\nER quality control checkpoints: The ER contains quality control checkpoints that monitor the folding status of proteins. If a protein fails to fold properly or assemble into its functional form, it is recognized by ER quality control sensors, leading to its retrotranslocation from the ER lumen to the cytosol for degradation via ERAD."
  },
  {
    "objectID": "chapters/week4.html#cellular-responses-to-proteotoxic-stresses",
    "href": "chapters/week4.html#cellular-responses-to-proteotoxic-stresses",
    "title": "4  Chaperones and Protein Homeostasis",
    "section": "4.3 Cellular Responses to Proteotoxic Stresses",
    "text": "4.3 Cellular Responses to Proteotoxic Stresses\n\n4.3.1 Proteostasis Network\n\n\n\n\n\nProteostasis Network\n\n\n\n\nThe Proteostasis Network refers to the intricate system within cells that regulates protein homeostasis, ensuring that proteins are properly folded, assembled, trafficked, and degraded. Maintaining proteostasis is essential for cellular health and function, as proteins are involved in virtually every aspect of cellular processes, from structural support to enzymatic reactions and signaling pathways.\nThe Proteostasis Network consists of various molecular components and pathways that work together to maintain protein quality control:\n\nChaperones and Folding Factors: Molecular chaperones, such as Hsp70 and Hsp90, assist in protein folding, preventing misfolding and aggregation. They guide nascent polypeptide chains to their proper three-dimensional structures and help proteins navigate through folding intermediates. Folding factors, such as protein disulfide isomerases (PDIs), aid in the formation of disulfide bonds, a crucial step in protein folding.\nProtein Degradation Pathways: Misfolded or damaged proteins are targeted for degradation by proteolytic systems such as the ubiquitin-proteasome system (UPS) and autophagy-lysosome pathway. The UPS involves the tagging of proteins with ubiquitin molecules, marking them for degradation by the proteasome. Autophagy sequesters cytoplasmic components, including protein aggregates, into autophagosomes for delivery to lysosomes, where they are degraded.\nQuality Control Mechanisms: Cells have quality control mechanisms that monitor protein folding and assembly. If a protein fails to fold properly or assemble correctly, it may be targeted for degradation or undergo retrotranslocation from the ER (endoplasmic reticulum) to the cytosol for ER-associated degradation (ERAD).\nRegulatory Pathways: Various signaling pathways and transcriptional regulators modulate the expression of chaperones, folding factors, and components of protein degradation pathways in response to cellular stress or changes in protein homeostasis. These regulatory mechanisms help cells adapt to changing conditions and maintain proteostasis under different physiological states.\nOrganelle-Specific Proteostasis: Different organelles within the cell, such as the ER, mitochondria, and nucleus, have specialized proteostasis networks tailored to their specific needs. For example, the ER is responsible for folding and processing secretory and membrane proteins, while the mitochondria have their own chaperones and quality control mechanisms to maintain mitochondrial protein homeostasis.\n\n\n\n4.3.2 Heat Shock Response\n\n\n\n\n\nHeat Shock Protein Illustration\n\n\n\n\nThe Heat Shock Response (HSR) is a cellular defense mechanism that is activated in response to elevated temperatures and other stressors, such as oxidative stress, heavy metals, and toxins. The primary function of the HSR is to protect cells from damage caused by these stressors and to restore cellular homeostasis.\nWhen cells are exposed to stress, heat shock transcription factors (HSFs), particularly HSF1, are activated. HSF1 undergoes a conformational change, leading to its trimerization and translocation to the nucleus. Once in the nucleus, HSF1 binds to specific DNA sequences known as heat shock elements (HSEs) located in the promoters of heat shock genes.\nActivation of HSF1 leads to the transcriptional upregulation of heat shock proteins (HSPs), a group of molecular chaperones that play essential roles in protein folding, stabilization, and degradation. HSPs help to protect cells from stress-induced damage by assisting in the refolding of denatured proteins, preventing protein aggregation, and facilitating the degradation of irreversibly damaged proteins.\nThe induction of HSP expression by the HSR is a highly conserved and tightly regulated process across species, from bacteria to humans. HSPs are classified into families based on their molecular weight, including HSP70, HSP90, HSP60, and small HSPs (sHSPs).\nIn addition to their roles in protein homeostasis, HSPs have been implicated in various cellular processes, including signal transduction, cell cycle regulation, and apoptosis. They also play important roles in development, immunity, and disease.\n\n4.3.2.1 HSF1 in Cancer and Neurodegenerative Diseases?\nTumorigenesis: HSF1 contributes to tumorigenesis by promoting cancer cell survival and proliferation through the regulation of heat shock proteins (HSPs). Elevated levels of HSPs induced by HSF1 activation confer a survival advantage to cancer cells by facilitating protein folding, inhibiting apoptosis, and enhancing cell migration and invasion.\nChemo- and Radiotherapy Resistance: HSF1 activation can lead to resistance to chemotherapy and radiation therapy in cancer cells. The upregulation of HSPs induced by HSF1 activation can protect cancer cells from the cytotoxic effects of these treatments, contributing to treatment failure and disease recurrence.\nMetastasis: HSF1 may also play a role in cancer metastasis by promoting epithelial-to-mesenchymal transition (EMT), a process that enhances cancer cell migration and invasion. HSF1-mediated upregulation of HSPs can facilitate EMT-associated changes in gene expression and cellular morphology, promoting metastatic spread.\nProtein Misfolding and Aggregation: HSF1 is activated in response to protein misfolding and aggregation, characteristic features of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases. HSF1 activation leads to the upregulation of HSPs, which can help to refold or degrade misfolded proteins, thereby mitigating their toxic effects.\nNeuronal Protection: Activation of HSF1 and induction of HSP expression provide neuroprotection in experimental models of neurodegenerative diseases. By promoting protein homeostasis and reducing cellular stress, HSPs can help to preserve neuronal function and viability in the face of disease-related insults.\nPotential Therapeutic Target: Targeting HSF1 or its downstream effectors, such as HSPs, has emerged as a potential therapeutic strategy for neurodegenerative diseases. Modulation of HSF1 activity may help to enhance cellular proteostasis and alleviate disease-associated pathology.\n\n\n\n4.3.3 Unfolded Protein Response\n\n\n\n\n\nIllustration of the UPR\n\n\n\n\nThe Unfolded Protein Response (UPR) is a cellular stress response pathway activated in response to the accumulation of unfolded or misfolded proteins within the endoplasmic reticulum (ER), a cellular organelle involved in protein synthesis and folding. The UPR plays a critical role in maintaining protein homeostasis, or proteostasis, by alleviating ER stress and restoring normal cellular function.\nWhen unfolded or misfolded proteins accumulate in the ER, they trigger the activation of three main transmembrane proteins: inositol-requiring enzyme 1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor 6 (ATF6). These sensors initiate signaling cascades that culminate in a coordinated cellular response aimed at reducing ER stress and promoting cell survival.\n\nIRE1 Pathway: Upon activation, IRE1 splices an mRNA encoding the transcription factor X-box binding protein 1 (XBP1), leading to the production of an active transcription factor called spliced XBP1 (XBP1s). XBP1s translocates to the nucleus and activates the transcription of genes involved in ER-associated degradation (ERAD), protein folding, and lipid biosynthesis, promoting ER function and protein folding capacity.\nPERK Pathway: PERK activation leads to the phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2α), resulting in global attenuation of protein synthesis. This temporary reduction in protein synthesis alleviates the burden on the ER, allowing cells to cope with ER stress. Additionally, PERK activation induces the expression of ATF4, a transcription factor that regulates the expression of genes involved in antioxidant defense, amino acid metabolism, and apoptosis.\nATF6 Pathway: ATF6 is transported to the Golgi apparatus upon ER stress, where it undergoes proteolytic cleavage to generate an active transcription factor fragment. This fragment translocates to the nucleus and activates the expression of genes encoding ER chaperones, such as BiP/GRP78, and other proteins involved in protein folding and ERAD.\n\nThe combined actions of these UPR pathways help to restore ER homeostasis by increasing the capacity of the ER to fold and degrade proteins, reducing the load of unfolded proteins, and promoting cell survival. However, if ER stress is severe or prolonged, the UPR can also induce apoptosis to eliminate irreversibly damaged cells and maintain overall tissue integrity.\n\n4.3.3.1 Splicing of XBP1 mRNA\n\n\n\n\n\nRegulating the Splicing of XBP1 mRNA\n\n\n\n\nThe splicing of X-box binding protein 1 (XBP1) mRNA is a critical step in the activation of the unfolded protein response (UPR), particularly the IRE1 pathway. This process, known as regulated splicing, is tightly regulated and plays a key role in the cellular response to endoplasmic reticulum (ER) stress.\nWhen unfolded or misfolded proteins accumulate in the ER, the ER stress sensor protein inositol-requiring enzyme 1 (IRE1) becomes activated. IRE1 is a transmembrane protein located in the ER membrane. Upon activation, IRE1 undergoes oligomerization and autophosphorylation, leading to its activation as an endoribonuclease.\nIRE1 then catalyzes the unconventional splicing of XBP1 mRNA, a process that removes a 26-nucleotide intron from the mRNA. This splicing event generates a shorter mRNA transcript, referred to as spliced XBP1 (XBP1s). XBP1s encodes a transcription factor that is a potent activator of genes involved in ER-associated degradation (ERAD), protein folding, and lipid biosynthesis.\nThe splicing of XBP1 mRNA is a highly regulated process that is specific to ER stress conditions. Under normal conditions, XBP1 mRNA remains unspliced, and the protein encoded by unspliced XBP1 (XBP1u) does not have transcriptional activity. However, upon ER stress, IRE1-mediated splicing of XBP1 mRNA is rapidly induced, leading to the production of XBP1s and subsequent activation of UPR target genes.\nThe activation of XBP1s and its downstream target genes is critical for restoring ER homeostasis and promoting cell survival during ER stress. XBP1s regulates the expression of genes involved in protein folding, ERAD, and lipid metabolism, thereby increasing the capacity of the ER to handle the influx of misfolded proteins and alleviate ER stress.\n\n\n4.3.3.2 PERK Activation\n\n\n\n\n\nActivation of PERK\n\n\n\n\nProtein kinase RNA-like ER kinase (PERK) is a key component of the unfolded protein response (UPR) pathway, activated in response to endoplasmic reticulum (ER) stress. One of the main functions of PERK activation is to suppress global translation initiation, a process essential for protein synthesis. This translational attenuation helps to alleviate the burden on the ER by reducing the influx of newly synthesized proteins into the ER lumen, where protein folding occurs.\nUpon activation, PERK phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α), a critical component of the translation initiation complex. Phosphorylation of eIF2α inhibits its activity, preventing the formation of the ternary complex required for translation initiation. As a result, global protein synthesis is attenuated, reducing the overall protein load on the ER and allowing cells to cope with ER stress.\nWhile global translation is suppressed, the translation of specific mRNAs is selectively enhanced or maintained during PERK activation. For example, the mRNA encoding activating transcription factor 4 (ATF4) contains specific regulatory elements in its 5’ untranslated region (UTR), known as upstream open reading frames (uORFs), which allow for preferential translation even under conditions of eIF2α phosphorylation. ATF4 is a transcription factor that regulates the expression of genes involved in various cellular processes, including antioxidant defense, amino acid metabolism, and apoptosis."
  },
  {
    "objectID": "chapters/week5.html",
    "href": "chapters/week5.html",
    "title": "5  Mitochondria in Aging and Neurodegeneration",
    "section": "",
    "text": "Photo of a Mitochondrion\n\n\n\n\nThe mitochondrion, often referred to as the “powerhouse of the cell,” is a complex organelle with a distinct structure that allows it to carry out essential cellular functions, particularly energy production through oxidative phosphorylation. Here’s an overview of its structure:\n\nMatrix:\nThe matrix is the innermost compartment of the mitochondrion and contains a gel-like substance rich in enzymes, including those involved in the oxidation of pyruvate and fatty acids, as well as enzymes of the Krebs cycle (also known as the citric acid cycle or tricarboxylic acid cycle). Additionally, the matrix houses the mitochondrial DNA (mtDNA) and the machinery for gene expression, including RNA polymerase and ribosomes.\nInner Membrane:\nThe inner membrane surrounds the matrix and is highly folded into structures called cristae, which increase the surface area available for biochemical reactions. The inner membrane contains the electron transport chain (ETC), a series of protein complexes that transfer electrons derived from nutrients to generate ATP through oxidative phosphorylation. It also houses ATP synthase, an enzyme complex responsible for ATP production, as well as various transporters that regulate the passage of ions and metabolites across the membrane.\nOuter Membrane:\nThe outer membrane surrounds the inner membrane and separates the mitochondrial interior from the cytoplasm. It is relatively permeable to small molecules with a molecular weight of less than 5 kilodaltons (kDa), allowing for the passage of ions, metabolites, and other small molecules.\nIntermembrane Space:\nThe intermembrane space is the region between the inner and outer mitochondrial membranes. It contains a lower concentration of proteins compared to the matrix but may contain proteins involved in processes such as apoptosis regulation.\n\n\n\n\n\n\n\n\nEnergy Converting Metabolism Diagram\n\n\n\n\nEnergy-converting metabolism in mitochondria is a complex process that involves several interconnected pathways aimed at generating adenosine triphosphate (ATP), the cell’s primary energy currency. Mitochondria play a central role in cellular respiration, a process that involves the oxidation of nutrients to produce ATP through oxidative phosphorylation. Here’s an overview of the key metabolic pathways involved:\n\nGlycolysis: Glycolysis is the initial stage of glucose metabolism that occurs in the cytoplasm. Glucose is broken down into pyruvate, producing a small amount of ATP and reducing equivalents in the form of NADH. Pyruvate is then transported into the mitochondria for further metabolism.\nPyruvate Oxidation: Pyruvate produced from glycolysis enters the mitochondria, where it undergoes oxidation to produce acetyl-CoA. This process generates reducing equivalents in the form of NADH and releases carbon dioxide. Acetyl-CoA then enters the citric acid cycle (also known as the Krebs cycle) for further metabolism.\nCitric Acid Cycle (Krebs Cycle): The citric acid cycle takes place in the mitochondrial matrix. Acetyl-CoA combines with oxaloacetate to form citrate, which undergoes a series of enzymatic reactions, ultimately regenerating oxaloacetate and producing reducing equivalents (NADH and FADH2) and ATP precursors (GTP). The cycle generates NADH and FADH2, which donate electrons to the electron transport chain (ETC).\nElectron Transport Chain (ETC): The electron transport chain is located in the inner mitochondrial membrane. It consists of a series of protein complexes (I-IV) and coenzyme Q and cytochrome c as electron carriers. As electrons move through the ETC, they release energy, which is used to pump protons (H+) across the inner mitochondrial membrane, establishing an electrochemical gradient.\nATP Synthesis: The proton gradient generated by the ETC drives ATP synthesis through ATP synthase, an enzyme complex located in the inner mitochondrial membrane. Protons flow back into the mitochondrial matrix through ATP synthase, driving the synthesis of ATP from adenosine diphosphate (ADP) and inorganic phosphate (Pi). This process is known as oxidative phosphorylation.\n\n\n\n\n\n\n\n\n\nNADH Generation\n\n\n\n\nGlucose undergoes several metabolic reactions to produce NADH during cellular respiration. The process begins with glycolysis, where glucose is converted into pyruvate. Here’s a simplified breakdown of the steps involved:\n\nGlycolysis: Glucose (a 6-carbon molecule) is phosphorylated and split into two molecules of glyceraldehyde-3-phosphate (G3P), each containing three carbons. These G3P molecules are further oxidized and phosphorylated, ultimately yielding two molecules of pyruvate (a 3-carbon molecule). Along the way, glycolysis produces a net gain of 2 ATP molecules and 2 NADH molecules per glucose molecule.\nPyruvate Oxidation: Each pyruvate molecule produced during glycolysis enters the mitochondria, where it undergoes oxidation to produce acetyl-CoA. This process generates reducing equivalents in the form of NADH. While pyruvate oxidation does not directly produce NADH molecules, it generates NADH during subsequent steps of the citric acid cycle (Krebs cycle).\nKrebs Cycle (Citric Acid Cycle): Acetyl-CoA combines with oxaloacetate to form citrate, initiating the citric acid cycle. Through a series of enzymatic reactions, citrate is metabolized, ultimately regenerating oxaloacetate and producing reducing equivalents (NADH and FADH2). While the precise contribution of each pyruvate to NADH production in the Krebs cycle varies, each glucose molecule ultimately yields multiple NADH molecules through this pathway.\n\n\n\n\n\n\n\n\nNADH Usage\n\n\n\n\nNADH (nicotinamide adenine dinucleotide, reduced form) is a critical molecule in cellular metabolism, serving as a carrier of electrons during various biochemical reactions. Its primary role is to transfer high-energy electrons to the electron transport chain (ETC) in the mitochondria, where they are ultimately used to generate ATP through oxidative phosphorylation.\nHere’s how NADH is used in cellular metabolism:\n\nElectron Transport Chain (ETC): NADH donates its electrons to complex I (NADH dehydrogenase) of the electron transport chain in the inner mitochondrial membrane. These electrons then pass through a series of protein complexes (I-IV), including flavin mononucleotide (FMN), iron-sulfur clusters, and cytochromes, leading to the pumping of protons (H+) from the mitochondrial matrix to the intermembrane space. This creates an electrochemical gradient across the inner mitochondrial membrane.\nATP Synthesis: The flow of protons back into the mitochondrial matrix through complex V (ATP synthase) harnesses the energy released to drive the synthesis of ATP from adenosine diphosphate (ADP) and inorganic phosphate (Pi). This process, known as oxidative phosphorylation, is responsible for the majority of ATP production in aerobic cells.\nRegeneration of NAD+: After donating its electrons to the ETC, NADH is oxidized back to its original form, NAD+, allowing it to participate in subsequent rounds of metabolism. This regeneration of NAD+ is crucial for sustaining glycolysis, the citric acid cycle, and other metabolic pathways that rely on NAD+ as a cofactor.\n\n\n\n\n\n\n\n\n\n\nIllustration of the Electron Transport Chain\n\n\n\n\nThe Electron Transport Chain (ETC) is a critical component of cellular respiration, occurring in the inner mitochondrial membrane of eukaryotic cells and the plasma membrane of prokaryotic cells. It is responsible for the final stage of oxidative phosphorylation, the process by which cells generate adenosine triphosphate (ATP), the primary energy currency.\nHere’s how the Electron Transport Chain works:\n\nElectron Carriers: The ETC consists of a series of protein complexes and small molecules that serve as electron carriers. These include flavoproteins, iron-sulfur proteins, cytochromes, and coenzyme Q (ubiquinone).\nElectron Flow: Electrons donated by NADH and FADH2 (produced during glycolysis, pyruvate oxidation, and the citric acid cycle) enter the ETC at complex I (NADH dehydrogenase) and complex II (succinate dehydrogenase), respectively. These electrons are transferred sequentially from one carrier to another along the ETC, losing energy with each transfer.\nProton Pumping: As electrons flow through the ETC, energy released from their transfer is used to pump protons (H+) from the mitochondrial matrix to the intermembrane space, creating an electrochemical gradient across the inner mitochondrial membrane. Complexes I, III, and IV are involved in this process.\nChemiosmosis: The electrochemical gradient generated by proton pumping creates a proton motive force (PMF), which drives protons back into the mitochondrial matrix through complex V, also known as ATP synthase. As protons flow through ATP synthase, the energy released is used to convert adenosine diphosphate (ADP) and inorganic phosphate (Pi) into ATP, a process known as oxidative phosphorylation.\nOxygen as the Final Electron Acceptor: At the end of the ETC, electrons are transferred to molecular oxygen (O2), the final electron acceptor. Oxygen combines with protons to form water (H2O), completing the electron transport chain.\n\n\n\n\n\n\n\n\nDifferent Paths in the Electron Transport Chain\n\n\n\n\nIn the Electron Transport Chain (ETC), there are two main pathways for the flow of electrons:\n\nComplex I → Complex III → Complex IV: This pathway begins with complex I (NADH dehydrogenase) receiving electrons from NADH. Complex I transfers these electrons to coenzyme Q (ubiquinone), which then delivers them to complex III (cytochrome bc1 complex). Complex III passes the electrons to cytochrome c, and finally, they are transferred to complex IV (cytochrome c oxidase). Complex IV uses these electrons to reduce molecular oxygen (O2) to water (H2O).\nComplex II → Complex III → Complex IV: This pathway involves complex II (succinate dehydrogenase) receiving electrons directly from succinate in the citric acid cycle. Complex II transfers these electrons to coenzyme Q, which then follows the same path as in the previous pathway, delivering the electrons to complex III and then complex IV for the reduction of oxygen to water.\n\n\n\n\n\n\n\n\n\n\nDifferent Models of the ER\n\n\n\n\nThe Baffle Model and the Crista Junction Model are two proposed mechanisms that describe the organization of cristae, the internal membrane structures within mitochondria, and their role in mitochondrial function. Let’s delve into each model:\n\nBaffle Model:\nThe Baffle Model suggests that cristae are formed by invaginations of the inner mitochondrial membrane (IMM) that protrude into the mitochondrial matrix. These invaginations create a labyrinth-like structure, increasing the surface area of the inner membrane and providing more space for oxidative phosphorylation (ATP production). The term “baffles” refers to the folds or ridges formed by these invaginations.\nIn this model, the cristae junctions, which are the points where the inner membrane folds connect to the outer membrane, are considered to be relatively sparse and randomly distributed. The spaces between cristae (intercristae spaces) are thought to allow for efficient diffusion of metabolites and ions, facilitating metabolic processes within the mitochondria.\nCrista Junction Model:\nThe Crista Junction Model proposes a different organization of cristae within mitochondria. According to this model, cristae are interconnected by narrow tubular structures known as cristae junctions. These junctions serve as gateways that regulate the exchange of molecules between the intermembrane space and the mitochondrial matrix.\nIn the Crista Junction Model, the cristae are believed to be more tightly packed and organized compared to the Baffle Model. The presence of cristae junctions allows for compartmentalization of the inner mitochondrial membrane, segregating different metabolic processes and creating microenvironments within the mitochondria.\n\n\n\n\n\n\n\n\n\nElectron Transport in the Cristae\n\n\n\n\nThe electron transport chain (ETC) in mitochondria is a crucial process in cellular respiration, where electrons derived from the oxidation of nutrients are passed along a series of protein complexes embedded in the inner mitochondrial membrane (IMM). This process generates a proton gradient across the membrane, which is used to produce adenosine triphosphate (ATP) through oxidative phosphorylation. Cristae, the inward-folded structures of the IMM, play a critical role in facilitating the ETC and ATP synthesis. Here’s how the ETC functions within the cristae:\n\nOrganization within Cristae: Cristae provide an extensive surface area for the assembly and functioning of the ETC complexes. The proteins comprising the ETC, including complex I (NADH dehydrogenase), complex II (succinate dehydrogenase), complex III (cytochrome bc1 complex), complex IV (cytochrome c oxidase), and ATP synthase (complex V), are embedded within the cristae membranes.\nElectron Transfer: The ETC begins with the transfer of electrons from NADH or FADH2 to complex I or complex II, respectively. These electrons are then passed sequentially through the ETC complexes, with each complex accepting and donating electrons to the next in the chain. As electrons move along the chain, they release energy that is used to pump protons (H+) across the cristae membrane from the mitochondrial matrix to the intermembrane space.\nProton Gradient Formation: The pumping of protons from the mitochondrial matrix into the intermembrane space creates a proton gradient across the cristae membrane. This gradient represents stored energy that can be harnessed to drive ATP synthesis.\nATP Synthesis: The proton gradient established by the ETC drives the rotation of the rotor subunit within ATP synthase (complex V). This rotational motion catalyzes the synthesis of ATP from adenosine diphosphate (ADP) and inorganic phosphate (Pi) in a process known as chemiosmosis. ATP synthase is located within the cristae membrane and utilizes the energy from proton movement to generate ATP.\n\n\n\n\n\n\n\n\n\nOrigins of the Mitochondria\n\n\n\n\nAround 1.5 billion years ago, a remarkable event occurred in the history of life on Earth: the engulfment of a free-living bacterium by a primitive eukaryotic cell. This bacterium was likely an alpha-proteobacterium, a group of bacteria closely related to modern-day mitochondria. Instead of being digested by the host cell, this bacterium formed a symbiotic relationship with it, possibly providing additional energy in the form of ATP through aerobic respiration.\nOver time, this symbiotic relationship evolved, with the engulfed bacterium becoming increasingly integrated into the host cell. This integration involved a gradual transfer of genetic material from the bacterium to the host cell nucleus, resulting in the loss of many bacterial genes and the retention of only a small genome within the mitochondria. This genome is now known as mitochondrial DNA (mtDNA).\nAs this symbiosis continued, the host cell and the engulfed bacterium became interdependent, with the bacterium specializing in energy production through oxidative phosphorylation (aerobic respiration) while the host cell provided protection and resources. This symbiotic relationship proved to be highly advantageous, allowing eukaryotic cells to generate more energy and thus thrive in diverse environments.\nThrough natural selection and genetic drift, the symbiotic bacterium gradually evolved into the mitochondria we see in modern eukaryotic cells. Mitochondria retained their own distinct characteristics, such as a double membrane structure and their own genome (mtDNA), while also becoming integrated into the cellular machinery of the host cell.\n\n\n\n\n\n\n\n\nBiogenesis of Respiratory Chain Proteins\n\n\n\n\nThe biogenesis of respiratory chain proteins, which are essential components of the electron transport chain (ETC) in mitochondria, involves a complex process of synthesis, assembly, and insertion into the inner mitochondrial membrane (IMM). Here’s an overview of the steps involved:\n\nSynthesis of Mitochondrial Proteins: The majority of mitochondrial proteins, including those involved in the respiratory chain, are encoded by nuclear genes and synthesized in the cytoplasm as precursor proteins. These precursor proteins typically contain N-terminal targeting sequences, called mitochondrial targeting sequences (MTS) or presequences, that direct them to the mitochondria.\nImport into Mitochondria: Upon synthesis in the cytoplasm, mitochondrial precursor proteins are recognized by cytoplasmic chaperones and escorted to the translocase of the outer membrane (TOM) complex, which is responsible for the initial recognition and translocation of precursor proteins across the outer mitochondrial membrane (OMM). The MTS directs the precursor protein through the TOM complex into the intermembrane space (IMS).\nSorting and Processing: Once in the IMS, the MTS is cleaved by the mitochondrial processing peptidase (MPP), resulting in the removal of the targeting sequence and yielding the mature protein. Some proteins require further processing by additional proteases within the IMS.\nAssembly of Respiratory Complexes: Mature proteins synthesized in the cytoplasm or imported into the mitochondria are assembled into multi-subunit complexes that constitute the respiratory chain. These complexes include complex I (NADH dehydrogenase), complex II (succinate dehydrogenase), complex III (cytochrome bc1 complex), complex IV (cytochrome c oxidase), and ATP synthase (complex V).\nInsertion into the Inner Mitochondrial Membrane (IMM): The assembled respiratory chain complexes are inserted into the IMM with the assistance of various assembly factors and chaperones. The precise mechanisms of insertion and assembly vary for each complex but often involve interactions with specific lipid components of the IMM and assembly factors that facilitate proper folding and integration into the membrane.\nFormation of Supramolecular Structures: Once inserted into the IMM, individual respiratory chain complexes can interact with each other to form supramolecular structures known as supercomplexes or respirasomes. These structures optimize electron transfer efficiency and minimize reactive oxygen species (ROS) production by facilitating the rapid and efficient transfer of electrons through the ETC.\n\n\n\n\n\n\n\n\nTargeting Sequences\n\n\n\n\nThe mitochondrial targeting sequence (MTS), also known as a mitochondrial transit peptide or presequence, is a short, hydrophobic peptide sequence found at the N-terminus of proteins destined for import into mitochondria. The MTS serves as a molecular tag that directs precursor proteins from the cytoplasm to the mitochondria, where they undergo further processing and are ultimately integrated into the mitochondrial compartments.\nHere’s how the mitochondrial targeting sequence works:\n\nRecognition in the Cytoplasm: Newly synthesized precursor proteins containing an MTS are recognized by cytoplasmic chaperones and targeting factors. These factors prevent the premature folding of the precursor protein and help maintain its unfolded state, facilitating its recognition by the mitochondrial import machinery.\nTranslocation across the Outer Membrane: The precursor protein, bound to cytoplasmic chaperones, is guided to the translocase of the outer membrane (TOM) complex, which is located in the outer mitochondrial membrane (OMM). The TOM complex recognizes the MTS and facilitates the translocation of the precursor protein across the OMM into the intermembrane space (IMS) of the mitochondria.\nProcessing and Sorting: Once in the IMS, the MTS is cleaved by the mitochondrial processing peptidase (MPP), resulting in the removal of the targeting sequence. This cleavage event releases the mature protein, which may then be further sorted and directed to its specific destination within the mitochondria, such as the matrix, inner mitochondrial membrane (IMM), or intermembrane space.\nIntegration into Mitochondrial Compartments: The mature protein is then integrated into the appropriate mitochondrial compartment, where it performs its specific function. This integration process may involve additional folding, assembly into multi-subunit complexes, or insertion into the IMM, depending on the protein’s destination and function within the mitochondria.\n\n\n\n\n\n\n\n\n\nImporting Proteins into the Mitochondria\n\n\n\n\nMitochondrial protein import is a fundamental process by which proteins synthesized in the cytoplasm are transported into mitochondria, where they perform essential functions in various mitochondrial compartments. This import process is highly regulated and involves several steps, ensuring that proteins are correctly targeted to their specific destinations within mitochondria. Here’s an overview of mitochondrial protein import:\n\nRecognition of Mitochondrial Targeting Sequence (MTS): Proteins destined for import into mitochondria typically contain an N-terminal mitochondrial targeting sequence (MTS), also known as a mitochondrial transit peptide or presequence. The MTS is recognized by cytoplasmic chaperones and targeting factors, which prevent premature folding of the precursor protein and facilitate its recognition by the mitochondrial import machinery.\nTranslocation Across the Outer Membrane: The precursor protein, bound to cytoplasmic chaperones, is directed to the translocase of the outer membrane (TOM) complex, located in the outer mitochondrial membrane (OMM). The TOM complex recognizes the MTS and facilitates the translocation of the precursor protein across the OMM into the intermembrane space (IMS) of the mitochondria.\nSorting and Processing in the Intermembrane Space (IMS): Once in the IMS, the MTS is cleaved by the mitochondrial processing peptidase (MPP), resulting in the removal of the targeting sequence. This cleavage event releases the mature protein, which may then be further sorted and directed to its specific destination within the mitochondria, such as the matrix, inner mitochondrial membrane (IMM), or intermembrane space.\nTranslocation Across the Inner Membrane: Proteins targeted to the mitochondrial matrix or inner mitochondrial membrane (IMM) undergo additional translocation steps across the inner membrane. This process is facilitated by protein translocases, including the presequence translocase-associated motor (PAM) complex and the TIM22 and TIM23 complexes. These translocases recognize and transport proteins with specific targeting signals across the IMM into the matrix or inner membrane.\nIntegration into Mitochondrial Compartments: Once inside the mitochondrial matrix or IMM, proteins may undergo further folding, assembly into multi-subunit complexes, or insertion into the membrane, depending on their specific functions within mitochondria. Some proteins may also remain in the IMS, where they perform specialized roles in processes such as protein folding, oxidative protein folding, or apoptosis regulation.\n\n\n\n\n\n\n\n\n\nEnergy Requirements During Import\n\n\n\n\nEnergy plays a crucial role in mitochondrial protein import, facilitating the translocation of precursor proteins across the mitochondrial membranes and their subsequent sorting and processing within mitochondria. Here’s how energy is involved in various stages of mitochondrial protein import:\n\nTranslocation Across the Outer Membrane: The translocation of precursor proteins across the outer mitochondrial membrane (OMM) is facilitated by the translocase of the outer membrane (TOM) complex. While some precursor proteins are passively translocated through the TOM complex, others require energy in the form of ATP to overcome the electrochemical gradient across the membrane and enter the intermembrane space (IMS) of the mitochondria. ATP hydrolysis provides the energy needed for the initial translocation step.\nTranslocation Across the Inner Membrane: Precursor proteins targeted to the mitochondrial matrix or inner mitochondrial membrane (IMM) undergo additional translocation steps across the inner membrane. This process is facilitated by protein translocases, including the presequence translocase-associated motor (PAM) complex and the TIM22 and TIM23 complexes. ATP hydrolysis by the PAM complex provides the energy required for the translocation of proteins across the inner membrane into the matrix or inner membrane.\nFolding, Sorting, and Processing: Once inside the mitochondrial matrix or IMM, precursor proteins may undergo folding, assembly into multi-subunit complexes, or insertion into the membrane. These processes often require energy in the form of ATP to facilitate protein folding, conformational changes, and membrane insertion. ATP-dependent chaperones and protein folding enzymes within mitochondria utilize ATP hydrolysis to assist in protein folding and quality control.\nMaintenance of Membrane Potential: The maintenance of an electrochemical gradient across the mitochondrial membranes, driven by proton pumping by the electron transport chain (ETC), is essential for mitochondrial protein import. This proton gradient provides the driving force for the import of precursor proteins into mitochondria and the translocation of proteins across the inner membrane. ATP hydrolysis by the ATP synthase complex, located in the inner membrane, contributes to the maintenance of the proton gradient by consuming ATP to drive proton pumping."
  },
  {
    "objectID": "chapters/week5.html#reactive-oxygen-species",
    "href": "chapters/week5.html#reactive-oxygen-species",
    "title": "5  Mitochondria in Aging and Neurodegeneration",
    "section": "5.2 Reactive Oxygen Species",
    "text": "5.2 Reactive Oxygen Species\n\n\n\n\n\nSuperoxide Generation from the Mitochondria\n\n\n\n\nSuperoxide generation by mitochondria is a natural byproduct of the electron transport chain (ETC) during oxidative phosphorylation, the process by which cells produce adenosine triphosphate (ATP). While mitochondria play a crucial role in cellular energy production, they can also generate reactive oxygen species (ROS), including superoxide radicals (O2•−), as a result of electron leakage from the ETC. Here’s how superoxide is generated by mitochondria:\n\nElectron Leakage: During oxidative phosphorylation, electrons are transferred along the ETC through a series of protein complexes embedded in the inner mitochondrial membrane (IMM). While the majority of electrons flow smoothly through the ETC, some leakage can occur at various points along the chain, particularly at complexes I and III. This electron leakage leads to the partial reduction of molecular oxygen (O2) to form superoxide radicals (O2•−).\nSite of Generation: The primary sites of superoxide generation within mitochondria are believed to be complexes I and III of the ETC. Complex I (NADH dehydrogenase) and complex III (cytochrome bc1 complex) are known to produce superoxide radicals as a result of single-electron reduction of molecular oxygen by ubisemiquinone radicals (ubisemiquinone-O2 reaction) and cytochrome b, respectively.\nRegulation and Mitochondrial ROS Production: Mitochondrial superoxide generation is regulated by various factors, including the redox state of electron carriers within the ETC, the proton motive force across the inner mitochondrial membrane (IMM), and the availability of oxygen as a terminal electron acceptor. Changes in mitochondrial membrane potential, substrate availability, or ETC inhibitors can alter ROS production by mitochondria.\nPhysiological and Pathological Roles: While superoxide generation by mitochondria is a natural process essential for cellular signaling and redox homeostasis, excessive ROS production can have detrimental effects on cellular components, leading to oxidative damage, mitochondrial dysfunction, and cell death. Mitochondrial ROS have been implicated in various physiological processes, including cell signaling, apoptosis, and aging, as well as in the pathogenesis of numerous diseases, including neurodegenerative disorders, cardiovascular diseases, and cancer.\n\n\n5.2.1 Radical Theory\n\n\n\n\n\nRadical Theory of Aging\n\n\n\n\nThe mitochondrial free radical theory of aging proposes that aging and age-related diseases are, at least in part, driven by the cumulative damage caused by reactive oxygen species (ROS) generated by mitochondria during cellular respiration. Here’s an overview of the theory:\n\nROS Production by Mitochondria: Mitochondria are the primary producers of ROS within cells. During oxidative phosphorylation, electrons leaking from the electron transport chain (ETC) can react with molecular oxygen (O2), resulting in the formation of superoxide radicals (O2•−). Superoxide can then be converted into other ROS, including hydrogen peroxide (H2O2) and hydroxyl radicals (•OH), through various enzymatic and non-enzymatic reactions.\nDamage to Cellular Components: ROS generated by mitochondria can react with and damage cellular components, including lipids, proteins, and DNA. This oxidative damage can lead to disruptions in cellular homeostasis, impaired cellular function, and ultimately contribute to the aging process. For example, ROS-induced lipid peroxidation can lead to membrane damage, protein oxidation can impair enzymatic function, and DNA damage can result in mutations and cellular dysfunction.\nMitochondrial Dysfunction: Over time, the accumulation of oxidative damage to mitochondrial components can lead to mitochondrial dysfunction, including impaired ATP production, altered mitochondrial membrane potential, and increased production of ROS. This creates a vicious cycle whereby dysfunctional mitochondria produce even more ROS, exacerbating oxidative damage and further compromising cellular function.\nAge-Related Diseases: Mitochondrial ROS and oxidative stress have been implicated in the pathogenesis of various age-related diseases, including neurodegenerative disorders (e.g., Alzheimer’s disease, Parkinson’s disease), cardiovascular diseases, metabolic disorders, and cancer. Oxidative damage to cellular components contributes to the development and progression of these diseases, highlighting the role of mitochondrial dysfunction in aging-related pathologies.\nAntioxidant Defenses and Longevity: While ROS are inherently reactive and damaging, cells possess antioxidant defense mechanisms to neutralize and mitigate their effects. These include enzymatic antioxidants (e.g., superoxide dismutase, catalase, glutathione peroxidase) and non-enzymatic antioxidants (e.g., vitamin C, vitamin E, glutathione). Enhanced antioxidant defenses have been associated with increased longevity and reduced age-related pathologies in various model organisms.\n\n\n\n5.2.2 Superoxide Dismutase\n\n\n\n\n\nIllustration of Superoxide Dismutase’s Function\n\n\n\n\nSuperoxide dismutase (SOD) is an enzyme that catalyzes the conversion of superoxide radicals (O2•−) into hydrogen peroxide (H2O2) and molecular oxygen (O2). However, hydrogen peroxide itself is also a reactive oxygen species (ROS) that can cause cellular damage if not properly neutralized. To further detoxify hydrogen peroxide, cells utilize other enzymes such as catalase and glutathione peroxidase. Here’s how the conversion of hydrogen peroxide to water (H2O) occurs:\n\nCatalase: Catalase is an enzyme found in peroxisomes and certain other cellular compartments. It catalyzes the decomposition of hydrogen peroxide into water and molecular oxygen, as follows:\n\\(2H_2O_2 \\rightarrow 2H_2O + O_2\\)\nCatalase rapidly converts hydrogen peroxide into water and oxygen, thereby neutralizing its harmful effects on cells.\nGlutathione Peroxidase: Glutathione peroxidase is another enzyme involved in the detoxification of hydrogen peroxide. It utilizes reduced glutathione (GSH) as a cofactor to reduce hydrogen peroxide to water while oxidizing glutathione to its disulfide form. The reaction is as follows:\n\\(2GSH + H_2O_2 \\rightarrow GSSG + 2H_2O\\)\nIn this reaction, glutathione peroxidase reduces two molecules of hydrogen peroxide to two molecules of water while simultaneously oxidizing two molecules of glutathione."
  },
  {
    "objectID": "chapters/week5.html#mitochondria-and-apoptosis",
    "href": "chapters/week5.html#mitochondria-and-apoptosis",
    "title": "5  Mitochondria in Aging and Neurodegeneration",
    "section": "5.3 Mitochondria and Apoptosis",
    "text": "5.3 Mitochondria and Apoptosis\n\n\n\n\n\nDifferences Between Apoptosis and Necrosis\n\n\n\n\nApoptosis, often referred to as programmed cell death, is a highly regulated process that occurs in multicellular organisms. It is characterized by a series of biochemical events that lead to the controlled and orderly dismantling of cells. Apoptosis is initiated by either extrinsic (death receptor-mediated) or intrinsic (mitochondrial-mediated) pathways. In the intrinsic pathway, various stress signals trigger the release of cytochrome c from mitochondria, which activates caspase enzymes, leading to cell death. In the extrinsic pathway, binding of death ligands to death receptors on the cell surface activates caspase enzymes directly.\nApoptosis exhibits specific characteristics, including cell shrinkage and condensation of chromatin, as well as the formation of apoptotic bodies, which are small membrane-bound vesicles containing cellular contents. These apoptotic bodies are subsequently phagocytosed by neighboring cells or professional phagocytes, such as macrophages. In terms of its physiological role, apoptosis plays essential roles in various processes, including tissue development, immune system regulation, and the elimination of damaged or infected cells. It helps maintain tissue homeostasis and contributes to overall organismal health.\nNecrosis, in contrast to apoptosis, is a form of cell death characterized by rapid and uncontrolled cellular degradation, often resulting from acute injury, ischemia, or toxic insults. Unlike apoptosis, necrosis does not follow a programmed pathway and is associated with inflammation and tissue damage. Necrosis typically involves cellular swelling, organelle dysfunction, and rupture of the plasma membrane, leading to the release of cellular contents into the extracellular space.\nNecrosis is not a regulated process and can occur as a result of various insults, such as physical trauma, infection, or exposure to toxins. The inflammatory response triggered by necrotic cell death serves to remove the damaged tissue and initiate repair processes. However, excessive or prolonged necrosis can contribute to tissue damage and exacerbate pathological conditions. Unlike apoptosis, necrosis is generally considered detrimental to organismal health and is often associated with pathological states, including ischemic injury, neurodegenerative diseases, and cancer.\n\n5.3.1 Caspase Activation\n\n\n\n\n\nCaspase Activation\n\n\n\n\nDuring apoptosis, caspases, which are a family of cysteine–aspartic protease enzymes, play a central role in orchestrating the dismantling of the cell. The process begins with the initiation of apoptosis by various signals, such as DNA damage, cellular stress, or signaling molecules from neighboring cells. These signals trigger the activation of initiator caspases, such as caspase 8 and caspase 9.\nInitiator caspases exist in an inactive form within the cell until they are activated by apoptotic signals. Once activated, caspase 8 is involved in the extrinsic pathway of apoptosis, while caspase 9 is involved in the intrinsic pathway. Both pathways ultimately converge to activate downstream effector caspases, including caspase 3, caspase 6, and caspase 7.\nActivated initiator caspases cleave and activate effector caspases, leading to the amplification of the apoptotic signal and the execution of cell death. Effector caspases, in turn, cleave multiple cellular substrates, including structural proteins, DNA repair enzymes, and signaling molecules, ultimately leading to the characteristic morphological and biochemical changes associated with apoptosis.\n\n\n5.3.2 Phagocytosis of Apoptotic Cells\n\n\n\n\n\nPhagocytosis of Apoptotic Cells\n\n\n\n\nPhagocytosis of apoptotic cells is a vital process in the clearance of dying cells and the maintenance of tissue homeostasis. When cells undergo apoptosis, they display specific signals on their surface that mark them for recognition and engulfment by phagocytes, such as macrophages and dendritic cells. Here’s how phagocytosis of apoptotic cells occurs:\n\nRecognition of Apoptotic Cells: During apoptosis, dying cells undergo changes in their membrane composition and structure. This includes the exposure of “eat-me” signals, such as phosphatidylserine (PS), on the outer leaflet of the plasma membrane. These signals serve as ligands for receptors on phagocytic cells, facilitating the recognition and binding of apoptotic cells by phagocytes.\nEngulfment by Phagocytes: Once recognized, apoptotic cells are engulfed by phagocytes through a process known as phagocytosis. This involves the extension of pseudopodia around the apoptotic cell, leading to its internalization within a phagocytic vesicle called a phagosome. The phagosome then undergoes maturation, fusing with lysosomes to form a phagolysosome, where the engulfed apoptotic cell is degraded.\nAnti-inflammatory Response: Phagocytosis of apoptotic cells typically triggers an anti-inflammatory response in the phagocytic cell. This is mediated by the release of anti-inflammatory cytokines, such as transforming growth factor-beta (TGF-β), and the inhibition of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β). This anti-inflammatory response helps to resolve inflammation and prevent tissue damage.\nProcessing and Clearance: Within the phagolysosome, the engulfed apoptotic cell is broken down by lysosomal enzymes, leading to the degradation of cellular components into their constituent molecules. These molecules, including amino acids, nucleotides, and lipids, can be recycled by the phagocyte or released back into the extracellular environment. Clearance of apoptotic cells by phagocytosis helps to maintain tissue homeostasis and prevent the release of potentially harmful cellular contents.\n\n\n\n5.3.3 Pathways of Apoptosis\n\n5.3.3.1 Extrinsic\n\n\n\n\n\nExtrinsic Pathway of Apoptosis\n\n\n\n\nThe extrinsic pathway of apoptosis, also known as the death receptor pathway, is one of the two main pathways by which apoptosis is initiated in multicellular organisms. This pathway is triggered by extracellular signals that bind to death receptors on the cell surface, leading to the activation of caspase enzymes and ultimately resulting in cell death. Here’s an overview of the extrinsic pathway:\n\nInitiation: The extrinsic pathway is initiated by the binding of extracellular death ligands, such as Fas ligand (FasL) or tumor necrosis factor-alpha (TNF-α), to specific death receptors on the cell surface. These death receptors belong to the tumor necrosis factor receptor (TNFR) superfamily and include Fas (CD95/APO-1), TNF receptor 1 (TNFR1), and TNF-related apoptosis-inducing ligand receptor (TRAIL-R).\nFormation of Death-Inducing Signaling Complex (DISC): Binding of the death ligand to its receptor induces conformational changes in the receptor, leading to the recruitment and clustering of adaptor proteins, such as Fas-associated death domain (FADD) and TNF receptor-associated death domain (TRADD), to the cytoplasmic domain of the receptor. These adaptor proteins then recruit procaspase-8 or procaspase-10 to form a multiprotein complex called the Death-Inducing Signaling Complex (DISC) at the cytoplasmic face of the plasma membrane.\nActivation of Caspases: Within the DISC, procaspase-8 or procaspase-10 molecules are brought into close proximity, facilitating their autoactivation by cleavage. Activated caspase-8 or caspase-10 then cleaves and activates downstream effector caspases, such as caspase-3, caspase-6, and caspase-7, initiating the execution phase of apoptosis.\nExecution of Apoptosis: Once activated, effector caspases cleave various cellular substrates, leading to characteristic morphological and biochemical changes associated with apoptosis, including DNA fragmentation, cytoskeletal reorganization, membrane blebbing, and formation of apoptotic bodies. These changes ultimately result in the dismantling of the cell and its phagocytic removal by neighboring cells or professional phagocytes.\n\n\n\n5.3.3.2 Intrinsic\n\n\n\n\n\nIntrinsic Pathway of Apoptosis\n\n\n\n\nThe intrinsic pathway of apoptosis, also known as the mitochondrial pathway, is a crucial mechanism by which cells initiate programmed cell death in response to internal stress signals, such as DNA damage, cellular injury, or nutrient deprivation. Unlike the extrinsic pathway, which is initiated by external death ligands binding to cell surface death receptors, the intrinsic pathway involves mitochondrial signaling events that lead to the release of pro-apoptotic proteins and the activation of caspase enzymes. Here’s an overview of the intrinsic pathway:\n\nMitochondrial Outer Membrane Permeabilization (MOMP): The intrinsic pathway is initiated by various intracellular stress signals, such as DNA damage or oxidative stress, which lead to the activation of pro-apoptotic proteins, including Bcl-2-associated X protein (BAX) and Bcl-2-antagonist/killer (BAK). These proteins undergo conformational changes and oligomerize on the outer mitochondrial membrane, leading to mitochondrial outer membrane permeabilization (MOMP).\nRelease of Pro-Apoptotic Proteins: MOMP results in the release of pro-apoptotic proteins from the intermembrane space of the mitochondria into the cytoplasm. These proteins include cytochrome c, Smac/DIABLO (Second mitochondria-derived activator of caspases/direct IAP-binding protein with low pI), and apoptosis-inducing factor (AIF). Cytochrome c binds to apoptotic protease-activating factor 1 (Apaf-1), forming the apoptosome complex, which activates caspase-9, an initiator caspase.\nActivation of Caspases: Activation of caspase-9 within the apoptosome complex leads to the activation of downstream effector caspases, such as caspase-3, caspase-6, and caspase-7. These effector caspases orchestrate the execution phase of apoptosis by cleaving various cellular substrates, leading to the characteristic morphological and biochemical changes associated with cell death.\nRegulation by Bcl-2 Family Proteins: The intrinsic pathway of apoptosis is tightly regulated by members of the Bcl-2 family of proteins, which include both pro-apoptotic (e.g., BAX, BAK, Bid) and anti-apoptotic (e.g., Bcl-2, Bcl-xL) members. The balance between pro-apoptotic and anti-apoptotic Bcl-2 family members determines the susceptibility of cells to undergo apoptosis in response to intracellular stress signals.\nPhysiological and Pathological Roles: The intrinsic pathway of apoptosis plays essential roles in various physiological processes, including tissue development, immune system regulation, and the elimination of damaged or infected cells. Dysregulation of this pathway can contribute to various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.\n\n\n\n\n5.3.4 Bak, Bax, and Cytochrome C Release\n\n\n\n\n\nBak and Bax Action\n\n\n\n\nBax and Bak are pro-apoptotic members of the Bcl-2 protein family that play a central role in initiating the intrinsic pathway of apoptosis. When cells undergo stress or receive apoptotic signals, inactive monomeric forms of Bax and Bak undergo a conformational change, leading to their activation and oligomerization. Here’s how the process unfolds:\n\nInactive Bax and Bak: Normally, Bax and Bak exist in an inactive monomeric state within the cytoplasm or associated with intracellular membranes, such as the outer mitochondrial membrane (OMM). In this state, they are unable to induce apoptosis.\nOligomerization of Bax and Bak: Upon receiving apoptotic signals, such as DNA damage or cellular stress, Bax and Bak undergo a conformational change that exposes their hydrophobic domains. This change allows multiple Bax and Bak molecules to interact and form oligomeric complexes on the OMM.\nPermeabilization of the Outer Mitochondrial Membrane (MOMP): The oligomerization of Bax and Bak leads to the permeabilization of the outer mitochondrial membrane (MOMP). This process allows the release of pro-apoptotic proteins, including cytochrome c, from the intermembrane space of the mitochondria into the cytoplasm.\nCytochrome c Release: Cytochrome c is a key protein involved in the intrinsic pathway of apoptosis. Once released into the cytoplasm following MOMP, cytochrome c binds to apoptotic protease-activating factor 1 (Apaf-1), leading to the formation of the apoptosome complex.\nActivation of Caspases: The apoptosome complex activates caspase-9, an initiator caspase, which in turn activates downstream effector caspases, such as caspase-3, caspase-6, and caspase-7. These effector caspases execute the apoptotic program by cleaving various cellular substrates, ultimately leading to cell death.\n\n\n\n5.3.5 Inactivating Bak and Bax with Bcl-2\n\n\n\n\n\nInactivation of Bak and Bax\n\n\n\n\nBcl-2 plays a crucial role in preventing apoptosis by inhibiting the activation of Bax and Bak. Here’s how Bcl-2 inhibits Bax and Bak:\n\nBinding and Sequestration: Bcl-2 can directly bind to Bax and Bak, preventing their activation and oligomerization. By sequestering Bax and Bak in an inactive state, Bcl-2 inhibits their ability to permeabilize the outer mitochondrial membrane (MOMP) and release pro-apoptotic proteins such as cytochrome c.\nMaintenance of Mitochondrial Integrity: Bcl-2 also helps maintain mitochondrial integrity by stabilizing the outer mitochondrial membrane and preventing its permeabilization. This stabilization further contributes to the inhibition of Bax and Bak activation and the prevention of cytochrome c release.\nInhibition of Apoptotic Signaling: By inhibiting Bax and Bak, Bcl-2 blocks the initiation of the intrinsic pathway of apoptosis. This prevents the downstream activation of caspases and the execution of the apoptotic program. As a result, cells are protected from undergoing apoptosis even in the presence of apoptotic stimuli.\nRegulation of Cell Fate: The balance between pro-apoptotic proteins like Bax and Bak and anti-apoptotic proteins like Bcl-2 determines the fate of the cell. In healthy cells, the presence of Bcl-2 maintains this balance, promoting cell survival. However, under conditions of cellular stress or damage, the balance may shift towards pro-apoptotic signaling, leading to the activation of Bax and Bak and the initiation of apoptosis.\n\n\n\n5.3.6 BH3-Only Proteins\nBH3-only proteins play a crucial role in regulating apoptosis by modulating the activity of Bcl-2 family proteins. These proteins are so named because they contain only the BH3 (Bcl-2 homology 3) domain, which is essential for their pro-apoptotic function. Here’s how BH3-only proteins function in the intrinsic pathway of apoptosis:\n\nProduction or Activation of BH3-only Protein: BH3-only proteins can be produced in response to various cellular stress signals, such as DNA damage, nutrient deprivation, or growth factor withdrawal. Alternatively, existing BH3-only proteins may become activated through post-translational modifications or changes in cellular localization. Once produced or activated, BH3-only proteins serve as sensors of cellular stress and initiate apoptotic signaling pathways.\nInactivation of Bcl-2: BH3-only proteins exert their pro-apoptotic effects by binding to and inhibiting the anti-apoptotic members of the Bcl-2 family, such as Bcl-2 itself. By binding to Bcl-2, BH3-only proteins disrupt its anti-apoptotic function, thereby promoting apoptosis. This frees up pro-apoptotic proteins like Bax and Bak to initiate the intrinsic pathway of apoptosis.\nBax, Bak Activation (Oligomerization): In the absence of inhibition by anti-apoptotic Bcl-2 proteins, pro-apoptotic proteins like Bax and Bak become activated and undergo oligomerization. Oligomerization refers to the formation of multimeric complexes of Bax and Bak proteins on the outer mitochondrial membrane. These oligomeric complexes lead to mitochondrial outer membrane permeabilization (MOMP), resulting in the release of pro-apoptotic proteins such as cytochrome c into the cytoplasm."
  },
  {
    "objectID": "chapters/week6.html",
    "href": "chapters/week6.html",
    "title": "6  Autophagy of Protein Aggregates and Mitochondria",
    "section": "",
    "text": "Autophagy Mechanism Illustrated\n\n\n\n\nAutophagy is a cellular process responsible for the degradation and recycling of damaged or unnecessary cellular components, including protein aggregates and dysfunctional organelles such as mitochondria. Here’s how autophagy mechanisms work in directing degradation targets to lysosomes:\n\nInitiation of Autophagy: Autophagy is initiated in response to various cellular stresses, such as nutrient deprivation, oxidative stress, or protein aggregation. The initiation phase involves the activation of key autophagy-related proteins, including the ULK1 (unc-51 like autophagy activating kinase 1) complex and the class III phosphatidylinositol 3-kinase (PI3K) complex.\nFormation of Autophagosome: Once initiated, autophagy progresses through several steps, including the formation of a specialized double-membrane structure called the autophagosome. The autophagosome sequesters cellular components targeted for degradation, including protein aggregates and dysfunctional organelles such as mitochondria.\nTargeting Degradation Targets: Selective autophagy mechanisms enable the specific targeting of degradation targets to autophagosomes. In the case of protein aggregates, selective autophagy receptors, such as p62/SQSTM1 (sequestosome 1), recognize ubiquitinated proteins and bind to both the cargo and the autophagosomal membrane, facilitating their engulfment into autophagosomes. Similarly, dysfunctional mitochondria are targeted for degradation through selective autophagy receptors, such as NIX (also known as BNIP3L) and FUNDC1, which recognize damaged mitochondria and recruit them to autophagosomes.\nFusion with Lysosomes: Following sequestration of cargo, autophagosomes undergo fusion with lysosomes to form autolysosomes. Lysosomes contain acidic hydrolases that degrade the engulfed cargo, resulting in the breakdown of proteins, lipids, nucleic acids, and other cellular components. This process releases the breakdown products, such as amino acids and fatty acids, for reuse by the cell.\nDegradation and Recycling: Within autolysosomes, the cargo undergoes degradation by lysosomal enzymes. Proteins are degraded into amino acids, which can be recycled for protein synthesis or used as an energy source. Lipids are broken down into fatty acids, while nucleic acids are degraded into nucleotides. This degradation process ensures the removal of damaged or unnecessary cellular components and contributes to cellular homeostasis and survival.\n\n\n\n\n\n\n\n\nFrom Cytosol to Lysosome\n\n\n\n\nThe journey of autophagy from the cytosol to the lysosome involves several key steps:\n\nInitiation: Autophagy is initiated in response to various cellular stresses, such as nutrient deprivation, oxidative stress, or protein aggregation. The initiation phase involves the activation of autophagy-related proteins, including the ULK1 (unc-51 like autophagy activating kinase 1) complex and the class III phosphatidylinositol 3-kinase (PI3K) complex.\nFormation of Phagophore: Once initiated, autophagy progresses with the formation of a phagophore, a crescent-shaped membrane structure derived from the endoplasmic reticulum (ER) or other membrane sources. The phagophore expands and engulfs cellular components targeted for degradation, including protein aggregates and dysfunctional organelles.\nFormation of Autophagosome: The edges of the phagophore seal to form a double-membrane vesicle called the autophagosome. The autophagosome encloses the cargo, sequestering it from the cytoplasm and creating a protective environment for degradation.\nLysosomal Fusion: The autophagosome then undergoes fusion with lysosomes, which are membrane-bound organelles containing acidic hydrolases. This fusion forms a structure called the autolysosome, where degradation occurs. Lysosomes provide the enzymes necessary for breaking down the engulfed cargo.\nCargo Degradation: Within the autolysosome, the cargo is exposed to the acidic pH and the enzymatic activity of lysosomal hydrolases. Proteins are degraded into amino acids, lipids into fatty acids, and nucleic acids into nucleotides. These breakdown products are then released back into the cytoplasm for reuse by the cell.\nRecycling and Reuse: The degraded components are recycled and can be used for various cellular processes, such as protein synthesis, energy production, or the maintenance of cellular membranes. This recycling process ensures the efficient utilization of cellular resources and contributes to cellular homeostasis.\n\n\n\n\n\n\n\n\n\n\n\nDiscovery of ATG Genes\n\n\n\n\nAutophagy was first discovered in yeast, particularly Saccharomyces cerevisiae, by Dr. Yoshinori Ohsumi, who was awarded the Nobel Prize in Physiology or Medicine in 2016 for his groundbreaking work. Dr. Ohsumi’s research led to the identification of a set of genes essential for autophagy, known as autophagy-related genes or ATG genes.\nThe discovery of ATG genes provided key insights into the molecular mechanisms underlying autophagy and paved the way for understanding the process in other organisms, including humans. By systematically studying yeast mutants defective in autophagy, Dr. Ohsumi and his team identified a series of genes involved in autophagosome formation, cargo recognition, and lysosomal degradation.\nSome of the key ATG genes identified in yeast include ATG1, ATG5, ATG6 (also known as VPS30), ATG8, and ATG12. These genes encode proteins that play crucial roles in different stages of the autophagy pathway, from the initiation of autophagosome formation to the fusion of autophagosomes with lysosomes.\nATG1 is a protein kinase involved in the initiation of autophagy, while ATG5 and ATG12 are involved in the conjugation of Atg8 (LC3 in mammals) to phosphatidylethanolamine, a critical step in autophagosome formation. ATG6/VPS30 is a subunit of the phosphatidylinositol 3-kinase (PI3K) complex, which regulates the nucleation of autophagosomal membranes.\n\n\n\n\n\n\n\n\n\nAutophagosome Formation\n\n\n\n\nThe autophagosome is a double-membraned vesicle that plays a central role in the process of autophagy, serving as the primary structure for sequestering and transporting cellular components destined for degradation within the lysosome. Here’s a closer look at the structure and function of the autophagosome:\n\nDouble-Membraned Structure: The autophagosome is characterized by its double-membraned structure, comprising an inner membrane and an outer membrane. These membranes are derived from various cellular sources, including the endoplasmic reticulum (ER), Golgi apparatus, plasma membrane, and mitochondria, among others.\nFormation: The formation of autophagosomes begins with the nucleation of a small membrane structure, known as the phagophore or isolation membrane. The phagophore expands and engulfs cytoplasmic components, including protein aggregates, damaged organelles, and invading pathogens, to form the autophagosome.\nSequestration of Cargo: As the phagophore expands, it sequesters cytoplasmic cargo within its lumen, encapsulating it within the double-membraned vesicle. This sequestration process allows for the selective targeting and isolation of cellular components destined for degradation, while excluding essential cellular structures from degradation.\nMaturation: Once formed, autophagosomes undergo maturation through a series of fusion events. They fuse with endosomes to form amphisomes, which subsequently fuse with lysosomes to form autolysosomes. These fusion events enable the delivery of autophagosomal cargo to lysosomes for degradation.\nDegradation of Cargo: Within autolysosomes, the acidic environment and the presence of lysosomal hydrolases facilitate the degradation of the sequestered cargo. Proteins, lipids, nucleic acids, and other cellular components are broken down into their constituent molecules, which can then be recycled by the cell.\nRole in Cellular Homeostasis: The autophagosome serves as a critical component of the cellular quality control system, allowing cells to eliminate damaged or unnecessary cellular components and maintain cellular homeostasis. Dysregulation of autophagosome formation and function has been implicated in various diseases, including neurodegenerative disorders, cancer, and metabolic diseases.\n\n\n\n\n\n\n\n\n\nSelective and Non-Selective Autophagy\n\n\n\n\nAutophagy is a highly regulated process that can be categorized into two main types based on the specificity of the cargo targeted for degradation: selective autophagy and non-selective autophagy.\n\nSelective Autophagy: Selective autophagy involves the targeted degradation of specific cellular components, such as damaged organelles, protein aggregates, or invading pathogens. Selective autophagy receptors recognize and bind to cargo destined for degradation, facilitating their engulfment into autophagosomes. Examples of selective autophagy include:\n\nMitophagy: Selective degradation of damaged or dysfunctional mitochondria.\nAggrephagy: Clearance of protein aggregates and inclusion bodies.\nPexophagy: Elimination of peroxisomes.\nLipophagy: Degradation of lipid droplets.\nXenophagy: Removal of intracellular pathogens, such as bacteria or viruses.\n\nNon-Selective Autophagy (Bulk Autophagy): Non-selective autophagy, also known as bulk autophagy, involves the indiscriminate degradation of cytoplasmic components to maintain cellular homeostasis during nutrient deprivation or other stress conditions. In non-selective autophagy, autophagosomes engulf cytoplasmic material randomly without specific cargo recognition. This form of autophagy is essential for recycling cellular constituents and generating nutrients and energy for cell survival during periods of stress.\n\n\n\n\n\n\n\n\nThree Different Kinds of Autophagy\n\n\n\n\nThe three different types of autophagy are:\n\nMacroautophagy: Macroautophagy, often simply referred to as autophagy, involves the sequestration of cytosolic components within double-membraned organelles called autophagosomes. These autophagosomes then fuse with lysosomes to form autolysosomes, where the engulfed cargo is degraded by lysosomal enzymes. Macroautophagy plays a fundamental role in the turnover of cellular components and the maintenance of cellular homeostasis.\nMicroautophagy: Microautophagy involves the direct engulfment of cytosolic components by lysosomes through invagination of the lysosomal membrane. Unlike macroautophagy, which involves the formation of autophagosomes, microautophagy occurs through direct membrane rearrangements at the lysosomal surface. Microautophagy contributes to the selective degradation of cytoplasmic constituents and plays a role in nutrient recycling and cellular quality control.\nChaperone-Mediated Autophagy (CMA): Chaperone-Mediated Autophagy (CMA) is a selective form of autophagy that targets specific cytosolic proteins for degradation. In CMA, chaperone proteins such as heat shock cognate 70 (HSC-70) recognize and bind to target proteins bearing a specific targeting motif. The chaperone-protein complex then interacts with lysosomal-associated membrane protein-2A (LAMP2A) on the lysosomal membrane, leading to the translocation of the unfolded target protein into the lysosome for degradation. CMA is essential for the removal of damaged or misfolded proteins and plays a role in cellular quality control and protein homeostasis.\n\n\n\n\n\n\n\n\n\n\nPhospholipid Structure\n\n\n\n\nPhospholipids are a crucial component of the lipid bilayer, the fundamental structure of cell membranes. Here’s how phospholipids contribute to the structure and function of the lipid bilayer:\n\nBasic Structure: Phospholipids consist of a hydrophilic (water-attracting) head region and two hydrophobic (water-repelling) tail regions. The hydrophilic head contains a phosphate group, which is polar and interacts with water molecules, while the hydrophobic tails consist of fatty acid chains that are nonpolar and repel water.\nArrangement in the Bilayer: In the lipid bilayer, phospholipids arrange themselves in a double layer with their hydrophilic heads facing outward toward the aqueous environment (extracellular space or cytoplasm) and their hydrophobic tails facing inward, away from water. This arrangement creates a hydrophobic core within the membrane, which acts as a barrier to the passage of water-soluble molecules.\nFluidity and Flexibility: Phospholipids confer fluidity and flexibility to the lipid bilayer. The presence of unsaturated fatty acid chains in some phospholipids introduces kinks in the hydrophobic tails, preventing them from packing tightly together. This results in a more fluid and flexible membrane that allows for lateral movement of phospholipids and membrane proteins.\nSelective Permeability: The lipid bilayer, composed primarily of phospholipids, exhibits selective permeability, allowing certain molecules to pass through while restricting the passage of others. Small, nonpolar molecules such as oxygen and carbon dioxide can diffuse freely through the lipid bilayer, while larger or charged molecules require specific transport proteins or channels for passage.\n\n\n\n\n\n\n\n\nFigures Pertaining to Phosphatidylinositol\n\n\n\n\nPhosphatidylinositol (PI) is a type of phospholipid that plays essential roles in cell signaling, membrane structure, and various cellular processes. Here are some key aspects of phosphatidylinositol:\n\nStructure: Phosphatidylinositol consists of a glycerol backbone, two fatty acid chains, and a phosphate group linked to the inositol head group. The inositol head group can be phosphorylated at different positions, leading to the formation of various phosphoinositides.\nCell Signaling: Phosphatidylinositol lipids are crucial components of cell signaling pathways. Phosphorylation of the inositol head group at the 3, 4, and 5 positions generates specific phosphoinositides, such as phosphatidylinositol 3-phosphate (PI3P), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), and phosphatidylinositol 3,4,5-trisphosphate (PIP3). These phosphoinositides serve as signaling molecules that regulate diverse cellular processes, including cell growth, proliferation, survival, and vesicle trafficking.\nMembrane Trafficking: Phosphatidylinositol lipids play critical roles in membrane trafficking and vesicle formation. They act as docking sites for proteins involved in vesicle budding, fusion, and trafficking between cellular compartments, such as the endoplasmic reticulum (ER), Golgi apparatus, endosomes, and lysosomes.\nCytoskeleton Regulation: Phosphatidylinositol lipids contribute to the regulation of the cytoskeleton, which is essential for cell shape, movement, and intracellular transport. Phosphoinositides interact with cytoskeletal proteins, such as actin-binding proteins and microtubule-associated proteins, to coordinate cytoskeletal dynamics and cellular processes such as cell migration and cytokinesis.\nMembrane Identity and Function: Phosphatidylinositol lipids help define the identity and function of cellular membranes. By interacting with specific proteins and other lipids, phosphoinositides contribute to membrane curvature, organization, and protein recruitment, thereby regulating membrane structure and function.\nImplications in Disease: Dysregulation of phosphatidylinositol signaling has been implicated in various human diseases, including cancer, neurodegenerative disorders, and metabolic diseases. Mutations in enzymes involved in phosphatidylinositol metabolism and signaling pathways can disrupt cellular homeostasis and contribute to disease pathogenesis.\n\n\n\n\n\n\n\n\n\n\nRegulating Autophagy\n\n\n\n\nThe initiation of autophagy involves a complex series of molecular events orchestrated by several key proteins and signaling pathways. Here’s an overview of the mechanism of autophagy initiation:\n\nActivation of Autophagy-Related Proteins: Autophagy initiation is regulated by a conserved protein kinase complex called the ULK1 (unc-51 like autophagy activating kinase 1) complex, which consists of ULK1, FIP200, ATG13, and ATG101. Under nutrient-rich conditions, the mammalian target of rapamycin complex 1 (mTORC1) phosphorylates ULK1 and inhibits its activity, thereby suppressing autophagy initiation. However, during nutrient deprivation or other stress conditions, mTORC1 is inhibited, leading to the activation of the ULK1 complex.\nNucleation of the Phagophore: Upon activation, the ULK1 complex phosphorylates and activates the class III phosphatidylinositol 3-kinase (PI3K) complex, which includes BECN1 (Beclin 1), VPS34 (vacuolar protein sorting 34), VPS15 (vacuolar protein sorting 15), and ATG14L. The activated PI3K complex generates phosphatidylinositol 3-phosphate (PI3P) on the endoplasmic reticulum (ER) membrane, promoting the nucleation of the phagophore or isolation membrane.\nPhagophore Expansion and Cargo Sequestration: The phagophore expands and engulfs cytoplasmic components, including protein aggregates, damaged organelles, and invading pathogens. This process involves the recruitment of ATG proteins, such as ATG12-ATG5-ATG16L1 complex, and the lipidation of LC3 (microtubule-associated protein 1A/1B-light chain 3) to form LC3-II, which is essential for phagophore elongation and cargo sequestration.\nClosure of the Autophagosome: As the phagophore expands and engulfs cytoplasmic cargo, it eventually closes to form a double-membraned vesicle called the autophagosome. The outer membrane of the autophagosome fuses with vesicles derived from the ER or other membrane sources, while the inner membrane sequesters the cargo destined for degradation.\nFusion with Lysosomes: After closure, autophagosomes undergo fusion with lysosomes, forming autolysosomes. This fusion event is mediated by proteins such as Rab7 and SNARE proteins. The lysosomal hydrolases within autolysosomes degrade the sequestered cargo, releasing breakdown products for recycling and reuse by the cell.\n\n\n\n\n\n\n\n\nModifying PE During Autophagy\n\n\n\n\nThe modification of Atg8 in yeast or LC3 in humans with phosphatidylethanolamine (PE) is a crucial step in the autophagy process. This modification plays a key role in autophagosome formation and cargo sequestration. Here’s how the PE modification of Atg8/LC3 occurs and its significance in autophagy:\n\nConjugation Process: Atg8 in yeast or LC3 in humans undergo a conjugation process to become lipidated with phosphatidylethanolamine (PE). This process involves a series of enzymatic reactions mediated by several autophagy-related proteins. First, Atg8/LC3 is cleaved at its C-terminus by the cysteine protease Atg4, exposing a glycine residue. Then, the exposed glycine residue is conjugated to the amino group of PE through a ubiquitin-like conjugation system. The conjugation of Atg8/LC3 to PE is catalyzed by the sequential action of Atg7 (E1-like enzyme) and Atg3 (E2-like enzyme). This results in the formation of the lipidated form of Atg8/LC3, known as Atg8-PE or LC3-II, which is associated with the autophagosomal membrane.\nMembrane Association: The lipidation of Atg8/LC3 with PE facilitates its association with the autophagosomal membrane. Atg8-PE or LC3-II is recruited to the expanding phagophore, the precursor structure of the autophagosome, where it plays a critical role in membrane elongation and closure. The lipidated form of Atg8/LC3 anchors the autophagosomal membrane to the cytosolic cargo, facilitating cargo sequestration within the autophagosome.\nCargo Sequestration: Atg8/LC3 lipidation with PE is essential for cargo sequestration during autophagy. The lipidated form of Atg8/LC3 acts as a molecular scaffold that binds to specific autophagy receptors, which in turn recognize and tether cargo molecules (such as protein aggregates, damaged organelles, or pathogens) to the autophagosomal membrane. This selective targeting and sequestration of cargo within the autophagosome are crucial for the degradation and recycling of cellular components.\nAutophagosome Maturation: The lipidation of Atg8/LC3 with PE also plays a role in autophagosome maturation and fusion with lysosomes. Once formed, autophagosomes undergo fusion with lysosomes to form autolysosomes, where the sequestered cargo is degraded by lysosomal enzymes. Atg8-PE or LC3-II remains associated with the autophagosomal membrane during this process and is eventually recycled upon autolysosome formation.\n\n\n\n\n\n\n\n\n\nMechanism of Autophagy Initiation\n\n\n\n\nThe initiation of autophagy involves various signaling pathways and regulatory proteins, one of which is the phosphatidylinositol 3-kinase (PI3K) complex. Here’s an overview of how PI3K contributes to autophagy initiation:\n\nFormation of the PI3K Complex: The PI3K complex involved in autophagy initiation consists of several subunits, including the class III PI3K, also known as VPS34 (vacuolar protein sorting 34), and its regulatory subunits such as VPS15 (vacuolar protein sorting 15) and Beclin 1 (BECN1). Under basal conditions or during nutrient-rich states, the activity of the PI3K complex is inhibited.\nActivation by Stress Signals: Autophagy initiation is often triggered by various stress signals, such as nutrient deprivation, oxidative stress, or accumulation of damaged proteins or organelles. These stress signals lead to the inhibition of the mTOR (mechanistic target of rapamycin) pathway, a negative regulator of autophagy, which in turn relieves the suppression of the PI3K complex.\nPhosphatidylinositol 3-Phosphate (PI3P) Production: Upon activation, the PI3K complex catalyzes the phosphorylation of phosphatidylinositol (PI) to generate phosphatidylinositol 3-phosphate (PI3P) on the membranes of various cellular compartments, including the endoplasmic reticulum (ER), Golgi apparatus, and endosomes. PI3P serves as a critical signaling lipid that recruits downstream autophagy-related proteins to initiate autophagosome formation.\nRecruitment of Autophagy Machinery: PI3P-enriched membranes act as nucleation sites for the assembly of the autophagy machinery. Autophagy-related proteins containing PI3P-binding domains, such as WIPI proteins (WD-repeat protein interacting with phosphoinositides), DFCP1 (double FYVE-containing protein 1), and FYCO1 (FYVE and coiled-coil domain-containing protein 1), are recruited to these membranes, where they initiate the formation of the phagophore, the precursor structure of the autophagosome.\nPhagophore Elongation and Cargo Sequestration: The recruitment of autophagy-related proteins to PI3P-enriched membranes promotes the elongation and expansion of the phagophore, leading to the formation of the autophagosomal membrane. Meanwhile, cargo molecules such as protein aggregates, damaged organelles, or intracellular pathogens are selectively recognized and sequestered within the growing autophagosomal membrane.\nAutophagosome Maturation and Fusion with Lysosomes: Following cargo sequestration, the autophagosome matures through membrane fusion events and eventually fuses with lysosomes, forming autolysosomes. Within autolysosomes, the sequestered cargo is degraded by lysosomal hydrolases, and the breakdown products are recycled back into the cytoplasm for reuse.\n\n\n\n\n\n\n\n\n\nCargo Selection\n\n\n\n\nCargo selection in autophagy is a highly regulated process that ensures the selective degradation of specific cellular components, such as damaged organelles, protein aggregates, and intracellular pathogens, while preserving essential cellular structures. Here’s how cargo selection occurs in autophagy:\n\nRecognition by Autophagy Receptors: Cargo selection begins with the recognition of specific cellular components by autophagy receptors. These receptors contain specific domains that recognize and bind to the cargo molecules destined for degradation. Autophagy receptors often contain LC3-interacting region (LIR) motifs, which allow them to interact with Atg8/LC3 proteins on the autophagosomal membrane.\nTargeting Signals and Tags: Cargo molecules destined for degradation may contain specific targeting signals or post-translational modifications that mark them for recognition by autophagy receptors. For example, damaged organelles may expose specific surface markers or undergo modifications that make them recognizable by autophagy receptors.\nInteraction with Autophagy Machinery: Once bound to autophagy receptors, cargo molecules are targeted to the expanding phagophore, the precursor structure of the autophagosome. The autophagy machinery, including Atg proteins and the lipidated form of Atg8/LC3 (such as Atg8-PE or LC3-II), facilitates the sequestration of cargo within the growing autophagosomal membrane.\nCargo Sequestration and Encapsulation: The autophagosomal membrane engulfs the cargo molecules, forming a double-membraned vesicle known as the autophagosome. The lipidated form of Atg8/LC3 anchors the autophagosomal membrane to the cargo, facilitating cargo sequestration within the autophagosome. This process ensures that only selected cargo molecules are enclosed within the autophagosomal vesicle.\nSelective Degradation in Autolysosomes: Autophagosomes subsequently fuse with lysosomes, forming autolysosomes, where the sequestered cargo is degraded by lysosomal hydrolases. The degradation products are then recycled back into the cytoplasm for reuse by the cell. Selective cargo degradation ensures the removal of damaged or unnecessary cellular components while preserving essential cellular structures and functions.\n\n\n\n\n\n\n\n\n\nReceptors in Autophagy\n\n\n\n\nAggrephagy and mitophagy are specialized forms of autophagy that target protein aggregates and damaged mitochondria, respectively, for degradation. The selective recognition and targeting of cargo in these processes involve specific receptors that play crucial roles in cargo recognition and autophagosome formation. Here are the receptors involved in aggrephagy and mitophagy:\n\nReceptors in Aggrephagy: Aggrephagy refers to the selective degradation of protein aggregates by autophagy. Several receptors have been identified to mediate the recognition and targeting of protein aggregates for autophagic degradation. Some of the key receptors involved in aggrephagy include:\n\np62/SQSTM1 (Sequestosome 1): p62 is a multifunctional protein that contains several domains, including an LC3-interacting region (LIR) motif. p62 binds to ubiquitinated protein aggregates via its ubiquitin-binding domain (UBA) and interacts with LC3 on the autophagosomal membrane, facilitating the sequestration of protein aggregates into autophagosomes.\nNBR1 (Neighbor of BRCA1 Gene 1): NBR1 is another autophagy receptor that contains LIR motifs and UBA domains. Similar to p62, NBR1 binds to ubiquitinated protein aggregates and recruits autophagy machinery components to promote their degradation by autophagy.\nOptineurin: Optineurin is a protein involved in various cellular processes, including autophagy. It contains LIR motifs and interacts with both ubiquitin and LC3, facilitating the selective targeting of protein aggregates for autophagic degradation.\n\nReceptors in Mitophagy: Mitophagy specifically targets damaged or dysfunctional mitochondria for degradation to maintain cellular homeostasis. The selective recognition and targeting of mitochondria for degradation involve specific receptors that recognize mitochondrial damage or stress signals. Some of the key receptors involved in mitophagy include:\n\nPINK1 (PTEN-induced putative kinase 1): PINK1 is a mitochondrial kinase that accumulates on the outer mitochondrial membrane (OMM) of damaged mitochondria. Upon mitochondrial depolarization, PINK1 is stabilized and phosphorylates both Parkin and mitochondrial substrates. This recruits Parkin to the depolarized mitochondria, where it ubiquitinates mitochondrial proteins, marking them for selective degradation.\nParkin: Parkin is an E3 ubiquitin ligase that is recruited to depolarized mitochondria by PINK1. Once recruited, Parkin ubiquitinates proteins on the OMM, leading to the recruitment of autophagy receptors such as p62/SQSTM1 and optineurin. These receptors bind to ubiquitinated mitochondrial proteins and interact with LC3 on the autophagosomal membrane, facilitating the engulfment of damaged mitochondria into autophagosomes for degradation.\nBNIP3 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3): BNIP3 is a mitochondrial outer membrane protein that contains an LC3-interacting region (LIR) motif. During hypoxia or other stress conditions, BNIP3 binds to LC3 on the autophagosomal membrane, mediating the selective engulfment of damaged mitochondria for degradation."
  },
  {
    "objectID": "chapters/week6.html#autophagy-and-neurodegeneration",
    "href": "chapters/week6.html#autophagy-and-neurodegeneration",
    "title": "6  Autophagy of Protein Aggregates and Mitochondria",
    "section": "6.2 Autophagy and Neurodegeneration",
    "text": "6.2 Autophagy and Neurodegeneration\n\n\n\n\n\nMitochondrial Dynamics\n\n\n\n\nMitochondrial dynamics, which include processes such as fusion, fission, and mitochondrial movement, play a crucial role in maintaining mitochondrial function and cellular homeostasis. Here’s how mitochondrial dynamics contribute to protecting mitochondrial function:\n\nMitochondrial Quality Control: Mitochondrial dynamics participate in quality control mechanisms by regulating the turnover of damaged or dysfunctional mitochondria. Fusion facilitates the mixing of mitochondrial contents, allowing damaged mitochondria to exchange components with healthy ones, which may help dilute damaged proteins or DNA. Fission, on the other hand, segregates damaged portions of mitochondria, facilitating their selective removal by mitophagy.\nEnergy Production and Metabolism: Mitochondrial fusion promotes the exchange of mitochondrial DNA, proteins, and metabolites, optimizing mitochondrial function and energy production. By creating interconnected mitochondrial networks, fusion helps to maintain efficient electron transport chain complexes, ensuring proper ATP production and metabolic homeostasis. Additionally, fusion can rescue partially dysfunctional mitochondria by complementing missing or defective components.\nDistribution of Mitochondria: Mitochondrial movement and distribution are essential for ensuring a balanced distribution of mitochondria throughout the cell, particularly in cells with high energy demands or polarized structures. Dynamic positioning of mitochondria allows them to respond rapidly to local energy needs, such as ATP production near sites of high metabolic activity or calcium buffering in regions with elevated calcium levels.\nMitochondrial Adaptation to Stress: Mitochondrial dynamics enable rapid responses to cellular stressors by modulating mitochondrial morphology and function. Under stress conditions such as nutrient deprivation, oxidative stress, or changes in energy demand, mitochondrial dynamics can shift towards fusion or fission to optimize mitochondrial function and promote cellular survival. For example, fusion can mitigate stress-induced mitochondrial fragmentation and maintain mitochondrial integrity.\nApoptosis Regulation: Mitochondrial dynamics also play a role in regulating apoptosis, a programmed cell death process. Alterations in mitochondrial fusion and fission dynamics can influence mitochondrial morphology and membrane permeability, affecting the release of apoptotic factors such as cytochrome c. Balanced mitochondrial dynamics contribute to cell survival by preventing excessive mitochondrial fragmentation and apoptosis induction.\n\n\n6.2.1 If Mitochondria Do Not Fuse or Divide\n\n\n\n\n\nMitochondria Without Fusion or Division\n\n\n\n\nIf mitochondria are unable to fuse or divide properly, it can lead to various cellular dysfunctions and pathologies due to the disruption of mitochondrial dynamics. Here are some consequences of impaired mitochondrial fusion or fission:\n\nAccumulation of Damaged Mitochondria: Without fusion, damaged mitochondria cannot mix their contents with healthy mitochondria, leading to the accumulation of dysfunctional components such as damaged proteins, lipids, and DNA. Similarly, impaired fission prevents the segregation and removal of damaged portions of mitochondria, further exacerbating mitochondrial dysfunction.\nMitochondrial Fragmentation: In the absence of fusion, mitochondria may undergo excessive fission, leading to mitochondrial fragmentation and the formation of smaller, dysfunctional organelles. Fragmented mitochondria have reduced capacity for ATP production, compromised membrane potential, and increased susceptibility to oxidative stress and apoptosis.\nEnergy Deficiency: Mitochondrial fusion is essential for maintaining interconnected mitochondrial networks that facilitate efficient ATP production and metabolic coordination. Impaired fusion results in fragmented mitochondria with reduced respiratory capacity, leading to cellular energy deficits and metabolic dysfunction.\nCellular Stress Sensitivity: Proper mitochondrial dynamics play a crucial role in cellular stress responses by modulating mitochondrial morphology and function. Cells with impaired fusion or fission may exhibit heightened sensitivity to various stressors such as nutrient deprivation, oxidative stress, or changes in energy demand, leading to increased susceptibility to cell death or dysfunction.\nNeurological Disorders: Dysfunction in mitochondrial dynamics has been implicated in the pathogenesis of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease. Impaired mitochondrial fusion or fission can disrupt neuronal function, synaptic transmission, and neuronal survival, contributing to the progression of neurological disorders.\n\n\n\n6.2.2 Drp1-Mediated Fission\n\n\n\n\n\nMechanism of Drp1\n\n\n\n\nDynamin-related protein 1 (Drp1) is a key regulator of mitochondrial fission, a process that involves the division of mitochondria into smaller organelles. Here’s how Drp1-mediated fission of mitochondria occurs:\n\nLocalization to Mitochondria: Drp1 is primarily a cytosolic protein, but it translocates to the outer mitochondrial membrane (OMM) in response to signals that trigger mitochondrial fission. The recruitment and activation of Drp1 at the OMM are tightly regulated by various factors, including post-translational modifications and binding partners.\nFormation of Oligomeric Rings: Upon translocation to the OMM, Drp1 assembles into higher-order structures, forming spiral or ring-like oligomers around constricted regions of mitochondria. This oligomerization process is facilitated by the GTPase activity of Drp1 and is essential for the subsequent scission of mitochondria.\nConstriction of Mitochondria: As Drp1 oligomers assemble on the OMM, they constrict the mitochondrial membrane at specific sites, often at the points where ER-mitochondria contact sites are located. This constriction process involves the coordinated action of Drp1 and other proteins, such as mitochondrial fission factor (Mff) and mitochondrial dynamics proteins of 49 and 51 kDa (MiD49/51), which serve as receptors for Drp1 recruitment.\nFission Machinery Activation: Once the mitochondria are constricted by Drp1 oligomers, the fission machinery is activated to complete the division process. GTP hydrolysis by Drp1 induces a conformational change that triggers the mechanical force required for mitochondrial scission. This leads to the division of the mitochondria into two daughter organelles.\nRelease of Daughter Mitochondria: Following scission, the daughter mitochondria are released into the cytosol as individual organelles. Drp1 remains associated with the mitochondrial fragments for a short period before being recycled back to the cytosol. The daughter mitochondria undergo further remodeling and fusion with other mitochondria to maintain mitochondrial homeostasis and function.\n\n\n\n6.2.3 Mitochondrial Fusion\n\n\n\n\n\nSchemaitc of Mitochondria Fusion\n\n\n\n\nMitochondrial fusion is a complex process involving the merger of two individual mitochondria to form a single, interconnected organelle. This process is crucial for maintaining mitochondrial function, morphology, and cellular homeostasis. Here’s an overview of the mechanism of mitochondrial fusion:\n\nOuter Membrane Fusion: Mitochondrial fusion begins with the fusion of the outer mitochondrial membranes (OMMs) of two adjacent mitochondria. The initial step involves tethering and docking of the outer membranes through protein-protein interactions. Several protein complexes facilitate this process, including mitofusins (Mfn1 and Mfn2) in mammals and Fzo1 in yeast. These dynamin-like GTPases are anchored in the OMM and mediate the physical interaction between adjacent mitochondria.\nGTP Hydrolysis and Membrane Fusion: After tethering, mitofusins/Fzo1 proteins undergo GTP hydrolysis, leading to a conformational change that promotes the fusion of the outer membranes. This process involves the formation of hemifusion intermediates, where the outer leaflets of the lipid bilayers merge, followed by the fusion of the inner leaflets, resulting in the complete fusion of the outer membranes. The exact mechanism by which mitofusins/Fzo1 facilitate membrane fusion is still under investigation but likely involves changes in protein conformation and lipid rearrangement.\nIntermembrane Space Fusion: Following outer membrane fusion, the inner mitochondrial membranes (IMMs) of the fused mitochondria come into close proximity. Proteins such as OPA1 (optic atrophy 1) in mammals and Mgm1 in yeast are responsible for mediating fusion of the inner membranes. OPA1 is a dynamin-like GTPase that exists in multiple isoforms, some of which are anchored in the IMM and regulate cristae morphology, while others are released into the intermembrane space (IMS) during fusion. The exact role of OPA1/Mgm1 in inner membrane fusion is not fully understood but likely involves tethering, hemifusion, and lipid mixing similar to outer membrane fusion.\nMatrix Content Mixing: Once the outer and inner membranes are fused, the contents of the matrix, including proteins, lipids, and mitochondrial DNA, can mix between the fused mitochondria. This allows for the exchange of metabolites and mitochondrial components, contributing to the maintenance of mitochondrial function, genome integrity, and metabolic homeostasis.\nRegulation of Fusion Machinery: Mitochondrial fusion is tightly regulated by various factors, including post-translational modifications of fusion proteins, calcium signaling, mitochondrial dynamics proteins, and cellular energy status. These regulatory mechanisms ensure the proper coordination of fusion events and prevent excessive or aberrant fusion, which could lead to mitochondrial dysfunction and cellular pathology.\n\n\n\n6.2.4 PINK1, Parkin, and Mitophagy\n\n\n\n\n\nPINK1 and Parkin Mode of Action\n\n\n\n\nPINK1 (PTEN-induced putative kinase 1) and Parkin are two key proteins involved in the regulation of mitophagy, a selective form of autophagy that targets damaged or dysfunctional mitochondria for degradation. Here’s how PINK1 and Parkin cooperate to initiate and execute mitophagy:\n\nPINK1 Activation: Under normal conditions, PINK1 is continuously imported into healthy mitochondria through the translocase of the outer membrane (TOM) complex and the translocase of the inner membrane (TIM)23 complex. Once inside the mitochondria, PINK1 undergoes proteolytic processing by mitochondrial processing peptidase (MPP) and presenilin-associated rhomboid-like protease (PARL), leading to its degradation in the inner mitochondrial membrane (IMM). However, upon mitochondrial damage or depolarization, PINK1 import is impaired, leading to its accumulation on the outer mitochondrial membrane (OMM).\nPINK1 Stabilization and Phosphorylation: Accumulated PINK1 on the OMM becomes stabilized and undergoes autophosphorylation. This phosphorylation activates PINK1’s kinase activity, allowing it to phosphorylate various substrates on the OMM, including Miro and ubiquitin.\nRecruitment of Parkin: Phosphorylated ubiquitin on the OMM serves as a signal for Parkin recruitment. Parkin is an E3 ubiquitin ligase that is normally cytosolic but translocates to damaged mitochondria upon activation by PINK1. Parkin is recruited to mitochondria through its interaction with phosphorylated ubiquitin and other OMM proteins.\nUbiquitination of Mitochondrial Proteins: Once recruited to the mitochondria, Parkin catalyzes the ubiquitination of various OMM proteins, including voltage-dependent anion channel (VDAC) and mitofusins (Mfn1 and Mfn2). Ubiquitination of these proteins serves as a signal for the targeting of damaged mitochondria for degradation.\nRecognition by Autophagy Machinery: Ubiquitinated proteins on the surface of damaged mitochondria are recognized by autophagy receptors such as p62/SQSTM1 and optineurin. These receptors bind to ubiquitin chains via their ubiquitin-binding domains (UBDs) and interact with LC3 on the forming autophagosomal membrane, thereby linking the damaged mitochondria to the autophagy machinery.\nSequestration and Degradation: The autophagosome engulfs the damaged mitochondria, forming an autophagosome-enclosed structure called the mitophagosome. The mitophagosome subsequently fuses with lysosomes to form an autolysosome, where the engulfed mitochondria are degraded by lysosomal enzymes, leading to the removal of damaged components and recycling of nutrients."
  },
  {
    "objectID": "chapters/week7.html",
    "href": "chapters/week7.html",
    "title": "7  Singalling Pathways and Telomeres in Aging",
    "section": "",
    "text": "Mechanism of mTORC1\n\n\n\n\nmTORC1 (mechanistic target of rapamycin complex 1) is a central regulator of cell growth, metabolism, and proliferation in response to various environmental cues, including nutrient availability, energy status, growth factors, and stress signals. Here’s how mTORC1 regulates cell growth:\n\nNutrient Sensing: mTORC1 acts as a nutrient sensor, integrating signals from amino acids, glucose, lipids, and other metabolites to regulate cellular metabolism and growth. Amino acids, particularly leucine and arginine, are potent activators of mTORC1, promoting its translocation to the lysosomal membrane where it becomes activated.\nActivation by Growth Factors: Growth factors such as insulin, insulin-like growth factor 1 (IGF-1), and epidermal growth factor (EGF) activate mTORC1 signaling through the phosphoinositide 3-kinase (PI3K)/Akt pathway. Upon growth factor stimulation, Akt phosphorylates and inhibits tuberous sclerosis complex 2 (TSC2), relieving its inhibitory effect on mTORC1 and promoting its activation.\nCellular Energy Status: mTORC1 activity is also influenced by cellular energy levels, particularly through the AMP-activated protein kinase (AMPK) pathway. AMPK, a sensor of cellular energy depletion, inhibits mTORC1 by phosphorylating TSC2 and raptor, leading to mTORC1 inhibition and energy conservation during metabolic stress.\nRegulation of Protein Synthesis: mTORC1 promotes protein synthesis by phosphorylating and activating key downstream effectors, including ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Activation of S6K1 leads to the phosphorylation of ribosomal proteins and the initiation factors involved in mRNA translation, while phosphorylation of 4E-BP1 releases it from eukaryotic initiation factor 4E (eIF4E), allowing it to initiate cap-dependent translation.\nLipid Biosynthesis and Lipogenesis: mTORC1 promotes lipid biosynthesis and lipogenesis by activating sterol regulatory element-binding proteins (SREBPs) and promoting the transcription of genes involved in fatty acid and cholesterol synthesis. This supports the increased demand for membrane biogenesis and lipid storage during cell growth and proliferation.\nCell Cycle Progression: mTORC1 signaling promotes cell cycle progression by regulating the expression of cyclins, cyclin-dependent kinases (CDKs), and cell cycle inhibitors. Activation of mTORC1 promotes entry into the cell cycle and progression through the G1 phase, facilitating cell growth and proliferation.\n\n\n\n\n\n\n\n\nDifferences Between mTORC1 and mTORC2\n\n\n\n\nmTOR (mechanistic target of rapamycin) exists in two distinct complexes: mTORC1 and mTORC2. While both complexes share the mTOR kinase as a core component, they have different compositions, substrates, and cellular functions. Here’s an overview of mTORC1 and mTORC2:\n\nmTORC1 (mechanistic target of rapamycin complex 1):\n\nComposition: mTORC1 consists of mTOR, regulatory-associated protein of mTOR (RAPTOR), mammalian lethal with SEC13 protein 8 (mLST8), proline-rich Akt substrate 40 kDa (PRAS40), and DEP domain-containing mTOR-interacting protein (DEPTOR).\nActivation: mTORC1 is primarily activated by growth factors, amino acids, energy status, and stress signals. Growth factors such as insulin and insulin-like growth factor 1 (IGF-1) activate mTORC1 through the PI3K/Akt pathway, while amino acids, particularly leucine, activate mTORC1 by promoting its translocation to the lysosomal membrane.\nSubstrates and Functions: mTORC1 regulates protein synthesis, lipid metabolism, autophagy, and cell growth by phosphorylating downstream effectors such as ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Activation of mTORC1 promotes protein synthesis, lipid biosynthesis, and cell proliferation, while inhibiting autophagy.\n\nmTORC2 (mechanistic target of rapamycin complex 2):\n\nComposition: mTORC2 consists of mTOR, rapamycin-insensitive companion of mTOR (RICTOR), mammalian stress-activated protein kinase-interacting protein 1 (mSIN1), protein observed with RICTOR 1 and 2 (PROTOR1/2), and mLST8.\nActivation: mTORC2 is less well understood than mTORC1, but it is activated by growth factors and regulates cell survival, cytoskeletal organization, and metabolism. Growth factor stimulation activates mTORC2 through PI3K/Akt pathway-dependent mechanisms.\nSubstrates and Functions: mTORC2 phosphorylates downstream effectors such as Akt at Serine 473 (Ser473), protein kinase C (PKC), and serum- and glucocorticoid-inducible kinase 1 (SGK1). Akt phosphorylation by mTORC2 at Ser473 enhances its kinase activity and promotes cell survival, proliferation, and metabolism. Additionally, mTORC2 regulates cytoskeletal dynamics and cell migration through its effects on PKC and SGK1.\n\n\n\n\n\n\n\n\n\n\nmTORC1 Inhibiting Autophagy\n\n\n\n\nYes, mTORC1 (mechanistic target of rapamycin complex 1) is a potent inhibitor of autophagy, a cellular process responsible for the degradation and recycling of damaged or unnecessary cellular components. Here’s how mTORC1 inhibits autophagy:\n\nRegulation of Autophagy Initiation: mTORC1 negatively regulates the initiation of autophagy by phosphorylating and inhibiting key components of the autophagy machinery, including the Unc-51-like kinase 1 (ULK1) complex. ULK1 is a key initiator of autophagy, and its activity is inhibited by phosphorylation by mTORC1. When mTORC1 is active, it phosphorylates ULK1 and inhibits its kinase activity, thereby suppressing the initiation of autophagy.\nInhibition of Autophagy Induction: mTORC1 also inhibits autophagy induction by regulating the activity of transcription factors involved in the expression of autophagy-related genes. For example, mTORC1 phosphorylates and inhibits the transcription factor EB (TFEB), a master regulator of lysosomal and autophagy gene expression. Inhibition of TFEB by mTORC1 prevents the transcriptional upregulation of genes involved in lysosome biogenesis and autophagy, thereby suppressing autophagy induction.\nRegulation of Autophagosome Formation: In addition to its effects on autophagy initiation and induction, mTORC1 also regulates the formation of autophagosomes, the double-membraned vesicles responsible for sequestering cellular cargo for degradation. mTORC1 inhibits the formation of autophagosomes by phosphorylating and inhibiting components of the phosphatidylinositol 3-kinase (PI3K) complex, which is required for the nucleation of the autophagosomal membrane.\n\n\n\n\n\n\n\n\n\nActivation at Lysosomes\n\n\n\n\nmTORC1 (mechanistic target of rapamycin complex 1) activation at lysosomes is a critical step in the regulation of cell growth, metabolism, and autophagy. Lysosomes serve as signaling platforms for mTORC1 activation in response to various environmental cues, including amino acids, growth factors, and cellular energy status. Here’s how mTORC1 is activated at lysosomes:\n\nAmino Acid Sensing: Amino acids, particularly essential amino acids such as leucine, arginine, and glutamine, are potent activators of mTORC1 signaling. Upon amino acid stimulation, a series of events occur at the lysosomal surface to promote mTORC1 activation.\nRag GTPases: The Rag GTPases, consisting of RagA/B and RagC/D heterodimers, play a central role in amino acid sensing and mTORC1 activation at lysosomes. Rag GTPases are anchored to the lysosomal membrane and function as molecular switches that regulate the recruitment of mTORC1 to lysosomes in response to amino acid availability.\nRagulator Complex: The Rag GTPases are regulated by the Ragulator complex, a pentameric protein complex associated with the lysosomal surface. The Ragulator complex acts as a guanine nucleotide exchange factor (GEF) for RagA/B, promoting their activation in the presence of amino acids.\nRag-mTORC1 Interaction: Activated Rag GTPases recruit mTORC1 to the lysosomal surface by interacting with the RAPTOR subunit of mTORC1. The interaction between Rag GTPases and mTORC1 is facilitated by the cytosolic scaffold protein folliculin-interacting protein 1 (FNIP1) and its homolog FNIP2.\nRheb-GTP Loading: Once recruited to the lysosomes, mTORC1 becomes activated by the small GTPase Ras homolog enriched in brain (Rheb). Rheb is a potent activator of mTORC1 and is localized to the lysosomal membrane in its active, GTP-bound state. Rheb-GTP directly binds to and activates mTORC1, leading to its phosphorylation and activation.\nDownstream Signaling: Activated mTORC1 phosphorylates a multitude of downstream targets involved in protein synthesis, lipid metabolism, and autophagy regulation, thereby coordinating cellular responses to nutrient availability and growth signals.\n\n\n\n\n\n\n\n\n\nRTK Activation\n\n\n\n\nReceptor tyrosine kinases (RTKs) are cell surface receptors that play crucial roles in signal transduction by initiating intracellular signaling cascades in response to extracellular stimuli such as growth factors, hormones, and cytokines. RTK activation typically occurs through dimerization, a process where two receptor molecules come together to form a functional complex. Here’s how RTK activation by dimerization works:\n\nLigand Binding: RTKs have an extracellular ligand-binding domain that interacts with specific ligands, such as growth factors or hormones, in the extracellular space. Ligand binding induces a conformational change in the receptor, leading to the formation of an active signaling state.\nReceptor Dimerization: Ligand binding promotes the association of two RTK monomers, either by bringing pre-existing receptors into close proximity or by inducing receptor clustering on the cell surface. This dimerization event can occur in various configurations, including homodimerization (two identical receptor monomers) or heterodimerization (two different receptor monomers).\nTransphosphorylation: Upon dimerization, the intracellular tyrosine kinase domains of the RTK monomers become juxtaposed, allowing for cross-phosphorylation of specific tyrosine residues within the kinase activation loop of the opposing receptor. This transphosphorylation event leads to the activation of the RTK’s intrinsic kinase activity.\nRecruitment of Signaling Molecules: Phosphorylated tyrosine residues on the activated RTK serve as docking sites for various cytoplasmic signaling molecules containing Src homology 2 (SH2) or phosphotyrosine-binding (PTB) domains. These signaling molecules, such as adaptor proteins and enzymes, are recruited to the phosphorylated RTKs, where they become activated or modulate downstream signaling cascades.\nInitiation of Downstream Signaling: The recruitment and activation of downstream signaling molecules at the activated RTKs initiate intracellular signaling cascades that propagate the signal from the cell surface to the nucleus. These signaling pathways regulate diverse cellular processes, including cell proliferation, survival, differentiation, and metabolism, depending on the specific RTK and its associated signaling partners.\n\n\n\n\n\n\n\n\n\nPI3K-AKT-mTOR Signalling Pathway\n\n\n\n\nThe PI3K-AKT-mTOR signaling pathway is a key intracellular signaling pathway involved in the regulation of various cellular processes, including cell growth, proliferation, survival, metabolism, and protein synthesis. Here’s an overview of how this pathway operates:\n\nActivation of PI3K: The pathway is initiated by the activation of phosphoinositide 3-kinase (PI3K) in response to extracellular stimuli such as growth factors (e.g., insulin, insulin-like growth factor 1, epidermal growth factor). Upon ligand binding to their respective receptor tyrosine kinases (RTKs), PI3K is recruited to the plasma membrane, where it phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3).\nActivation of AKT: PIP3 serves as a second messenger that recruits AKT (also known as protein kinase B) to the plasma membrane via its pleckstrin homology (PH) domain. Once localized to the membrane, AKT is phosphorylated and activated by phosphoinositide-dependent kinase 1 (PDK1) at threonine 308. Full activation of AKT also requires phosphorylation at serine 473, which can be mediated by mTOR complex 2 (mTORC2) or other kinases.\nAKT-Mediated Signaling: Activated AKT phosphorylates and regulates numerous downstream targets involved in various cellular processes. Some of the key targets of AKT include:\n\nmTORC1: AKT activates mTORC1 by phosphorylating and inhibiting tuberous sclerosis complex 2 (TSC2), leading to the activation of mTORC1 and subsequent stimulation of protein synthesis and cell growth.\nGlycogen synthase kinase 3 (GSK3): AKT phosphorylates and inhibits GSK3, which regulates glycogen synthesis, protein translation, and cell survival.\nBad: AKT phosphorylates and inactivates the pro-apoptotic protein Bad, preventing its association with anti-apoptotic Bcl-2 family members and promoting cell survival.\nFOXO transcription factors: AKT phosphorylates FOXO transcription factors, leading to their cytoplasmic sequestration and inhibition of their transcriptional activity, which regulates genes involved in apoptosis, cell cycle arrest, and oxidative stress response.\n\nmTOR Signaling: The activation of mTORC1 by AKT leads to the phosphorylation and activation of downstream effectors such as ribosomal protein S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Activation of these effectors promotes protein synthesis, ribosome biogenesis, and cell growth.\nCellular Responses: The PI3K-AKT-mTOR signaling pathway regulates various cellular processes in response to extracellular cues, including cell growth, proliferation, survival, metabolism, and protein synthesis. Dysregulation of this pathway is implicated in numerous diseases, including cancer, diabetes, and neurological disorders.\n\n\n\n\n\n\n\n\n\nCells With and Without Glucose\n\n\n\n\nInsulin plays a central role in the regulation of glucose uptake by cells, particularly in skeletal muscle, adipose tissue, and liver. Here’s how insulin facilitates glucose uptake:\n\nInsulin Secretion: After a meal, blood glucose levels rise, triggering the secretion of insulin from pancreatic beta cells. Insulin acts as a hormone that signals cells to take up glucose from the bloodstream.\nInsulin Receptor Activation: Insulin binds to its receptor, the insulin receptor (IR), which is a receptor tyrosine kinase located on the cell surface of target cells. Binding of insulin to the IR leads to autophosphorylation and activation of the receptor’s tyrosine kinase activity.\nInsulin Signaling Cascade: Activated insulin receptors phosphorylate intracellular substrates, including insulin receptor substrate proteins (IRS), which serve as docking sites for downstream signaling molecules. Phosphorylated IRS proteins recruit and activate phosphoinositide 3-kinase (PI3K), initiating a signaling cascade.\nActivation of GLUT4 Translocation: PI3K activation leads to the phosphorylation and activation of protein kinase B (AKT), which in turn phosphorylates and activates AS160 (Akt substrate of 160 kDa). Phosphorylated AS160 facilitates the translocation of glucose transporter 4 (GLUT4) vesicles from intracellular storage compartments to the cell membrane.\nGlucose Uptake: Upon translocation to the cell membrane, GLUT4 facilitates the uptake of glucose from the extracellular space into the cytoplasm of target cells. In skeletal muscle and adipose tissue, this process significantly increases glucose uptake, allowing cells to utilize glucose for energy production or storage as glycogen or fat.\nGlucose Metabolism: Once inside the cell, glucose undergoes metabolism through glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation to produce ATP, the cell’s primary energy source. Additionally, glucose can be stored as glycogen in the liver and muscle or converted to fatty acids for storage in adipose tissue."
  },
  {
    "objectID": "chapters/week7.html#telomeres-and-aging",
    "href": "chapters/week7.html#telomeres-and-aging",
    "title": "7  Singalling Pathways and Telomeres in Aging",
    "section": "7.2 Telomeres and Aging",
    "text": "7.2 Telomeres and Aging\n\n\n\n\n\nEnd-Replication Problem\n\n\n\n\nCellular senescence is a phenomenon where cells undergo irreversible growth arrest in response to various stressors, such as DNA damage, telomere shortening, oxidative stress, or oncogenic signaling. One of the key mechanisms underlying cellular senescence is the “end-replication problem.”\nThe end-replication problem refers to the inability of DNA polymerases to fully replicate the ends of linear chromosomes during DNA replication. In eukaryotic cells, chromosomes are capped by structures called telomeres, which consist of repetitive DNA sequences and associated proteins. Telomeres play a crucial role in protecting the integrity of chromosomes and preventing the loss of genetic information during DNA replication.\nDuring each round of DNA replication, the DNA polymerase complex synthesizes new DNA strands in the 5’ to 3’ direction. However, due to the nature of DNA polymerases and the absence of a primer at the end of the template strand, the replication machinery is unable to replicate the extreme ends of linear chromosomes completely. As a result, with each round of cell division, telomeres progressively shorten.\nTelomere shortening serves as a “mitotic clock” that limits the replicative lifespan of cells. When telomeres become critically short, they lose their protective function, leading to the activation of DNA damage response pathways and triggering cellular senescence. Additionally, dysfunctional telomeres can undergo inappropriate DNA repair mechanisms, resulting in genomic instability and promoting oncogenic transformation.\nCellular senescence mediated by the end-replication problem serves as a tumor suppressive mechanism by preventing the proliferation of cells with damaged or unstable genomes. However, excessive accumulation of senescent cells over time contributes to aging and age-related diseases, as senescent cells secrete pro-inflammatory cytokines, growth factors, and proteases collectively known as the senescence-associated secretory phenotype (SASP), which can disrupt tissue homeostasis and promote chronic inflammation.\n\n7.2.1 End Replication by Telomerase\n\n\n\n\n\nTelomerase Replication\n\n\n\n\nTelomerase is a specialized enzyme that counteracts the end-replication problem by adding repetitive DNA sequences to the ends of linear chromosomes, known as telomeres. Telomerase activity is particularly important in cells with high proliferative capacity, such as stem cells and cancer cells, as it helps maintain telomere length and ensures genomic stability during repeated rounds of cell division.\nHere’s how telomerase mediates the end-replication process:\n\nTelomere Structure: Telomeres consist of repetitive DNA sequences (TTAGGG in humans) and associated proteins that cap the ends of linear chromosomes. Telomeres protect chromosome ends from degradation and prevent them from being recognized as DNA breaks by the cellular DNA repair machinery.\nTelomerase Enzyme: Telomerase is a ribonucleoprotein complex composed of two main components: a catalytic protein subunit called telomerase reverse transcriptase (TERT) and an RNA component called telomerase RNA (TERC). TERC serves as a template for the synthesis of telomeric DNA by TERT.\nExtension of Telomeres: During DNA replication, the lagging strand of the chromosome cannot be fully replicated due to the end-replication problem. Telomerase acts to extend the telomeres by adding repetitive DNA sequences to the 3’ end of the lagging strand.\nTelomerase Action: Telomerase extends telomeres in a processive manner by using the RNA template within TERC to synthesize repetitive telomeric DNA sequences onto the chromosome ends. This elongation process compensates for the telomere shortening that occurs during each round of DNA replication.\nTelomere Length Maintenance: By counteracting telomere shortening, telomerase helps maintain telomere length and prevents telomeres from becoming critically short. This ensures the stability of linear chromosomes and promotes cell proliferation and genomic integrity.\nRole in Stem Cells and Cancer: Telomerase activity is particularly high in stem cells and cancer cells, where it helps maintain telomere length and sustains the replicative capacity of these cells. In cancer cells, upregulation of telomerase activity allows for unlimited cell proliferation, contributing to tumor growth and progression.\n\n\n\n7.2.2 DNA Damage Response\n\n\n\n\n\nIllustration of the DNA Damage Response\n\n\n\n\nThe DNA damage response (DDR) is a complex network of signaling pathways that detects and repairs damaged DNA, maintaining genomic stability and preventing the accumulation of mutations that can lead to diseases such as cancer. The DDR involves a series of coordinated molecular events that are activated in response to various types of DNA damage, including DNA double-strand breaks (DSBs), single-strand breaks (SSBs), cross-links, and base modifications. Here’s an overview of the key components and processes involved in the DDR:\n\nDetection of DNA Damage: DNA damage is detected by sensor proteins that recognize specific types of lesions or abnormalities in the DNA structure. These sensor proteins include the MRN complex (MRE11-RAD50-NBS1), Ku70/Ku80 heterodimer, PARP1 (poly(ADP-ribose) polymerase 1), and various DNA damage checkpoint proteins.\nActivation of Checkpoint Signaling: Upon detection of DNA damage, sensor proteins activate checkpoint signaling pathways to halt the cell cycle and prevent the propagation of damaged DNA to daughter cells. Key checkpoint kinases involved in this process include ATM (ataxia telangiectasia mutated), ATR (ataxia telangiectasia and Rad3-related), and DNA-PK (DNA-dependent protein kinase).\nTransduction of DNA Damage Signals: Activated checkpoint kinases phosphorylate downstream effector proteins, including CHK1 and CHK2, which in turn phosphorylate a variety of target proteins involved in cell cycle regulation, DNA repair, and apoptosis. Phosphorylation of these effector proteins leads to the activation of DNA damage response pathways and the initiation of appropriate cellular responses.\nDNA Repair Pathways: The DDR coordinates several DNA repair pathways to remove or repair damaged DNA lesions, including:\n\nNon-homologous end joining (NHEJ): Repairs DNA DSBs by directly ligating broken DNA ends together. NHEJ is error-prone and can lead to the introduction of small insertions or deletions.\nHomologous recombination (HR): Repairs DNA DSBs using an undamaged sister chromatid or homologous DNA sequence as a template. HR is a high-fidelity repair pathway that restores the original DNA sequence.\nBase excision repair (BER): Repairs damaged DNA bases and single-strand breaks by excising the damaged nucleotide and replacing it with a new one.\nNucleotide excision repair (NER): Repairs bulky DNA lesions, such as UV-induced thymine dimers or chemical adducts, by removing a short stretch of nucleotides surrounding the lesion and replacing it with newly synthesized DNA.\n\nCellular Responses: Depending on the extent and type of DNA damage, cells may undergo various responses, including cell cycle arrest, DNA repair, senescence, or apoptosis. These responses are critical for maintaining genomic integrity and preventing the propagation of damaged DNA to daughter cells.\n\n\n\n7.2.3 Shelterin\n\n\n\n\n\nShelterin\n\n\n\n\nShelterin is a protein complex that plays a critical role in protecting and regulating the structure of telomeres, the repetitive DNA sequences located at the ends of linear chromosomes. Telomeres function to maintain chromosome stability by preventing the ends of chromosomes from being recognized as DNA breaks and undergoing inappropriate DNA repair or degradation processes. Shelterin proteins bind to telomeric DNA and help to form a specialized nucleoprotein structure that shields telomeres from being recognized as damaged DNA.\nThe Shelterin complex consists of several key protein components, each with specific functions:\n\nTRF1 (Telomeric Repeat-binding Factor 1) and TRF2 (Telomeric Repeat-binding Factor 2): TRF1 and TRF2 are DNA-binding proteins that specifically recognize and bind to double-stranded telomeric DNA. They play essential roles in forming and maintaining the structure of telomeres by facilitating the formation of higher-order telomeric loops, known as T-loops. TRF2 is particularly important for protecting telomeres from being recognized as DNA double-strand breaks and promoting telomere end-capping.\nTIN2 (TRF1-interacting Nuclear factor 2): TIN2 serves as a central scaffold protein within the Shelterin complex, interacting with TRF1, TRF2, and other Shelterin components. TIN2 helps to stabilize the Shelterin complex and regulate its interactions with other proteins involved in telomere maintenance and DNA repair.\nRAP1 (Repressor/activator Protein 1): RAP1 binds to the telomeric DNA sequence in a sequence-specific manner and interacts with TRF2. RAP1 plays a role in regulating telomere length and function, as well as in coordinating telomere maintenance with other cellular processes such as transcriptional regulation and DNA repair.\nPOT1 (Protection of Telomeres 1): POT1 binds specifically to the single-stranded DNA overhang present at the 3’ end of telomeres. POT1 protects telomeres from inappropriate DNA damage responses and regulates telomere length by interacting with telomerase and regulating its access to telomeric DNA.\nTPP1 (Adrenocortical Dysplasia Homolog (ACD) Protein 1): TPP1 interacts with POT1 and TIN2 within the Shelterin complex and plays a crucial role in stabilizing POT1 binding to telomeric DNA. TPP1 also facilitates the recruitment and activation of telomerase at telomeres, promoting telomere elongation and maintenance.\n\n\n7.2.3.1 Telomerase and Shelterin\n\n\n\n\n\nTelomere Loop\n\n\n\n\nThe telomere loop, or T-loop, is a specialized nucleoprotein structure that forms at the ends of linear chromosomes, where telomeric DNA sequences are located. The T-loop plays a crucial role in protecting chromosome ends from being recognized as DNA double-strand breaks and from undergoing inappropriate DNA repair processes. It consists of the single-stranded 3’ overhang of telomeric DNA invading and pairing with double-stranded telomeric DNA upstream, creating a looped structure.\nTelomerase and Shelterin proteins work together to solve the end-replication problem and maintain telomere integrity:\n\nTelomerase: Telomerase is a specialized enzyme that adds repetitive DNA sequences to the ends of chromosomes, compensating for the loss of telomeric DNA during each round of DNA replication. Telomerase contains an RNA component (TERC) that serves as a template for synthesizing telomeric DNA and a catalytic protein component (TERT) that carries out the DNA synthesis reaction. By adding telomeric repeats to chromosome ends, telomerase helps counteract the gradual shortening of telomeres and ensures their stability.\nShelterin Complex: The Shelterin complex is a group of proteins that bind to telomeric DNA and help maintain the structural integrity of telomeres. Key components of the Shelterin complex include TRF1, TRF2, TIN2, RAP1, POT1, and TPP1. Shelterin proteins play essential roles in protecting telomeres from being recognized as DNA damage sites, regulating telomere length, and coordinating telomere maintenance with other cellular processes.\n\nTogether, telomerase and Shelterin proteins collaborate to solve the end-replication problem and maintain telomere stability. Telomerase adds telomeric repeats to chromosome ends, counteracting telomere shortening, while Shelterin proteins help form and stabilize the T-loop structure, preventing chromosome ends from being recognized as DNA breaks and protecting them from inappropriate DNA repair mechanisms.\n\n\n\n7.2.4 Cellular Senescence\n\n\naging.png){fig-align=‘center’ width=506}\n\n\nCellular senescence is a process in which cells undergo irreversible growth arrest in response to various stressors, such as DNA damage, telomere shortening, oncogene activation, or oxidative stress. Senescent cells display distinct phenotypic changes, including altered gene expression patterns, increased secretion of inflammatory cytokines and growth factors (known as the senescence-associated secretory phenotype or SASP), and changes in cell morphology.\nOne of the key triggers for cellular senescence is telomere shortening. Telomeres are repetitive DNA sequences located at the ends of linear chromosomes, and they protect chromosome ends from degradation and fusion with neighboring chromosomes. During each round of cell division, telomeres undergo gradual shortening due to the end-replication problem, where DNA polymerases are unable to fully replicate the ends of linear chromosomes.\nIn normal somatic cells, telomerase activity is typically repressed or downregulated, leading to progressive telomere shortening with each cell division. Eventually, telomeres become critically short, triggering a DNA damage response and cellular senescence. This downregulation of telomerase expression in somatic cells serves as a tumor suppressive mechanism, as it limits the proliferative potential of cells and prevents the accumulation of genetic mutations that could lead to cancer.\nThe regulation of telomerase expression in somatic cells is complex and involves multiple factors, including epigenetic modifications, transcriptional regulation, and telomere-associated proteins. Various signaling pathways, such as the p53/p21 and p16INK4a/Rb pathways, play important roles in controlling telomerase expression and cellular senescence. For example, activation of the p53 tumor suppressor pathway in response to DNA damage or other stress signals can lead to transcriptional repression of the TERT gene, which encodes the catalytic subunit of telomerase.\n\n\n7.2.5 Shelterin and Non-Homologous End Joining\n\n\n\n\n\nNHEJ and Shelterin\n\n\n\n\nTelomeres play a critical role in maintaining genomic stability by protecting chromosome ends from being recognized as DNA double-strand breaks (DSBs) and undergoing inappropriate DNA repair mechanisms. Dysfunctional telomeres, resulting from excessive shortening or loss of telomeric proteins, can lead to genome instability and contribute to the development of cancer.\nThe Shelterin complex, comprised of several key proteins including TRF1, TRF2, TIN2, RAP1, POT1, and TPP1, is essential for maintaining telomere integrity and function. Shelterin proteins bind to telomeric DNA and help form a specialized nucleoprotein structure that protects chromosome ends. One of the critical functions of Shelterin is to prevent non-homologous end joining (NHEJ) at telomeres.\nNHEJ is an error-prone DNA repair pathway that directly ligates broken DNA ends together, often resulting in the loss or addition of nucleotides and potentially leading to chromosomal rearrangements or deletions. At dysfunctional telomeres, NHEJ-mediated repair can result in telomere fusion, chromosome end-to-end fusions, or other chromosomal abnormalities, all of which contribute to genome instability and promote tumorigenesis.\nShelterin proteins help prevent NHEJ at telomeres through several mechanisms:\n\nTRF2-Mediated Protection: TRF2 plays a key role in protecting telomeres from being recognized as DSBs and inhibiting the activation of the DNA damage response (DDR) at chromosome ends. By forming a protective cap at telomeres, TRF2 prevents the binding of NHEJ factors and blocks the initiation of inappropriate DNA repair processes.\nInhibition of Ku70/Ku80: The Ku70/Ku80 heterodimer is a critical component of the NHEJ pathway and is involved in DNA end recognition and tethering during repair. Shelterin proteins, particularly TRF2, have been shown to inhibit the recruitment and function of Ku70/Ku80 at telomeres, thereby preventing NHEJ-mediated repair.\nShelterin-Mediated Sequestration: Shelterin proteins help maintain the structural integrity of telomeres and promote the formation of higher-order nucleoprotein structures, such as the T-loop. These structures sequester the chromosome end and prevent it from being recognized as a DNA break, thereby minimizing the likelihood of NHEJ-mediated repair."
  },
  {
    "objectID": "chapters/week8.html",
    "href": "chapters/week8.html",
    "title": "8  Mechanism of Intracellular Protein Deposition",
    "section": "",
    "text": "Hsp104 Action\nProtein disaggregation is a critical cellular process that helps maintain protein homeostasis by resolving protein aggregates and misfolded proteins. One key player in this process is the heat shock protein 104 (Hsp104), a molecular chaperone found in certain organisms such as yeast.\nHsp104 functions as a disaggregase, meaning it is capable of dissociating and solubilizing protein aggregates, thereby restoring proteins to their functional, native state. Here’s how Hsp104 accomplishes this task:"
  },
  {
    "objectID": "chapters/week8.html#cystic-fibrosis",
    "href": "chapters/week8.html#cystic-fibrosis",
    "title": "8  Mechanism of Intracellular Protein Deposition",
    "section": "8.1 Cystic Fibrosis",
    "text": "8.1 Cystic Fibrosis\n\n\n\n\n\nCFTR Gene\n\n\n\n\nCystic fibrosis (CF) is a genetic disorder characterized by the buildup of thick, sticky mucus in the lungs, digestive system, and other organs. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes a protein that regulates the flow of salt and fluids in and out of cells.\nThe CFTR protein is a chloride channel found primarily in the epithelial cells lining the respiratory, digestive, and reproductive tracts. It plays a crucial role in maintaining the balance of salt and water across cell membranes, which is essential for normal fluid secretion and mucus clearance in various organs.\nMutations in the CFTR gene can lead to dysfunction or absence of the CFTR protein, resulting in impaired chloride transport and dysregulated fluid secretion. This leads to the buildup of thick, sticky mucus in the airways, pancreas, liver, intestines, and other organs, leading to a range of symptoms and complications characteristic of cystic fibrosis.\nSome common symptoms of cystic fibrosis include:\n\nPersistent coughing with thick mucus\nFrequent lung infections, such as pneumonia and bronchitis\nDifficulty breathing and shortness of breath\nPoor growth and weight gain despite a good appetite\nSalty-tasting skin\nDigestive problems, including pancreatic insufficiency and intestinal blockages\nMale infertility due to congenital absence of the vas deferens\n\nTreatment for cystic fibrosis aims to manage symptoms, prevent complications, and improve quality of life. This may include medications to help thin mucus, antibiotics to treat infections, airway clearance techniques, nutritional support, and, in some cases, lung transplantation. Emerging therapies, such as CFTR modulators, target specific defects in the CFTR protein and aim to correct or improve chloride transport function, offering promising new treatment options for individuals with cystic fibrosis.\n\n8.1.1 Mucous Production in Cystic Fibrosis\n\n\n\n\n\nMucous Production in Cystic Fibrosis\n\n\n\n\nThe CFTR gene encodes the cystic fibrosis transmembrane conductance regulator protein, which plays a crucial role in regulating the flow of salt and fluids across cell membranes. Mutations in the CFTR gene result in dysfunctional or absent CFTR protein, leading to impaired chloride transport and dysregulated fluid secretion in various organs.\nOne of the hallmark features of cystic fibrosis is the buildup of thick, sticky mucus in the airways, digestive tract, and other organs. This mucus accumulation impairs mucociliary clearance, which is a key defense mechanism of the lungs. Mucociliary clearance involves the coordinated movement of mucus and its contents, including potentially harmful substances like bacteria and debris, out of the lungs via ciliary action.\nIn individuals with cystic fibrosis, the impaired clearance of mucus from the airways leads to the retention of mucus, along with trapped bacteria and other pathogens. This creates an environment conducive to recurrent lung infections, inflammation, and progressive damage to lung tissue, ultimately resulting in respiratory symptoms such as persistent coughing, difficulty breathing, and recurrent lung infections.\n\n\n8.1.2 CFTR Aggregation\n\n\n\n\n\nCFTR Aggregation\n\n\n\n\nIn cystic fibrosis (CF), the cystic fibrosis transmembrane conductance regulator (CFTR) protein undergoes both degradation and aggregation, contributing to the pathophysiology of the disease.\n\nDegradation of CFTR: CFTR protein degradation occurs when mutated CFTR proteins are recognized as misfolded or defective by the cellular quality control machinery. This recognition typically leads to the targeting of mutant CFTR proteins for degradation through the cellular degradation pathways, such as the ubiquitin-proteasome system or the lysosomal degradation pathway.\n\nUbiquitin-Proteasome System (UPS): Misfolded or defective CFTR proteins may be tagged with ubiquitin molecules, marking them for degradation by the proteasome, a cellular complex responsible for degrading unwanted or damaged proteins. Defective CFTR proteins that fail to pass quality control are ubiquitinated and targeted for degradation by the proteasome.\nLysosomal Degradation Pathway: Alternatively, misfolded CFTR proteins may be trafficked to lysosomes, where they are degraded by lysosomal enzymes. Lysosomes are cellular organelles containing enzymes capable of breaking down proteins, lipids, and other macromolecules. CFTR proteins that are misfolded or fail to properly fold may be targeted to lysosomes for degradation.\n\nAggregation of CFTR: In addition to degradation, misfolded or defective CFTR proteins may also form aggregates or clumps within cells. Aggregation occurs when mutated CFTR proteins, unable to fold properly, accumulate and interact with each other, leading to the formation of insoluble protein aggregates.\n\nImpact on Cellular Function: The aggregation of CFTR proteins can disrupt cellular processes and impair cellular function. Aggregated CFTR proteins may interfere with intracellular trafficking pathways, impair protein folding and assembly, and disrupt normal cellular signaling processes. Additionally, protein aggregates can trigger cellular stress responses and contribute to cellular toxicity.\nContribution to Disease Pathology: The accumulation of misfolded CFTR proteins and protein aggregates is thought to contribute to the pathogenesis of cystic fibrosis by impairing CFTR function, disrupting cellular homeostasis, and promoting cellular dysfunction and tissue damage. The presence of protein aggregates may also exacerbate inflammation and oxidative stress, further contributing to disease progression.\n\n\n\n8.1.2.1 APP\n\n\n\n\n\nAPP Forming Aggresomes\n\n\n\n\nAnother membrane protein known to form aggresomes is the amyloid precursor protein (APP). APP is a type I transmembrane protein that plays a role in synaptic function and has been implicated in the pathogenesis of Alzheimer’s disease (AD) when processed aberrantly.\n\nAmyloid Precursor Protein (APP): APP is primarily known for its involvement in the pathogenesis of Alzheimer’s disease, where abnormal processing of APP leads to the production and accumulation of amyloid-beta (Aβ) peptides. However, under certain conditions, misfolded or aggregated forms of APP can accumulate in cells and contribute to the formation of aggresomes.\nAggresome Formation: Similar to CFTRΔF508, misfolded or aggregated forms of APP can overwhelm the cellular quality control machinery, leading to the formation of aggresomes. Aggresomes serve as sites for sequestering and concentrating misfolded proteins, preventing their toxic effects and facilitating their subsequent degradation.\nConsequences for Cellular Function: The accumulation of misfolded APP in aggresomes can disrupt cellular homeostasis and impair cellular function. Aggresome formation may interfere with normal cellular processes, such as protein trafficking, organelle dynamics, and cellular signaling pathways. Additionally, the sequestration of misfolded APP in aggresomes may prevent its proper localization and function at the cell membrane, where it is involved in synaptic transmission and neuronal signaling.\nPathological Implications: In the context of Alzheimer’s disease, the aggregation of APP and the accumulation of Aβ peptides are key pathological features associated with the formation of amyloid plaques in the brain. Aggresome formation may represent a cellular response to the accumulation of misfolded APP and Aβ peptides, serving as a protective mechanism to mitigate their toxic effects.\nTherapeutic Considerations: Understanding the mechanisms underlying APP aggregation and aggresome formation is important for developing therapeutic strategies to alleviate protein misfolding and aggregation in Alzheimer’s disease and related neurodegenerative disorders. Approaches aimed at promoting proper protein folding, enhancing protein degradation pathways, or disaggregating protein aggregates may hold promise for treating Alzheimer’s disease and mitigating its progression."
  },
  {
    "objectID": "chapters/week8.html#cytoskeleton-organization-during-cell-division",
    "href": "chapters/week8.html#cytoskeleton-organization-during-cell-division",
    "title": "8  Mechanism of Intracellular Protein Deposition",
    "section": "8.2 Cytoskeleton Organization During Cell Division",
    "text": "8.2 Cytoskeleton Organization During Cell Division\n\n\n\n\n\nChanges in Cytoskeleton Organization During Mitosis\n\n\n\n\nDuring cell division, the cytoskeletal organization undergoes dynamic changes to facilitate various processes such as chromosome segregation and cytokinesis.\n\nActin Filaments Reorganization: Actin filaments, which determine the shape of the cell’s surface and are involved in cellular locomotion, undergo reorganization during cell division. Initially, actin filaments are reorganized, and the cell assumes a spherical shape. Subsequently, after chromosome segregation, actin filaments form a contractile ring at the center of the cell, which pinches the cell in two during cytokinesis.\nMicrotubule Rearrangement: The polarized microtubule array undergoes rearrangement to form a bipolar mitotic spindle. This mitotic spindle is responsible for aligning and segregating duplicated chromosomes during cell division. Microtubules determine the positions of organelles and facilitate intracellular transport.\nDaughter Cell Cytoskeletal Reorganization: After cell division is complete, the two daughter cells reorganize their microtubule and actin cytoskeletons into smaller versions of those present in the mother cell. This reorganization ensures that each daughter cell has the necessary cytoskeletal components for cellular functions such as maintaining cell shape, facilitating intracellular transport, and supporting cellular movement.\n\n\n8.2.1 Microtubules and Centromeres\nThe centrosome and microtubules play essential roles in organizing the cell’s cytoskeleton and facilitating various cellular processes.\n\nCentrosome: The centrosome is a cellular organelle that serves as the main microtubule-organizing center (MTOC) in animal cells. It consists of a pair of centrioles surrounded by pericentriolar material (PCM). The centrosome is involved in nucleating, anchoring, and organizing microtubules within the cell.\nMicrotubules: Microtubules are dynamic protein filaments composed of tubulin subunits. They extend outward from the centrosome throughout the cell, forming a network of tracks along which molecular motors and vesicles can move. Microtubules have a polarity, with one end referred to as the “plus end” and the other end as the “minus end.”\nOrganization of Microtubules: Within the cell, the centrosome serves as the primary site for microtubule nucleation. Microtubules extend outward from the centrosome, with their plus ends pointing toward the cell periphery. This radial array of microtubules provides structural support to the cell and facilitates intracellular transport, cell division, and cell motility.\nCellular Functions: Microtubules are involved in various cellular processes, including:\n\nIntracellular transport: Microtubules serve as tracks for molecular motors such as dynein and kinesin, facilitating the movement of organelles, vesicles, and proteins within the cell.\nCell division: Microtubules form the mitotic spindle during cell division, facilitating the alignment and segregation of chromosomes.\nCell shape and motility: Microtubules contribute to cell shape maintenance and are involved in processes such as cell migration and ciliary/flagellar movement.\n\n\n\n\n8.2.2 Mitotic Spindle\nThe mitotic spindle is a dynamic structure composed of microtubules that forms during cell division (mitosis) and is essential for the accurate segregation of chromosomes into daughter cells. Microtubules are long, cylindrical polymers made up of tubulin protein subunits arranged in a helical fashion. Each tubulin subunit consists of an α-tubulin and a β-tubulin molecule, which assemble end-to-end to form the microtubule filament.\nThe structure of a microtubule can be described as follows:\n\nPolarity: Microtubules exhibit polarity, with one end referred to as the “plus end” and the other end as the “minus end.” The plus end is characterized by the addition of tubulin subunits, while the minus end is associated with the removal of subunits.\nGrowth and Shrinking: Microtubules undergo dynamic instability, a process in which they alternate between periods of growth (polymerization) and shrinking (depolymerization). During polymerization, tubulin subunits are added to the growing plus end of the microtubule, while during depolymerization, subunits are removed from the plus end.\nStructural Features: Microtubules have a hollow cylindrical structure, with an outer diameter of approximately 25 nanometers. The tubulin subunits assemble longitudinally along the microtubule axis, forming a protofilament. Thirteen protofilaments are arranged in parallel to form the wall of the microtubule.\nDynamic Instability: The dynamic instability of microtubules allows them to explore space within the cell and rapidly reorganize their structure. This property is crucial for the formation and function of the mitotic spindle during cell division."
  },
  {
    "objectID": "chapters/week9.html",
    "href": "chapters/week9.html",
    "title": "9  Plant Genome",
    "section": "",
    "text": "Illustration of Genomic Levels\nThe plant genome is like a library of instructions that tells a plant how to grow, survive, and do all the things it needs to do. But not all plant genomes are the same. They can be big or small, and the size can vary a lot from one plant to another. This is like having different-sized books in the library.\nWhat’s interesting is that a plant doesn’t just have one set of instructions; it has three! It’s like having three different books in the library. These books are the nuclear genome, the chloroplast genome, and the mitochondrial genome. They all contain different sets of instructions, but they need to work together for the plant to function properly.\nIn the plant genome, there are lots of repeated and noncoding sequences. These are like paragraphs and pages in the books that don’t contain the main instructions but are still important. They play a role in how the plant responds to changes in its environment. Imagine reading a book, and when you see certain words or pictures, you know it’s time to do something specific. That’s how these sequences work.\nPlants are pretty smart because many of their genes, which are like sentences in the books, can change how they work based on what’s happening around them. If the environment changes, the plant can switch some genes on or off to adapt. It’s like having a special set of instructions for different situations.\nEven when we look at different plant species that are related, we can see that they have some parts of their genome that are similar. It’s like finding similar chapters in different books. This tells us that some parts of the plant genome have stayed the same throughout plant evolution, just like some stories are classics that people still enjoy reading."
  },
  {
    "objectID": "chapters/week9.html#single-copy-sequences-and-repetitive-sequences",
    "href": "chapters/week9.html#single-copy-sequences-and-repetitive-sequences",
    "title": "9  Plant Genome",
    "section": "9.1 Single Copy Sequences and Repetitive Sequences",
    "text": "9.1 Single Copy Sequences and Repetitive Sequences\n\n\n\n\n\nConserved, Arranged Orthologs Across Genes\n\n\n\n\nIn the plant genome, we have something called “single copy sequences.” These sequences are like unique pages in the library books, meaning they don’t repeat themselves much. Surprisingly, many of these single copy sequences don’t give instructions to the plant. To put it in perspective, if you think about the entire genome of a tobacco plant, around 40% of it consists of single copy DNA, but only a tiny 2% is used for making mRNA, which is like the plant’s way of reading those instructions.\nNow, when it comes to repetitive sequences, it’s a bit like having chapters or pages that keep showing up throughout the books but aren’t exactly the same. These repetitive sequences can be divided into two groups: tandem repeats and dispersed repeats. The “tandem repeats” are like chapters with a common theme that you find in the same place over and over in the book. On the other hand, “dispersed repeats” are more like chapters with similar themes that pop up randomly throughout the book.\nHere’s the thing – these repetitive sequences can be useful instructions for the plant, but not always. Some of them might be codes for certain plant functions, while others might be repetitive but not have a specific purpose. It’s kind of like having a book where some repeated sections are important and others are just there to fill space.\n\n9.1.1 Tandem Repeats\n\n\n\n\n\nIllustration of a Tandem Repeat\n\n\n\n\nThere are some genes that follow a repetitive pattern in plants – it’s like having chapters in a book that talk about the same topic over and over. But here’s the interesting part: these repetitive genes are usually responsible for making stuff that the plant needs a lot. It’s a bit like having a cookbook with many recipes for a favorite dish because you want to make it over and over.\nThese repetitive genes often make things like ribosomal RNAs (the plant’s protein-making machinery), seed storage proteins (to store food for later), Rubisco (a key player in photosynthesis), the light-harvesting complex (for catching sunlight), and histones (proteins that help DNA stay neat and organized). Just think of them as the most important recipes in the cookbook.\nNow, these genes aren’t just randomly scattered. They hang out in clusters or tandem repeats – sort of like a cookbook with all the recipes for your favorite dish placed together. Each gene in these clusters has its own little switch to turn it on or off, which is pretty cool. It’s like having individual recipes in the cookbook that you can choose to cook or skip.\n\n9.1.1.1 Non-Coding Tandem Repeats\n\n\n\n\n\nNon-Coding Tandem Repeats\n\n\n\n\nIn plants, there’s something called “satellite DNA,” which is like a special type of repetitive DNA that doesn’t code for any specific genes. It’s a bit like having a section in a book that’s filled with random letters – it doesn’t tell a story, but it’s there.\nNow, some of these repetitive sequences hang out in the centromere, which is a part of the chromosome. The centromere sequences can be quite different from plant to plant. It’s like having a secret code unique to each plant.\nOn the other hand, there are repetitive sequences in the telomere, which is another part of the chromosome. These sequences are actually pretty similar among different living things, like plants and animals. They help to keep the chromosomes the right size, and they work together with something called telomerase, which is like the chromosome’s length keeper.\n\n\n\n9.1.2 Transposable Elements (i.e., TEs)\n\n\n\n\n\nIllustration of Transposable Elements\n\n\n\n\nImagine the genome of a plant is like a big puzzle made of different pieces. Some of these pieces are called “transposable elements.” They’re like tiny jumping parts that can copy and paste themselves into the genome.\nThese transposable elements can make up a huge part of the plant’s genome, sometimes as much as 90%. They’re like the puzzle pieces that are scattered everywhere, making the puzzle much bigger. These elements are often of the “retrotransposon” variety, which means they use a special trick to copy themselves and spread around even more.\n\n9.1.2.1 Transposable Elements in Maize\n\n\n\n\n\nIllustration of Transposable Elements in Maize\n\n\n\n\nImagine you have a special kind of plant, like maize (corn), and inside its DNA, there are these little elements called Transposable Elements (TE). They’re like tiny DNA movers.\nAmong these elements, there are two important ones: “Ac” and “Ds.” Ac is the leader, and Ds is the follower. Ac is the one that can move around on its own, kind of like a leader, while Ds needs Ac to move. So, Ds is like a follower that can only move when Ac is around.\nWhen these elements move, they leave behind a mark called a “footprint.” It’s like a little trail they leave in the DNA.\nInterestingly, similar systems with Ac and Ds-like elements are found in other plants, like snapdragons, where they have their own versions of these DNA movers.\n\n\n9.1.2.2 Classes of Transposable Elements in Plants\n\n\n\n\n\nClasses of Transposable Elements in Plants\n\n\n\n\nPlants have special elements inside their DNA called “transposable elements.” There are two classes of these elements: Class II and Class I.\nClass II transposons are like DNA cutters and pasters. They can cut themselves out from one place in the DNA and paste themselves into another. It’s kind of like cutting a picture from one page and sticking it onto another.\nClass I transposons, on the other hand, are more like DNA copiers and pasters. They make copies of themselves and then paste those copies into different parts of the DNA. It’s similar to making photocopies of a picture and placing them in different folders.\n\n\n9.1.2.3 Functions of Transposable Elements in Plants\nTransposable elements (TEs) found in plants have some pretty fascinating functions that are often referred to as “drivers of evolution.” They were once thought of as “selfish DNA parasites,” but we’ve come to learn that they play essential roles in shaping a plant’s genetic makeup. When TEs move around in the DNA, they can sometimes disrupt or alter functional genes. This can lead to changes in the plant’s characteristics, even after the TE has relocated. In other words, TEs can create genetic mutations that stick around.\nTEs don’t just shuffle genes; they can also act as sneaky promoters. Sometimes, the promoters within TEs can cause nearby genes to be expressed in unusual ways, which can result in mutant traits in the plant. It’s like TEs are the mischievous conductors of a genetic orchestra, making genes play their music in unique and unexpected styles.\nAnother role of TEs is epigenetic regulation, mainly through a process called methylation. It’s like putting temporary sticky notes on certain parts of a book to mark important sections. TEs can add these “sticky notes” to genes, which can either increase or decrease their activity. Sometimes, TEs can even influence the behavior of genes located far away from them, sort of like a butterfly flapping its wings and causing changes in distant weather patterns.\nOne of the most exciting things about TEs is that they can help develop new gene variants. It’s like mixing and matching different puzzle pieces to create new and exciting pictures. The movement and activity of TEs in a plant’s DNA can lead to the creation of entirely new versions of genes.\nMany TEs are silenced or kept quiet by methylation. However, this silencing isn’t permanent, and it can be reversed, especially when the plant is under stress. Think of it as pressing the mute button on a TV remote, but you can unmute it when you want to hear the sound again. In this way, TEs have a dynamic role in shaping a plant’s genetic evolution."
  },
  {
    "objectID": "chapters/week9.html#genomes-in-plants",
    "href": "chapters/week9.html#genomes-in-plants",
    "title": "9  Plant Genome",
    "section": "9.2 Genomes in Plants",
    "text": "9.2 Genomes in Plants\n\n\n\n\n\nIllustration of the Endosumbiont Hypothesis\n\n\n\n\nPlants are like treasure chests of genetic material because they house not one, not two, but three different sets of genomes within their cells. This genetic trio includes the nuclear genome, the chloroplast genome, and the mitochondrial genome. It’s like having three different instruction manuals for building and maintaining the plant!\nScientists believe that the origins of these genetic powerhouses are connected to a fascinating idea called the endosymbiont hypothesis. Imagine this: a long, long time ago, tiny prokaryotic cells (the ancestors of modern bacteria) were gobbled up by other prokaryotic cells. Instead of becoming a tasty snack, these little prokaryotic travelers set up shop inside their new hosts. Over time, these cell-squatters evolved into the chloroplasts and mitochondria we see in plant cells today. It’s almost like these tiny squatters turned into helpful housemates.\nThere’s evidence that supports this idea. When scientists compare the genetic code found in ribosomal RNAs, they see similarities between the genes in chloroplasts and mitochondria and those in modern-day cyanobacteria and proteobacteria. It’s like finding ancient family photos that show how everyone is connected. These similarities suggest that the chloroplast and mitochondria indeed have their roots in these ancient prokaryotes.\nSymbiotic relationships, where different organisms team up to help each other out, aren’t unique to plants and their internal roommates. There are examples all around us, like marine nudibranchs, which are sea slugs that munch on algae. The algae help the nudibranchs by providing food and the nudibranchs give the algae a place to live. It’s like a tiny underwater apartment-sharing arrangement! So, just as plants share their homes with these mini prokaryotic guests, many other living things have their own symbiotic stories to tell.\n\n9.2.1 Chloroplast Genome\n\n\n\n\n\nIllustration of Chloroplast Genomes\n\n\n\n\nInside plant cells, the chloroplast genome holds some fascinating secrets. It’s like a carefully preserved book of instructions that gets passed down from generation to generation in plants. What’s really intriguing is that this chloroplast genome is quite consistent across various plant species. Imagine it as a well-organized circular chromosome with four different sections, kind of like how you divide a notebook into different chapters.\nThese sections include a large region filled with single-copy genes, a smaller region with more single-copy genes, and two segments known as inverted repeats A and B (IRA and IRB). These inverted repeats are like having two copies of the same chapter back-to-back. But here’s the twist: the size of this chloroplast genome can vary from one plant species to another, ranging from 69 to 521 kilobytes. It’s like different versions of the same book, but with a few extra pages here and there.\nNow, what’s really important is what these genes in the chloroplast genome are up to. They’re like the main characters in a thrilling story of photosynthesis. These genes include all the instructions for creating ribosomal RNAs (rRNAs) and a full set of genes for transfer RNAs (tRNAs). In addition, there are around 100 single-copy genes that mostly code for proteins essential in the magical world of photosynthesis.\nFor instance, there’s a gene called rbcL that’s responsible for making a protein crucial in photosynthesis. It’s like the superstar of the show. And then there’s ndh, which plays an essential role in energy production. All these genes work together like a well-coordinated cast to perform the incredible act of turning sunlight into energy. It’s like a plant’s secret recipe for turning light into life!\n\n\n9.2.2 Mitochondrial Genome\n\n\n\n\n\nIllustration of a Plant Mitochondrial Genome\n\n\n\n\nThe interesting thing is that plant mitochondrial genomes can be incredibly diverse in size, ranging from around 200 kilobytes to a whopping 10 megabytes. That’s like having a storybook that can be as short as a postcard or as long as an entire library! In contrast, animal mitochondrial genomes are usually compact, around 16 kilobytes, and don’t contain those extra blank pages.\nNow, what makes plant mitochondrial genomes even more intriguing is the abundance of noncoding sequences. These noncoding regions are like the margins and empty pages in a book, taking up more than 90% of the Arabidopsis mitochondrial DNA. It’s as if there are pages upon pages of text that don’t directly tell the story but are there for some mysterious reason.\nAnother notable feature is that plant mitochondrial genomes don’t have a full set of transfer RNAs (tRNAs), which are essential for the translation of genetic instructions into proteins. So, it’s like having a storybook with missing words that need to be borrowed from other books in the cell’s library to make sense of the story. This unique structure and content of plant mitochondrial genomes make them quite different from their animal counterparts, adding another layer of complexity to the incredible world of plant genetics.\n\n\n\n\n\nRecombination in Plant Mitochondrial Genomes\n\n\n\n\nNonetheless, picture the plant mitochondrial genome as a novel that has been cut into circles, just like those classic fairy tales that you read in an interactive pop-up book.\nThe reason behind these subgenomic circles is something called recombinations. It’s like taking pages from different parts of the book and connecting them in new and unexpected ways, creating a fascinating twist in the plot. These circular segments have their own distinct stories to tell, and together, they make up the entire narrative of the mitochondrial genome.\n\n\n9.2.3 DNA Movement in Plants\n\n\n\n\n\nDNA Movements in Plants\n\n\n\n\nImagine DNA as a set of secrets that different parts of a plant’s cells share with each other. In the world of plants, these secrets move around like characters in an intriguing drama. You see, the mitochondrial genomes in plants hold pieces of information that are similar to what’s found in chloroplast DNA and nuclear DNA.\nIt’s like having overlapping storylines in different books. These shared secrets are not only within the mitochondria but also in the chloroplasts and the nucleus. Some might call it “promiscuous DNA” because these DNA sequences are a bit like characters who appear in multiple books – in this case, the three genetic systems of plant cells.\n\n\n9.2.4 Polyploidy in Plants\nPolyploidy is like a genetic superstar in the plant world. It’s when plants have extra copies of their entire set of genes, which makes them a bit like having a spare key to the genetic code. In fact, this phenomenon is super common among plants. To put it in numbers, around half to two-thirds of all flowering plants are polyploids. And when we look at ferns, it’s more than 99% of them, and for grasses, it’s about 80%.\nNow, let’s dive into some real-life examples. Take wheat, for instance. It started with an ancestor that had 14 chromosomes (the genetic code). But over time, it doubled its chromosomes to 28, and then the emmer or durum wheat doubled them again to 42. It’s like having more puzzle pieces to work with.\nOr, consider Lotus, a plant that decided to double its chromosomes when dinosaurs were still roaming the Earth. This might sound strange, but it was its way of adapting and surviving in a changing world.\nSo why is polyploidy such a big deal for plants? Well, it gives them more flexibility to adapt and change. They can handle significant shifts in their body plans and, in some cases, even thrive when their environment throws curveballs. Sometimes, polyploidy happens accidentally when different plants interbreed. And in other cases, humans have a hand in selecting plants with extra genes to create better crops. It’s like nature’s way of remixing the genetic code, leading to a diverse and resilient plant kingdom.\n\n9.2.4.1 History of Wheat\n\n\n\n\n\nIllustration of Einkorn Wheat’s History\n\n\n\n\nThe story of wheat is like a fascinating puzzle that unfolded over thousands of years. It all began around 10,000 years ago when two different types of grasses decided to mix their genetic codes. This was the first step in creating what we now know as bread wheat, scientifically called Triticum aestivum.\nBut the story doesn’t stop there. Around 8,000 years ago, this newly formed hybrid wheat met another type of wheat called Emmer wheat. When they got together, something magical happened: the number of chromosomes doubled in the new hybrid. So, instead of the typical 14 chromosomes that these grasses usually had, this new species had 42 chromosomes. It’s like the plant world’s version of a genetic jigsaw puzzle.\nThis complex history of hybridization and chromosome doubling gave us the wheat we know today. It’s a plant with six complete sets of seven chromosomes each, making it one of the most important crops in the world. The journey of wheat, from its humble beginnings to becoming a crucial food source, is a testament to the power of nature and human cultivation.\n\n\n\n9.2.5 Whole Genome Duplications\n\n\n\n\n\nPhylogenetic Tree for Plants\n\n\n\n\nImagine going back in time millions of years to witness a remarkable event in plant evolution. It’s called Ancient Whole Genome Duplication, or WGD for short. This phenomenon occurred several million years ago and played a crucial role in shaping the world of plants.\nOne of the most significant WGD events took place around 160 million years ago, and it’s believed to have set the stage for all the flowering plants we see today. You can think of it as the common ancestor of all modern flowering plants.\nDuring these ancient WGD events, plants ended up with extra copies of their entire set of genes. It might sound like a genetic surplus, but over time, it turned out to be a blessing. This redundancy allowed the genes to evolve in different ways, free from the usual selection pressures. In simple terms, it gave plants more room to adapt and thrive.\nAs time went on, many of these extra gene copies became dormant or were lost. This process is known as diploidization, and it helped the plants return to their usual genetic status. For example, if you take a look at a plant like Arabidopsis or even humans, you’ll find evidence of this ancient duplication in their genomes.\nSo, why is this ancient WGD so important for plants? Well, first, it allowed plants to tinker with their genes, which ultimately led to better adaptation to their environments. It also improved their agronomics, making them more suitable for domestication and human use. Plus, it played a significant role in the creation of new plant species."
  },
  {
    "objectID": "chapters/week9.html#evolution-of-c4-photosynthesis",
    "href": "chapters/week9.html#evolution-of-c4-photosynthesis",
    "title": "9  Plant Genome",
    "section": "9.3 Evolution of C4 Photosynthesis",
    "text": "9.3 Evolution of C4 Photosynthesis\n\n\n\n\n\nIllustration of C4 Photosynthesis\n\n\n\n\nLet’s journey back to the days when plants were just starting to figure out the best way to photosynthesize, or make their food using sunlight. This was a crucial evolutionary moment, leading to something known as C4 photosynthesis.\nImagine a time when the Earth’s atmosphere had less carbon dioxide, or CO2, and the climate was hot and dry. During this period, plants were under pressure to find a better way to capture CO2 and make food efficiently. That’s where C4 photosynthesis comes into play.\nC4 photosynthesis is like a special trick that certain plants developed to thrive in these challenging conditions. It’s an adaptation that helps plants work more efficiently, especially when there’s not much CO2 around.\nNow, here’s the fascinating part: C4 photosynthesis didn’t just happen once. It’s an example of what scientists call convergent evolution, which is a bit like when different groups of plants figure out the same solution to a problem. In fact, it’s happened over 60 times in various plant species around the world.\n\n9.3.1 Evolution of C4 Plants\n\n\n\n\n\nEvolution of C4 Plants’s Fitness\n\n\n\n\nImagine 62 different branches of plants, each with its unique adaptation for C4 photosynthesis. These branches are spread across two big plant groups: the eudicots (like sunflowers) and the monocots (like grasses). Among these, 21 branches are what scientists call “C3-C4 intermediates.” This means they have features that are kind of in between the older C3 photosynthesis and the more advanced C4 system.\nWhen we look at the geographic map, it’s fascinating to see that many of these C4 plant lineages are concentrated in regions with arid or semi-arid climates. It’s like nature’s way of helping these plants deal with challenging environments.\nNow, let’s break down the evolutionary journey. The first step was the development of something called “proto-Kranz anatomy.” This involves the plant making changes to its leaves, like reducing the space between leaf veins and making the bundle sheath cells (BSC) larger.\nNext came the evolution of a sort of “photo-respiratory CO2 pump.” This is like fine-tuning the plant’s engine to work more efficiently. It involved improving a process called the glycine shuttle, making it more effective.\nFinally, the C4 cycle itself evolved. In this phase, plants increased the activity of enzymes, such as PEPC, in the mesophyll cells (MC), which allowed them to capture carbon dioxide better. They also improved the work of enzymes in the bundle sheath cells (BSC), where the C3 cycle was becoming confined. Essentially, the plant got really good at taking in CO2 and using it to make food, even when it’s scarce.\n\n\n9.3.2 mRNA Blueprint for C4 Photosynthesis\nScientists embarked on a remarkable journey by carefully selecting closely related plant species: Cleome spinosa (a C3 plant), Cleome gynandra (a C4 plant), and Arabidopsis thaliana (another C3 plant). These plants became the stars of their study.\nImagine the scientists used a cutting-edge method called massive parallel mRNA sequencing. It’s like reading the genetic instruction manuals (mRNA) of these plants on a grand scale. They then carefully annotated these sequences, like highlighting important passages in a book.\nHere’s what they discovered:\n\nDifferences in Gene Abundance: The mRNA sequences from these plants showed significant differences in the abundance of certain genes. These genes included those responsible for transcription factors, transport proteins, and others involved in chloroplast movement, cell wall modifications, and plasmodesmatal connectivity. These genes are like the architects and builders of the C4 photosynthesis system.\nShifting Transcription Profiles: They found that these plants had large shifts in their transcription profiles for specific functional classes. This means that the genes responsible for C4 photosynthesis were more active in the C4 plant (Cleome gynandra) than in the C3 plants (Cleome spinosa and Arabidopsis thaliana). It’s like the C4 plant had a team of workers putting in overtime to make C4 photosynthesis happen.\nReduced Need for Photorespiration: In the C4 plant, Cleome gynandra, they noticed a lower demand for a process called photorespiration. This process usually slows down photosynthesis, but C4 plants have figured out how to minimize it.\nHigh Levels of C4 Enzymes: They confirmed their findings by looking at the enzymatic activities in these plants. The C4 plant had high levels of transcripts (genetic instructions) for enzymes specifically involved in C4 photosynthesis.\n\n\n\n9.3.3 Genome Duplication and Origin of C4 Photosynthesis\nImagine that scientists carefully selected two closely related plant species: Gynandropsis gynandra (a C4 plant) and Tarrenaya hassleriana (a C3 plant) that went through a whole-genome duplication event. It’s like comparing two siblings to understand the family’s history.\nThese scientists then performed whole gene sequencing and meticulously compared the genetic material in these plants, almost like reading the entire genetic book of their lives.\nHere’s what they uncovered:\n\nShared Whole Genome Duplication: Gynandropsis gynandra (the C4 plant) shared the history of a whole genome duplication with Tarrenaya hassleriana (the C3 plant). It’s like both siblings having a common ancestor who gave them a duplicate set of genes.\nSimilar Gene Copy Numbers: Despite this shared duplication, the number of gene copies was quite similar between the C4 and C3 plants. It’s like both siblings inherited nearly identical sets of books, even though there were duplicates.\nTranscript Regulation: They also looked at how genes are expressed, or turned on, in these plants. What they found was that the C4 plant, Gynandropsis gynandra, had fewer differences in gene regulation compared to the C3 plant, Tarrenaya hassleriana. It’s like one sibling adhering closely to the original story, while the other made slight adaptations.\n\nBased on these discoveries, scientists drew a conclusion - it’s more likely that the shift to C4 photosynthesis involved tweaking the regulation of existing genes rather than creating entirely new functions from duplicated genes. It’s as if both siblings had the same set of Lego blocks, but one built a new structure using different arrangements."
  },
  {
    "objectID": "chapters/week9.html#genomics",
    "href": "chapters/week9.html#genomics",
    "title": "9  Plant Genome",
    "section": "9.4 Genomics",
    "text": "9.4 Genomics\nSo, what’s genomics all about? It’s the science that dives deep into an organism’s genetic makeup. This genetic makeup influences everything about that organism, from how it grows to how it functions.\nThere are two key components in genomics:\n\nWhole Genome Sequencing: Imagine reading every single letter in a book, cover to cover, to understand the whole story. In genomics, we do the same, but instead of letters, we’re dealing with DNA, the genetic code.\nFunction Characterization: Now, reading the book is just the beginning. We want to know how the story unfolds. That’s where things like transcriptomics (studying gene activity), metabolomics (examining the molecules involved in metabolism), proteomics (investigating proteins), and epigenomics (exploring how genes are regulated) come into play. They help us understand how genes actually work and interact.\n\n\n9.4.1 Whole Genome Sequencing\nImagine you have a really exciting book, but you want to read every word in it. That’s what scientists do with whole genome sequencing (WGS). They read every single letter in an organism’s DNA, which is like the book of life for that organism. But here’s the cool part: this technology has gone through some amazing changes.\n\n\n\n\n\nCost of Sequencing the Whole Human Genome\n\n\n\n\nIn the beginning, it was pretty expensive and slow, like the first generation of WGS, where they used a method called Sanger sequencing. It was like carefully reading the book one letter at a time.\nThen, things got faster and cheaper with the second generation. They used super high-tech machines like Illumina’s sequencers that could read millions of letters all at once. It was like speed-reading a whole library!\nAnd now, we’re in the third generation of WGS. This is like having a magical book that you can read without tearing it apart. These new technologies don’t need to cut the DNA into tiny pieces, and they give us long, uninterrupted sequences. It’s kind of like reading a really long story without any breaks.\n\n9.4.1.1 Why do Whole Genome Sequencing?\nWhole genome sequencing is like opening a treasure chest of knowledge in the world of genetics. When we unlock the secrets hidden in an organism’s entire genetic code, we can uncover remarkable insights.\nFirstly, it offers a window into the past, helping us understand how species have evolved over time. It’s like looking at old family photos to see where you came from.\nThen, there are those elusive genes that are quite shy and don’t like to be cloned the traditional way. Whole genome sequencing gives us a sneak peek at these mysterious genes that play crucial roles in essential plant processes, such as building wood or making flowers bloom.\nIt’s like having a backstage pass to a concert – we get to see the stars behind the scenes.\nWhole genome sequencing also shines a spotlight on gene families. These are like different branches of the same big genetic tree. They help us confirm the unique qualities of a species. It’s like discovering that all the members of a family have a shared love for music.\nMoreover, this incredible technology helps us create a comprehensive catalog of all the DNA variations within a species. Think of it as collecting all the different colors in a painter’s palette. When we know these variations, we can use them to understand traits and even guide breeding.\n\n\n\n9.4.2 Illumina Sequencing Technology\nFirst, scientists create something called a genomic library. Imagine it’s like a treasure chest filled with tiny DNA fragments. Each of these fragments is like a piece of a puzzle. They add special sequences to these puzzle pieces that help the sequencing machine do its job.\nNow, here’s where the magic happens. The machine takes these little DNA fragments and makes a bunch of copies of them, like a photocopier. It creates hundreds of identical copies in what they call clusters.\nOnce the clusters are ready, the machine starts sequencing. It’s like reading a book, but in this case, it’s reading the DNA letters. For each letter (A, T, C, or G), they use a special tag that’s like a tiny colored flag. As they read the DNA, the machine records which flag (or base) is added. They do this over and over, like reading one page after another.\nAfter they’ve read everything, they analyze the data. They look at all the flagged bases to figure out the DNA’s sequence.\nWhat’s really amazing is that this technology can do all of this for millions of DNA clusters at once, making it super fast. And because they read the DNA twice, once for each strand, it’s incredibly accurate. It’s like having two proofreaders for every book, so you don’t miss a single typo.\n\n\n9.4.3 Single Molecule Real Time (i.e., SMRT) Sequencing\n\n\n\n\n\nSteps Involved in SMRT Sequencing\n\n\n\n\nFirst, scientists take their DNA and put these special hairpin loop adapters on it. These adapters have a spot where the sequencing process can begin. Imagine the DNA bending back on itself to form a circle. This circular DNA is now ready for sequencing.\nNext, they bring in the star of the show: a DNA polymerase. Think of it like a tiny machine that reads the DNA. This polymerase is placed in something called a zero-mode wave guide (ZMW) chamber. The ZMW chamber is super tiny and acts like a little room where only one DNA fragment is allowed in at a time.\nNow, the exciting part begins. They start reading the DNA. As each DNA letter (A, T, C, or G) gets added, a special color-changing molecule, or fluorophore, is also attached. This molecule is like a tiny glowstick. When it lights up, it’s a signal that a DNA letter has been read.\nBut there’s a twist. Once the DNA letter is read, the fluorophore is cleaved, which means it’s snipped off. As it’s snipped, it emits a little flash of detectable light. This flash tells scientists which DNA letter was there. It’s like the DNA is revealing its secrets in real-time.\nThe coolest thing is that this polymerase enzyme is super-efficient and fast, so it can read really long stretches of DNA without making mistakes. That’s why SMRT sequencing is so amazing – it gives us incredibly long and accurate reads of DNA. It’s like reading a whole book in one go instead of just a single page.\n\n\n9.4.4 Arabidopsis Genome Findings\nScientists first started working on Arabidopsis’s genome back in 1996 and managed to finish it by 2000. To put that in perspective, it’s like they started decoding a secret message and, four years later, they could read it all.\nThey didn’t just read the DNA letter by letter, though. Instead, they broke it into smaller pieces called Bacterial artificial chromosomes, or BACs for short. It’s like taking apart a big puzzle and then putting it back together to see the whole picture.\nThe Arabidopsis plant has a pretty small genome. We’re talking about 115.4 million bases, which are like the DNA building blocks. That might sound like a lot, but compared to other plants, it’s quite compact.\nNow, the cool part. Arabidopsis’s genome has around 25,498 genes. These genes are like sentences in the plant’s instruction manual, and they belong to about 11,000 different families. It’s like having 11,000 different groups of sentences in the manual.\nBut here’s the catch – we don’t know what all of these genes do. Scientists have only figured out the job of 69% of them by comparing them to genes with known functions. And when it comes to doing experiments to understand how these genes work, they’ve only studied about 9% of them. So, it’s like having a manual with lots of pages still waiting to be read.\nHere’s another interesting thing: Arabidopsis’s evolution story is pretty unique. It went through a whole-genome duplication, which means it had two copies of its entire instruction manual at one point. Then, over time, it lost some of those genes and even made extra copies of some others. It’s like having a book, making a photocopy of the whole thing, and then deciding which pages you don’t need while printing some pages twice.\n\n9.4.4.1 More on the Genome\n\n\n\n\n\nIllustration of the Arabidopsis Genome\n\n\n\n\nFirst off, when we look at the parts of the genome that code for important stuff (those are called exons), we find something intriguing. These exons are quite rich in a particular set of building blocks known as GC pairs. In fact, about 44% of these pairs are GC, which is more than the 32% in the non-coding regions called introns. It’s like certain chapters in a book are written in a unique and special language.\n\n\n\n\n\nSegmentally Duplicated Regions in Arabidopsis’s Genome\n\n\n\n\nNow, when it comes to the genes, there’s a mix of uniqueness and togetherness. Imagine you have a bunch of friends. In the Arabidopsis genome, 35% of genes are like those unique pals who don’t have many other similar friends around. But there’s also a club where 37.4% of the genes belong to a multigene family, which is like having lots of cousins in your family tree.\nBut wait, there’s more to this genetic landscape. It’s kind of like a wild garden where you find some jumping genes, also known as transposons. These transposons make up at least 10% of the genome. Interestingly, the areas where these genes hang out have fewer regular genes and don’t swap genetic material as often. Think of it as a neighborhood where folks keep to themselves.\nNow, here’s where things get really exciting. A big chunk of the genome is all about supporting the plant’s metabolic processes, kind of like how your body has organs to keep you healthy. These genes help with various tasks, from photosynthesis (basically the plant’s way of making food) to respiration (yes, plants breathe too), and even acquiring important minerals. It’s like having a multitasking team working around the clock to keep the plant alive and well.\nThe genome doesn’t stop there. It’s got a bunch of other genes responsible for making things like lipids (think plant fats), fatty acids, amino acids (the building blocks of proteins), and even nucleotides (the pieces that make up DNA). These genes are like the plant’s very own recipe book for life.\nBut there’s more – pyruvate kinase and cell wall metabolism genes. They help create, repair, and modify the plant’s protective outer layer. It’s like having a construction crew to build and renovate the plant’s fortress.\n\n\n\n9.4.5 Challenges of Plant Genome Sequencing\n\n\n\n\n\nChallenges Regarding Genome Sequencing in Plants\n\n\n\n\nThe last two decades, from 2000 to 2020, have been truly remarkable in the world of plant genome sequencing. Scientists have made some incredible progress and faced some exciting challenges.\nDuring this time, they’ve published over a thousand plant genomes, which represent a whopping 788 different plant species. Imagine having a thousand different blueprints for plants! In the first ten years, most of the focus was on well-known model plants and essential crops, like the superstars of the plant world. These genomes were like the building blocks of our knowledge.\nHowever, the second decade was a game-changer. The number of genomes sequenced skyrocketed, increasing by 50 times! Researchers didn’t just stick to the familiar faces; they ventured into the world of diverse and lesser-known species. They also improved the quality of these genome assemblies, ensuring they were more detailed and accurate. They even tackled some really big genomes, like the heavyweight champions of the plant world.\nBut the adventure doesn’t stop here. There are many more plant genome sequencing projects in the pipeline. One exciting example is the 10KP project, which aims to sequence the genomes of 10,000 different plant species. It’s like a grand expedition to discover the genetic secrets of plant life.\nHowever, with every exciting journey, there are challenges. Scientists are striving to create gapless reference genomes, where there are no missing pieces in the plant’s genetic puzzle. They also want to tackle more complex genomes, the ones that are like intricate mazes waiting to be unraveled. And they’re working on building reference pan-genomes for a species, which means understanding not just one version of a plant’s genome but all the possible variations.\n\n\n9.4.6 Genome of Durian\n\n\n\n\n\nLocal Chinese Publications Regarding Durian Sequencing\n\n\n\n\nThe fascinating world of genomics recently took a delightful detour to explore the genome of the durian, a fruit of great local interest. To unlock the secrets within, scientists employed some impressive technical approaches. They used a combination of Single Molecule Real Time (SMRT) sequencing for those long reads and Illumina for shorter ones, like having both a telescope and a magnifying glass. They also performed RNA-seq, which is like eavesdropping on the conversations of different parts of the durian plant, such as the fruit, leaf, stem, and root.\nThe genome they unveiled turned out to be 738 million base pairs in size, like a massive book of genetic information. Inside this genetic book, they discovered 45,335 predicted gene models, with an average size of 1.7 kilobases. Surprisingly, only 4% of these genes were unique to the durian. It’s like finding a few unique words in a gigantic novel.\nThe genome also contained a repeating theme, literally. About 54.8% of the genome was made up of repeated sequences, like reading the same sentence over and over.\nBut here’s where it gets even more exciting. The durian’s genes started singing during the fruiting season. Genes related to sulfur, ethylene, and lipids became more active. Two special genes called methionine lyase (MCL) and aminocyclopropane carboxylic acid synthase (ACS) were in the spotlight. They joined forces with their entourage of molecules, creating something called volatile sulfur compounds (VSC) and ethylene.\nWhat’s even more interesting is that the durian shares a whole-genome duplication event with cotton. It’s like they’re distant relatives who once had a similar family reunion in their genetic history.\nWhy does all of this matter? Well, the durian’s genome is the first in the Helicteroideae subfamily to be fully sequenced. This achievement is a game-changer for researchers and could have a big impact on our understanding of tropical fruit biology and agronomy, like having the ultimate guide to growing and enjoying these unique fruits. It’s a bit like discovering a treasure map for the world of durians."
  },
  {
    "objectID": "chapters/week9.html#gene-function-annotation",
    "href": "chapters/week9.html#gene-function-annotation",
    "title": "9  Plant Genome",
    "section": "9.5 Gene Function Annotation",
    "text": "9.5 Gene Function Annotation\n\n\n\n\n\nTypes of -omics\n\n\n\n\nImagine you’re in a massive library filled with countless books, each representing a gene. Your task is to decipher the meaning and importance of every single book, which is akin to figuring out what each gene does. It’s like a puzzle where you need to connect the dots.\nFunctional genomics is our way of tackling this monumental challenge. We’re equipped with tools and methods to tackle the entire genome at once. Instead of reading one book at a time, we’re trying to read the entire library in one go. This approach allows us to see how all the genes in an organism work together, kind of like watching all the characters in a complex story play their roles.\n\n9.5.1 Challenges with Gene Function Annotation and Characterization\n\n\n\n\n\nOutline of Functional Annotation\n\n\n\n\nFirstly, many of the genes we find through sequencing are like undiscovered treasures. They’re novel, unique, and not quite like anything we’ve seen before. In fact, in Arabidopsis, a model plant, over 40% of the genes are entirely novel. It’s like finding new species in a jungle.\nEven when we look at genes from different organisms, they may seem similar on the surface, but figuring out their specific role in a particular organism can be as tricky as solving a riddle. Just because they look alike doesn’t mean they act the same way.\nImagine you have a big family with many cousins who look nearly identical. Some might have the same hobbies and interests, but others could be completely different. That’s what it’s like when we discover multi-gene families. They may share strong similarities in their genetic sequences and behave similarly, but each one has a unique role, just like cousins with their own talents and interests."
  },
  {
    "objectID": "chapters/week10.html",
    "href": "chapters/week10.html",
    "title": "10  Bioenergy and Biomaterials",
    "section": "",
    "text": "Gasoline, the fuel we use for cars, comes from a surprising source. It’s made from ancient plants called lycophytes and ferns that lived around 300 million years ago. These plants have long been replaced by modern seed plants. To create just one gallon of gasoline, we need around 89 metric tons, which is about 180,000 pounds, of these ancient plants. That’s a lot of prehistoric vegetation packed into a tiny gas tank!\nNow, let’s talk about fossil fuels. They are a massive source of energy for our world, and they come from the remains of these ancient plants and other organic materials. Fossil fuel reserves are like a big savings account of carbon that nature has been building for millions of years. There’s an estimated 5,000 gigatons (that’s a really huge number!) of carbon stored in these reserves. These reserves are essentially our planet’s ancient energy storage, and we’ve been using them to power our world for a long time."
  },
  {
    "objectID": "chapters/week10.html#political-actions-regarding-global-warming",
    "href": "chapters/week10.html#political-actions-regarding-global-warming",
    "title": "10  Bioenergy and Biomaterials",
    "section": "10.1 Political Actions Regarding Global Warming",
    "text": "10.1 Political Actions Regarding Global Warming\n\n10.1.1 IPCC Report From August 2021\n\n\n\n\n\nFigures from the IPCC’s August 2021 Report\n\n\n\n\nThe IPCC Report AR6 from August 2021 delivers a clear message: human activities are undeniably responsible for heating up our planet. This warming affects not only the atmosphere but also the ocean and the land. As a result of this human-induced climate change, we’re already experiencing changes in our weather and climate patterns all around the world.\nIn Singapore, for instance, the weather is changing too. In fact, it’s getting warmer there even faster than the global average. Over the years since 1948, Singapore has seen a temperature rise of 1.8 degrees Celsius, which is higher than the global increase of 1.1 degrees Celsius. This means that Singapore is warming up at a faster rate.\nThe changes in Singapore’s weather also include more heavy storms. In 1980, there were five days with intense rainfall exceeding 70 millimeters per hour, but in 2012, that number doubled to ten days. This shows that the frequency of severe storms is increasing.\nThe city is also experiencing heavier rainfall. The maximum amount of rain in a single day has increased from 80 millimeters to 107 millimeters. This means that when it rains heavily, it’s even more intense than before.\nAnother issue is the increase in haze days. Haze is when the air is filled with tiny particles that reduce visibility and can be harmful to breathe. Singapore is facing more of these hazy days, which can impact the quality of the air people breathe and their overall health. So, the IPCC report and the changes in Singapore’s weather patterns remind us that climate change is a real and pressing issue with observable impacts.\n\n\n10.1.2 Climate Change\n\n“Environmental migrant refers to people who are forced to migrate from or flee their home region due to sudden or long-term changes to their local environment which compromise their well being or secure livelihood, such changes are held to include increased droughts, desertification, sea level rise, and disruption of seasonal weather patterns such as monsoons.”\n– Wikipedia\n\n\n\n10.1.3 Paris Agreement\nThe Paris Agreement is a significant international deal focused on addressing the issue of greenhouse gas emissions. In 2015, 195 countries came together and reached a consensus to combat climate change. Their main goals were to prevent the global average temperature from rising by more than 2 degrees Celsius above pre-industrial levels. Later, in October 2018, they even considered aiming for a stricter target of 1.5 degrees Celsius to limit temperature increase.\nTo achieve these goals, each country agreed to create their own plans, called ‘Nationally Determined Contributions’ or NDCs, to reduce their emissions. As of now, 196 members of the United Nations Framework Convention on Climate Change (UNFCCC) have signed this treaty. The agreement officially took effect on November 4, 2016.\nThere were some changes related to the Paris Agreement involving the United States. While the U.S. initially joined the agreement, they withdrew from it under the presidency of Donald Trump on November 4, 2020. However, they rejoined the agreement on February 19, 2021, under the leadership of President Biden.\nCountries have also made commitments to reduce emissions. For example, France has announced ambitious plans to ban all petrol and diesel vehicles by 2040 and aims to achieve carbon neutrality by 2050.\nSingapore, as a part of its NDCs, has set specific targets. They plan to reduce their emissions intensity, which is the amount of carbon emissions produced for each dollar of the Gross Domestic Product (GDP), by 36% compared to 2005 levels by 2030. They also aim to stabilize their emissions with the goal of reaching their peak around 2030. Ultimately, Singapore is striving to achieve net-zero emissions by 2050, which means they want to balance out the amount of greenhouse gases they release with the amount they remove or offset."
  },
  {
    "objectID": "chapters/week10.html#bioenergy",
    "href": "chapters/week10.html#bioenergy",
    "title": "10  Bioenergy and Biomaterials",
    "section": "10.2 Bioenergy",
    "text": "10.2 Bioenergy\nBioenergy is a type of renewable energy that comes from biological sources. This energy can be used for various purposes like heating, generating electricity, or powering vehicles. It’s a sustainable energy source, and the United States Department of Agriculture (USDA) defines it this way. Bioenergy is one of the fastest-growing types of renewable energy, which means it’s becoming more and more popular.\n\n\n\n\n\nGraphic Illustrating Flow of Energy in the Ecosystem\n\n\n\n\nThere are several forms of bioenergy. One of them is bio-ethanol, which can be used as a substitute for gasoline in our cars. It’s made through the fermentation of simple sugars or starches. Another form is cellulosic ethanol, which is produced from the fermentation of biomass, like plant materials.\nBio-diesel is another type of bioenergy, and it’s used as a replacement for regular diesel fuel. It can be made from fatty acids found in plants, animals, or even algae. This means we can use these natural sources to power our vehicles in a more environmentally friendly way.\nBio-gas, often in the form of methane, can replace natural gas. It’s created through a process called anaerobic fermentation using biomass. This is a way to produce gas for heating and cooking that’s better for the environment.\nFinally, biomass can be directly burned to produce energy. This means using plant and organic materials as a fuel source. It’s another way to harness the power of nature for our energy needs. So, bioenergy offers many different ways to make our energy consumption more sustainable.\n\n10.2.1 Why Bother with Bioenergy?\nBioenergy has some really attractive qualities. One of the biggest advantages is that it’s a sustainable energy source. This means that we can keep using it without worrying about running out, unlike some other energy sources that can be depleted.\nAnother great thing about bioenergy is that it’s carbon neutral. This means it doesn’t add new carbon dioxide (CO2) into the atmosphere when we use it. This is important for fighting climate change because CO2 is a major contributor to global warming.\nIn addition to being better for the environment, bioenergy is also less polluting in other ways. It doesn’t release pollutants like aromatics, sulfur, or silt, which can harm our air and water quality.\nFurthermore, bioenergy can have positive economic effects. It can create business opportunities and jobs in the bioenergy industry. This means that not only is it good for the environment, but it can also benefit our economies by providing employment and stimulating business growth. So, bioenergy has a lot of appealing features that make it an attractive option for a sustainable and cleaner energy future.\n\n\n10.2.2 Energy Prices\n\n\n\n\n\nFigures Relating Energy Prices\n\n\n\n\nEnergy prices are on the rise, and there are a few important reasons for this. As our economy bounces back and becomes more active, our carbon emissions, which are harmful to the environment, are also increasing. This happens because when we use more energy, it often comes from sources like fossil fuels, which release carbon emissions when burned.\nHowever, there’s a silver lining to this story. Renewable energy sources, like solar and wind power, are becoming more popular. They’re gaining a bigger share of the energy market. This is great news for the environment because renewable energy is much cleaner and doesn’t produce the harmful emissions that fossil fuels do. So, even though energy prices are going up, the increasing use of renewable energy is a positive step in reducing the impact on our planet.\n\n\n10.2.3 Energy Measurements and Content Comparison\nWhen we talk about energy, we use specific measurements to understand it better. These measurements help us figure out how much energy something contains. There are two main ways to express energy content: the Lower Heating Value (LHV) and the Higher Heating Value (HHV). Which one we use depends on whether the energy is taken from hot exhaust gas or not.\nTo make these measurements more relatable, here are some basic units and conversions that can help us understand them better:\n\n1.0 joule (J) is a small amount of energy, and it’s equivalent to the force of one Newton applied over a distance of one meter. It’s also about 0.239 calories (cal).\n1.0 British thermal unit (Btu) is a measure of energy used in some countries, and it’s equal to about 1055 joules (1.055 kJ).\n1.0 gigajoule (GJ) is a much larger unit of energy. It’s equal to 1 billion joules, which is about 0.948 million Btu, 239 million calories, or 278 kilowatt-hours (kWh).\n1.0 watt (W) is a measure of power, which is the rate at which energy is used. It’s equivalent to 1 joule per second or about 3.413 Btu per hour (Btu/hr).\n1.0 horsepower (hp) is another unit of power. It’s equal to 550 foot-pounds per second, which is approximately 2545 Btu per hour, 745.7 watts (W), or 0.746 kilowatts (kW).\n1.0 kilowatt (kW) is also a measure of power and is equal to 3413 Btu per hour or about 1.341 horsepower (hp).\n1.0 kilowatt-hour (kWh) is a measure of energy commonly used in our homes. It’s equal to 3.6 megajoules (MJ), 3413 Btu, or the amount of energy a 1-kilowatt device uses in one hour.\n\nThese measurements help us understand and compare different forms and amounts of energy, which is important for things like designing energy systems, calculating energy costs, and making informed decisions about energy use.\nEnergy content can also vary greatly between different sources, and it’s important to know these values for various purposes. Here’s a comparison of the energy content of different fuels and substances:\n\nWood fuel (air dry, 20% moisture) contains about 15 gigajoules per metric ton (GJ/t). This is the energy you get from one ton of dry wood.\nAgricultural residues can range from 10 to 17 GJ/t, depending on their moisture content. These residues come from crops and farming.\nCharcoal, which is derived from about 6 to 12 metric tons of air-dry wood, has an energy content of 30 GJ/t.\nCoal, a widely used fossil fuel, has an energy content of about 27 GJ/t.\nEthanol has an energy content of 26.7 GJ/t, but it’s important to note that this value is based on its Lower Heating Value (LHV) and its density is approximately 0.79 kilograms per liter.\nGasoline, the fuel we use in our cars, has a high energy content of about 43.5 GJ/t, with a density of around 0.73 kilograms per liter.\nDiesel fuel contains approximately 42.8 GJ/t, and its density is about 0.84 kilograms per liter.\nBiodiesel, which is made from biological sources, has an energy content of 37.8 GJ/t and a density of about 0.88 kilograms per liter.\nNatural gas (methane) has an energy content of about 37.8 megajoules per cubic meter (MJ/m3).\nLiquid natural gas (LNG), which is a supercooled form of natural gas, contains a substantial 53.6 GJ/t with a low density of approximately 0.187 kilograms per liter.\nLiquid hydrogen, often used as a rocket fuel, has a very high energy content of 143 GJ/t with an extremely low density of about 0.07 kilograms per liter.\nNuclear fission of U-235 in a nuclear power plant has an enormous energy content of 88,250,000 GJ/t. This is the result of nuclear reactions in nuclear power plants.\n\nThese energy content values are essential for understanding the efficiency and feasibility of different energy sources and fuels for various applications.\n\n\n10.2.4 Bioethanol\nBioethanol is a type of biofuel made through a process called fermentation. It’s created from different types of substances, primarily polysaccharides or simple sugars. The sources of these materials vary and include the following:\n\nSugarcane, sugar beet, or sweet sorghum juices are often used to make bioethanol. These juices contain mainly simple sugars, which are easily converted into ethanol through fermentation.\nCorn or wheat are also commonly used to produce bioethanol. In this case, the main source is starch, which gets broken down into sugars and then fermented.\nThere are also other sources of starch, such as yam, potato, tapioca (cassava), and more, which can be utilized to create bioethanol. These starchy materials can be processed to release the sugars needed for fermentation.\n\nBioethanol is a sustainable and renewable fuel source that can be used in place of traditional gasoline, and it’s made from a variety of natural sources, depending on what’s most available and efficient in different regions.\n\n10.2.4.1 Case Study: Brazil\nBrazil has an impressive success story when it comes to sugarcane ethanol. In 2022, they produced a whopping 31.6 billion liters of ethanol. This incredible amount is made possible because they have a vast sugarcane plantation area that covers 9 million hectares. One remarkable thing about their production is that it’s cost-effective, with a production cost of only US$0.75 per gallon of ethanol. This means they can make a lot of ethanol without breaking the bank.\nNot only is Brazil producing a lot of ethanol, but they’re also doing it in an environmentally friendly way. The energy balance of their ethanol production is quite impressive, with an output/input ratio of more than 8. This means they get a lot more energy out of the process than they put in. It’s a smart and efficient way to produce fuel.\nAnother fantastic benefit is that using sugarcane ethanol results in far fewer greenhouse gas emissions compared to gasoline. Gasoline emits 20.4 units of greenhouse gases, while ethanol only emits 9 units. This means that using ethanol instead of gasoline helps reduce greenhouse gas emissions by 56%. It’s a big win for the environment.\nIn Brazil, you’ll also find that nearly 95% of the cars sold are equipped with a ‘flexi’ engine, which can run on both gasoline and ethanol. This flexibility gives people more options and encourages the use of ethanol. In fact, ethanol provides more than half, or 52%, of the fuel used in cars and light trucks in the country.\nOne of the key factors contributing to Brazil’s success is the remarkable sugarcane itself. It grows rapidly in the tropical climate, thanks to its unique photosynthesis process. This, in turn, results in high yields of sugar, which is used to make ethanol. Brazil’s success in sugarcane ethanol is not only impressive but also serves as an example of how sustainable and eco-friendly practices can lead to a more environmentally responsible and economically efficient fuel industry.\n\n\n10.2.4.2 Case Study: US\n\n\n\n\n\nProcess of Generating Ethanol in the US\n\n\n\n\nIn the United States, bioethanol production mainly relies on corn as its primary source. Corn is used to make bioethanol, but the way it’s done is a bit different compared to some other countries. Here, the government provides subsidies to support the production of bioethanol. This means that the government gives financial help to make it easier for people to produce this eco-friendly fuel.\nHowever, one important thing to know is that the production cost of bioethanol in the U.S. is relatively higher compared to other countries. This can affect how much bioethanol is produced and how competitive it is in the market.\nThere are some ongoing discussions and debates about bioethanol in the United States. Some of the key points people are talking about include the energy balance. This is about how much energy you get out of bioethanol compared to the energy put into making it. There are also concerns about intensive farming practices and the potential impact on the environment. Additionally, there’s a debate about using crops like corn for bioethanol when they could also be used for food, raising concerns about competition for food resources. These are all important topics to consider when thinking about bioethanol in the United States.\n\n\n10.2.4.3 Bioethanol versus Biobutanol\nWhen we compare bio-butanol to bio-ethanol, we find some interesting similarities and differences that are worth exploring.\nSimilarities: Both bio-butanol and bio-ethanol are short-chain alcohols, and they can both be used as alternatives to gasoline. They have something in common when it comes to where they come from. You can make them from the same raw materials, like plant-based sources, but you use different processes and microorganisms to do it.\nDifferences: Now, here’s where they start to stand apart. Bio-butanol has a higher volumetric energy density compared to bio-ethanol, which means it contains more energy in the same amount of space. Think of it as having more power packed into a smaller container.\nAnother cool thing about bio-butanol is that it’s less prone to absorbing water and evaporating. This makes it easier to store and transport without losing its qualities.\nBut perhaps one of the most significant differences is that bio-butanol is more similar to regular gasoline. It’s what we call a ‘drop-in’ fuel, which means you can use it in vehicles designed for gasoline without making any changes to the engine. It’s like a direct replacement. Bio-ethanol, on the other hand, might need some adjustments to work in gasoline engines.\nHowever, there’s a catch. Right now, when we make bio-butanol, we get a bit less energy out of the same raw materials compared to bio-ethanol.\n\n\n\n10.2.5 Cellulosic Ethanol\n\n\n\n\n\nBiomass Composition\n\n\n\n\nCellulosic ethanol is a fascinating concept in the world of biofuels. It’s all about taking the cellulose found in various plant materials and turning it into ethanol, which can be used as an eco-friendly fuel. This is a significant advancement because it allows us to use parts of plants that are typically harder to convert into fuel.\nWhen it comes to choosing which plants are the best candidates for making cellulosic ethanol, grasses and trees are at the top of the list. Grasses and trees, like switch grass in the United States or willow trees in New Zealand and Australia, are great choices. These plants are not only abundant but also excellent at capturing and storing carbon dioxide from the atmosphere, which makes them super eco-friendly. So, cellulosic ethanol is all about using the natural power of these plants to create a greener fuel source.\n\n10.2.5.1 Making Cellulosic Ethanol\n\n\n\n\n\nSteps Involved in Making Cellulosic Ethanol\n\n\n\n\n\n\n\nSteps Involved in Making Cellulosic Ethanol\n\n\n\n\n\n\n10.2.5.2 Challenges with Making Cellulosic Ethanol\nCellulosic bioethanol is an exciting field, but it does come with some technical challenges. One of the main difficulties is separating cellulose from lignin, which is another component found in plant materials. This separation process can be a bit tricky because these two parts are naturally bonded together.\nOnce we have the cellulose, the next step is breaking it down into its sugar components, which can then be turned into ethanol. This process takes some time and isn’t very speedy. To put it in perspective, it can take a whole week to produce just 70 gallons of ethanol from one ton of biomass. This is not as efficient or fast as some other methods of ethanol production.\nMoreover, cellulosic bioethanol tends to be less efficient in terms of the amount of fuel you get from the biomass you start with. Additionally, the production cost can be higher compared to other methods, which can make it less economically competitive. These are some of the challenges and limitations that researchers and scientists are working to overcome to make cellulosic bioethanol a more viable and efficient fuel source.\n\n\n\n10.2.6 Biodiesel\n\n\n\n\n\nSteps Involved in Making Biodiesel\n\n\n\n\nBiodiesel is a special type of fuel made from natural sources. It’s technically the mono alkyl esters of long chain fatty acids that come from renewable lipid sources. To make biodiesel, you use a chemical reaction called trans-esterification on substances like triglycerides, which are found in fats.\nBiodiesel has some really cool advantages. For one, it has a lower viscosity and a lower melting point compared to regular diesel fuel. This means it flows more easily and can work well in cold weather. Even better, you can use biodiesel directly in diesel engines without making any modifications, so it’s a smooth transition.\nBiodiesel also has a high cetane number, which is a good thing for diesel engines. Plus, it doesn’t have sulfur or aromatics, which can be bad for the environment. This makes biodiesel a more environmentally friendly choice.\nOne last perk is that biodiesel provides good lubrication to the engine, which helps keep everything running smoothly.\n\n10.2.6.1 Sources of Biodiesel\n\n\n\n\n\nJatropha curcas as a Feedstock for Bio-Kerosene\n\n\n\n\nWhen it comes to making biodiesel, there are various sources of fatty acids that can be used. These fatty acids are essential ingredients for creating biodiesel, and they can come from a variety of places. Some of the common sources include used cooking oil or animal fat, which are things we often have as waste in our kitchens and food processing.\nIn Europe, canola oil is a popular source for making biodiesel. It’s abundant and can be converted into this eco-friendly fuel. In the United States, soybean oil is commonly used for biodiesel production. It’s a readily available resource that can be used sustainably.\nIn some parts of the world, like Malaysia and Indonesia, palm oil is a significant source of fatty acids for biodiesel. This oil has been widely used, although there are concerns about its environmental impact.\nThere are also some emerging sources of fatty acids for biodiesel. These include plants like Jatropha, Pongamia, and the Chinese tallow tree, as well as microorganisms like algae. These newer sources are being explored and developed to create more sustainable and environmentally friendly biodiesel options.\n\n\n10.2.6.2 Biodiesel Terminology\n\\[\\begin{align}\n  SN &= \\frac{\\sum(560 \\times A_i)}{MW_i} \\\\\n  IV &= \\frac{\\sum(254 \\times D \\times A_i)}{MW_i} \\\\\n  CN &= 46.3 + \\frac{5458}{SN} - 0.225 \\times IV\n\\end{align}\\]\nIn the world of biodiesel, there are some special terms that help us understand and measure its characteristics. Let’s break them down:\n\nSN (Saponification Number): This number tells us about the length of the fatty acids in biodiesel. It’s a way to measure the structure of the fatty acids.\nIV (Iodine Value): The IV is about the degree of unsaturation in biodiesel. Oils with a high IV can become thicker when they’re heated. A common standard is an IV of less than 115.\nCN (Cetane Number): The CN measures how quickly a fuel can ignite. Different countries and organizations have biodiesel standards, with values usually greater than 47, 49, or 51.\nOthers: There are some additional characteristics to consider when it comes to biodiesel, such as melting points, cloud points, and cold filter plugging points (CFPP). These values help us understand how biodiesel behaves under different temperature conditions.\n\nUnderstanding these terms is essential for making and using biodiesel effectively and safely. They provide valuable information about its composition, properties, and performance.\n\n\n10.2.6.3 Comparing Biodiesel and Bioethanol\nLet’s compare two important biofuels: bioethanol and biodiesel. Each has its own set of characteristics and considerations.\nBioethanol: - When bioethanol is used, it can lead to corrosion of pipelines. This is because ethanol has properties that can affect the materials used in pipelines. - Blends of more than 15% ethanol in gasoline may require a few modifications to the engine to work properly. These changes ensure that the engine can handle the higher ethanol content. - Bioethanol has higher evaporation losses due to its higher vapor pressure. This means it can evaporate more quickly, which may affect its efficiency. - It also has a lower calorific value, meaning it provides less energy per unit compared to some other fuels. As a result, vehicles may need larger fuel tanks to go the same distance.\nBiodiesel: - Biodiesel has an advantage when it comes to energy content. It contains about 25% more energy compared to bioethanol. This means it can provide more power and efficiency for engines. - It’s relatively easy to store and transport biodiesel. This makes it a convenient choice for many applications. - Biodiesel has lubricating properties, which can be beneficial for engines. It helps reduce wear and tear, making it a good choice for vehicles and machinery.\n\n\n\n10.2.7 Biogas\n\n\n\n\n\nSteps Involved in Biogas Production\n\n\n\n\nWhen we talk about anaerobic digestion of biomass for biogas production, we’re essentially describing a process where bacteria break down organic materials, like food waste or agricultural residues, in an environment without oxygen. This absence of oxygen is crucial for this process to work.\nAs a result of this breakdown, biogas is generated, and it’s primarily made up of two main gases: methane and carbon dioxide. Methane is a valuable component because it can be used as a source of energy, similar to natural gas. The carbon dioxide produced in this process is a common greenhouse gas, but in biogas, it can be harnessed and used as well. This anaerobic digestion of biomass is an environmentally friendly way to generate useful energy from organic waste materials.\n\n\n10.2.8 Generating Biogas\n\n\n\n\n\nFuels from Sugar Fermentation\n\n\n\n\nPyrolysis and gasification are two different ways to turn biomass, like wood or plant materials, into useful energy sources. Let’s break them down:\nPyrolysis: This is a process where biomass is heated without any air or oxygen around. The result can be either charcoal or a special liquid called bio-oil. This bio-oil can be used like regular fuel oil or turned into synthetic gasoline or diesel fuel. It’s a bit like cooking without using oxygen to create something valuable from biomass.\nGasification: Gasification is another way to change biomass into energy. It’s done by heating biomass at really high temperatures, usually around 800°C or more. This heat breaks down the biomass into a gaseous form, which is like a gas that can be used for energy. This gas, often called “producer gas,” contains different gases like hydrogen, carbon monoxide, carbon dioxide, and methane. The cool thing is that depending on how you do the process, you can get gas with different energy values. For example, if you use air in the process, you get gas with lower energy, suitable for things like boilers and engines. But if you use oxygen, you get gas with a bit more energy, which can be used for making things like methanol and gasoline.\n\n10.2.8.1 Biomass from Algae\nLet’s talk about using fatty acids or biomass from algae as a source of biofuel. Algae are tiny aquatic plants, and some of them are incredibly rich in fatty acids, making up as much as 40% of their total mass. These fatty acids can be taken out and turned into a special kind of biofuel called biodiesel. It’s a bit like turning these plants into a fuel for our cars.\nAlgae are quite remarkable because they’re fantastic at photosynthesis, the process where they use sunlight to make their own food. Some types of algae can grow really quickly and efficiently, almost like they’re supercharged plants. This efficiency means that from just one hectare of algae, you could potentially produce over 10,000 gallons of biofuel in a single year. That’s a lot of fuel!\nOne interesting thing is that you can even use the exhaust gases from power plants to help these algae grow. It’s like giving them extra food to make even more biofuel. But, like anything, there are challenges to overcome. When it comes to algae, there are some problems with things like culturing and harvesting them, as well as getting the oil out of them for the biodiesel. Plus, the fatty acids in algae tend to have a high level of unsaturation, which can make the biodiesel less stable.\n\n\n\n10.2.9 Densifying Biomass Fuel\n\n\n\n\n\nDensified Biomass Fuel\n\n\n\n\nDensified biomass fuel is a clever solution to some common issues with regular biomass. Regular biomass can be bulky and doesn’t contain much energy per unit of volume, which can make it challenging to store and transport.\nDensified biomass fuel, on the other hand, addresses these problems. It’s been processed in a way that significantly increases its bulk density, making it three to four times denser than regular biomass. This means that it weighs more and has less moisture content, making it easier to store and transport.\nThe increased density also results in higher energy content per unit of volume, which is fantastic for power generation and heating. In other words, you get more energy from the same amount of space, which is both efficient and environmentally friendly. This densified biomass fuel is a great way to make the most of biomass resources for various energy applications.\n\n\n10.2.10 Net Energy Gain\n\n\n\n\n\nNEB of Corn Grain Ethanol and Soybean Bioethanol Production\n\n\n\n\nWhen we’re talking about the impact of biofuels on the environment, we’re looking at something called “net energy gain” or NEG. This is all about figuring out if we’re getting more energy out of biofuels than we put in during the whole process.\nThe inputs are all the energy and resources needed to make biofuels. This includes the energy used for planting, fertilizing, running machinery on the farm, operating the biofuel production facility, and even building houses for the workers. It’s a lot of stuff that goes into the process.\nOn the other side, the outputs are the energy we get back from the biofuel-making process, like co-products. For example, when we make bioethanol from corn, we also get a co-product called DDGS. For biodiesel, we get glycerol. These co-products contain energy too, and that’s a good thing.\nTo figure out if biofuels are a net gain in terms of energy, scientists use a bunch of data and math. They look at things like how much energy we get from farms, how much all the ingredients cost, how efficiently the production plants work, and what kind of environmental impact biofuels have. All this info helps us see if biofuels are a good choice for getting more energy without harming the environment too much. It’s like doing some careful math to make sure we’re making the right energy choices.\n\n\n10.2.11 Potential Problems with Bioenergy Projects\nLet’s explore some of the potential issues that can come up with bioenergy projects.\nDeforestation: One problem is that when we create bioenergy, we sometimes cut down forests to get the materials we need. This is called deforestation, and it’s not good for the environment because it reduces the number of trees that absorb carbon dioxide and provide habitats for animals.\nCompetition for Food and Land: Bioenergy projects can also compete with food production and agricultural land. When we use crops or land for bioenergy, it means there’s less space and resources available for growing food. This competition can drive up food prices and cause shortages.\nDirty Processes for Clean Fuel: It might sound strange, but some processes used to make clean biofuels are not very environmentally friendly. They can release pollution and harm the air and water, even though the end product is meant to be clean fuel.\nHigh Energy Input and CO2 Emissions: In some cases, making bioenergy takes a lot of energy and results in carbon dioxide (CO2) emissions. This means that the process contributes to climate change and might not be as environmentally friendly as we hoped.\nLow Yield and High Costs: Some bioenergy projects don’t give us a lot of energy in return for the effort and resources we put into them. They can also be expensive to set up and maintain.\nWastewater Issues: Finally, bioenergy projects can create wastewater that contains substances with high biochemical oxygen demand (BOD). This means they take oxygen from water bodies and harm aquatic life. When oxygen is reduced in water, it can cause problems for fish and other creatures that live there.\n\n\n10.2.12 Other Sources of Renewable Energy\nLet’s check out some other cool sources of renewable energy besides bioenergy:\nSolar Energy: We can capture energy from the sun in a couple of ways. One is using solar cells, which you might have seen on rooftops or in calculators. They turn sunlight into electricity. Another way is with solar thermal power stations. These use the sun’s heat to make electricity. Both methods are super eco-friendly.\nWind Turbines: You’ve probably seen these giant windmills spinning in the wind. They’re like super-efficient fans that turn wind energy into electricity. Wind turbines can be found in wind farms and are a great source of renewable power.\nTide: The rising and falling of the ocean’s tides can be used to generate electricity. It’s a bit like harnessing the power of the sea to create energy. This is called tidal energy, and it’s a pretty clever way to go green.\nGeothermal or Underground Heat: Under the Earth’s surface, it’s toasty warm. We can tap into this heat using geothermal energy. Sometimes, we create Engineered Geothermal Systems (EGS) to make use of this underground heat. It’s like having a natural heater beneath the Earth’s crust that we can use for electricity and heating.\n\n10.2.12.1 Research and Development on Biofuel Feedstock\nLet’s explore what’s happening in the world of research and development (R&D) for biofuel feedstock. The goal here is to create new crops that are specifically designed for making fuel. We want these crops to be great at producing the raw materials we need, called feedstock. Then, we can take this feedstock and turn it into fuels that people not only like but can also afford.\nIn the current R&D directions, scientists are working on some exciting things. They’re aiming for crops like grasses, trees, and algae to grow faster in a broader range of climates. This means we can get these materials in more places, making biofuels more accessible.\nThere’s also a focus on creating larger, energy-rich alcohols or Isoprenoid biofuels. These have the potential to pack more power into our fuels. Scientists are looking into bioprocessing, which is a way to change plant fatty acids into smaller molecules known as biocrude. This process can make biofuel production more efficient."
  },
  {
    "objectID": "chapters/week10.html#bioenergy-and-singapore",
    "href": "chapters/week10.html#bioenergy-and-singapore",
    "title": "10  Bioenergy and Biomaterials",
    "section": "10.3 Bioenergy and Singapore",
    "text": "10.3 Bioenergy and Singapore\n\n\n\n\n\nParanoma Shot of Jurong Island\n\n\n\n\nSingapore is diving into the world of bioenergy with a multi-faceted approach. They’re setting up an R&D center, which stands for Research and Development. This center will be like a hub for discovering new ideas and technologies in the field of bioenergy. Scientists and researchers will work here to find better and more sustainable ways to use bioenergy.\nThere’s also going to be a financial and operation center. This is where the business side of bioenergy happens. They’ll handle the money and operations to make sure everything runs smoothly. It’s a bit like the control room of a big bioenergy operation.\nSingapore is also getting into manufacturing biofuel. That means they’ll be producing biofuel on a larger scale, turning the science and ideas into real products that can be used for energy. It’s like a bioenergy factory.\nLastly, there’s a logistics center. This is where all the planning and organization takes place to move bioenergy products from one place to another. They’ll figure out the best ways to get biofuels to where they’re needed.\n\n10.3.1 Petrochemicals and Singapore’s History\nLet’s take a look at why we’ve relied on petrochemicals for so long and why we’re now considering a shift back to nature.\nPetrochemicals: These are chemicals and materials made from petroleum, which is a type of fossil fuel. Petrochemicals have been popular because they’re relatively cheap to get from the ground, and they have a consistent and predictable composition. It’s like using building blocks that are easy to work with. The process of turning them into useful things is also quite straightforward.\nGoing Back to Nature: The reason we’re thinking about moving away from petrochemicals and returning to natural sources is because it’s better for our planet. First, using petrochemicals contributes to global warming because they release greenhouse gases. Going back to nature with bio-based materials can help reduce our impact on the environment. It’s part of a more sustainable and renewable future where we use resources that can be replaced naturally.\nAdditionally, advancements in “green chemistry” are making it possible to create materials and chemicals from natural sources in more environmentally friendly ways."
  },
  {
    "objectID": "chapters/week10.html#kinds-of-biomaterials",
    "href": "chapters/week10.html#kinds-of-biomaterials",
    "title": "10  Bioenergy and Biomaterials",
    "section": "10.4 Kinds of Biomaterials",
    "text": "10.4 Kinds of Biomaterials\nTraditional Biomaterials: These are the ones we’ve been using for a long time. Think of wood, timber, paper, and pulp, along with materials like particleboard. These have been our go-to materials for ages, and they come from plants and trees.\nNew Biomaterials: Now, we’ve got some exciting new players in the game. These are bioplastics, bio-composites, and others. They’re designed to replace the “classic” materials we’re used to, like plastics, aluminum, steel, minerals, fibers, and concrete. These new biomaterials are made from renewable sources and are more eco-friendly.\nBiomolecules: These are like the tiny building blocks of life, and they’re turning into biomaterials too. Biomolecules include things like solvents, lubricants, surfactants, and more. They’re used in various sectors, expanding the reach of biomaterials in industries like soap, starch, pharmaceuticals, and fine chemistry.\nBiofuels: These are special biomaterials that are used for energy. Biofuels are like eco-friendly fuels that can replace things like gasoline and diesel. They’re made from renewable resources like plants and algae.\n\n10.4.1 Approaches for Processing Biomass\n\n10.4.1.1 Deconstruction Approach\nAdvantages: This method comes with some real perks. It helps us separate and collect valuable molecules that are tricky or even impossible to make through traditional methods. The beauty of it is that these molecules have a “natural” origin, and there’s a wide variety of structures to work with. It’s like discovering hidden treasures in nature.\nLimitations: But, like anything, there are some limitations. Sometimes, natural materials like wood and plant cells are a tangled mess of biopolymers, which are complex structures made up of lots of molecules. Separating these can be quite challenging, and it’s often hard to get super pure compounds. So, we might need to make some modifications to these molecules to increase their value. For example, we can turn sugar into a valuable compound like succinic acid, or wood pulp into useful things like cellophane or insulation thermoplastics.\n\n\n10.4.1.2 Cracking Approach\n\n\n\n\n\nOutline of the Cracking Process\n\n\n\n\nThe cracking approach is all about breaking things down using heat. This method involves thermal decomposition, which is a fancy way of saying that we use heat to break apart materials and get energy and chemical building blocks.\nImagine it as if you’re heating something up so much that it starts to split into its smaller parts. This process helps us not only generate energy but also collect the basic components we need to make other useful chemicals. It’s like taking apart a complex puzzle to get all the individual pieces we can use to build something new and valuable.\n\n\n\n10.4.2 Problems with Petrochemical Plastics\nMassive Plastic Production: Since the 1950s, the world has produced an enormous amount of plastic – over nine billion tons! That’s a staggering amount of plastic stuff.\nHeavy Oil Usage: Surprisingly, around 8% of the world’s oil is used to make all this plastic. That’s a significant chunk of our precious oil resources.\nOcean Pollution: Here’s where it gets really concerning. A whopping 165 million tons of plastic waste have ended up in our oceans. And what’s even worse, nearly 9 million more tons find their way into the oceans every year. This pollution in the seas is causing major environmental problems.\nLow Recycling Rates: When it comes to recycling, only about 9% of plastic gets recycled. Most of the remaining plastic ends up polluting our environment or is buried in landfills. Here’s the kicker: plastic can take up to 500 years to break down in landfills, and as it does, it can release harmful chemicals into the soil.\n\n\n10.4.3 Bioplastics\nStarch-Based Bioplastics: These are plastics made mainly from starch, which is a natural carbohydrate found in plants like corn and potatoes.\nCellulose-Based Bioplastics: These materials come from cellulose, a component found in plant cell walls. It’s kind of like using nature’s own building blocks.\nProtein-Based Plastics: Some bioplastics are created from proteins, which are molecules that make up a part of living things like beans or peas.\nLipid-Derived Polymers: These are made from lipids, which are fats found in plants and animals. It’s another way of turning natural resources into useful materials.\nBioplastics from Fermentation: In this approach, bioplastics are created through a process called fermentation, where microorganisms like bacteria or yeast convert natural sugars into plastic.\nBio-Derived Polyethylene: This type of bioplastic is made from bio-ethanol, which is a type of alcohol that comes from renewable sources.\nPolyhydroxyalkanoates (PHA): PHA bioplastics are produced through bacterial fermentation of sugars or lipids, like fats, and they have some interesting properties.\nPolylactic Acid (PLA): PLA bioplastics are made through the fermentation of sugars, and they can be used for various things.\nThese bioplastics are pretty cool because they use natural and renewable materials to create eco-friendly alternatives to traditional plastics. It’s like turning plants, sugars, and other natural resources into materials we can use without causing harm to the environment.\n\n10.4.3.1 Polyhydroxyalkanoates (i.e., PHA)\n\n\n\n\n\nInformation on PHAs\n\n\n\n\nLet’s dive into the world of Polyhydroxyalkanoates (PHA), which are a unique type of bioplastic. Here are some key features:\nIntracellularly Accumulated: PHA is a special bioplastic because it’s created inside the cells of certain microorganisms. It’s like a natural storage material produced by these tiny creatures.\nPlastic-Like Properties: What’s fascinating about PHA is that it shares properties with synthetic plastics. It can be used in a similar way and has similar characteristics to traditional plastics.\nSuitable for Medical Devices: Because of its unique properties, PHA is often used in the medical field. It’s a great fit for making medical devices, which need to meet high standards of safety and performance.\nIn essence, PHA is a natural bioplastic that’s made inside microorganisms and behaves a lot like the plastics we’re used to. This makes it a fantastic choice for producing items, especially in the medical field, where quality and safety are top priorities.\n\n\n10.4.3.2 Polylactic Acid (i.e., PLA)\n\n\n\n\n\nMaking PLA Bioplastic\n\n\n\n\nLet’s talk about Polylactic Acid (PLA), which is an exciting material that can lead us towards a greener future.\nNatural Origins: PLA is typically made from the sugars found in plants like corn starch, cassava, or sugarcane. These natural sources are renewable, which means we can grow more of them without harming the environment.\n\n\n10.4.3.3 Noting Points\nPlant Sugar Derivatives: Bioplastics are usually created from derivatives of plant sugars. This means they come from things like corn or sugarcane, which are renewable and can be grown again and again.\nBlended Materials: Sometimes, bioplastics are mixed with other materials to make them work better. For example, you might find bioplastics blended with something called thermoplastic starch to improve their performance.\nGrowing in Popularity: Bioplastics are gaining popularity. While they made up only 4% of the global plastics market in 2019, they’re growing rapidly at about 30% per year. It’s estimated that by 2030, they could make up a significant 40% of the market.\nBiodegradability Varies: It’s important to note that not all bioplastics are biodegradable. Some will break down naturally, while others may not.\nEnvironmental Impact: Bioplastics have different environmental impacts, and there are some debates and controversies surrounding their overall eco-friendliness.\nChallenges Remain: Even though bioplastics are on the rise, they still face challenges in terms of cost and performance. Making them both affordable and high-performing is an ongoing process.\nBiodegradable: One of the great things about PLA is that it’s biodegradable. This means it can break down naturally over time, unlike traditional plastics that stick around for a very long time.\nPlastic-Like Qualities: Even though PLA is eco-friendly, it can still look and behave a lot like regular polyethylene, which is a common plastic. This means we can use it for various things while being kind to the planet.\nIn a nutshell, PLA is a fantastic solution for a greener tomorrow. It comes from renewable plant sources, it’s biodegradable, and it can be used just like regular plastic. It’s a step in the right direction for a more eco-friendly and sustainable future.\n\n\n\n10.4.4 Natural Plant Fibers\n\n\n\n\n\n\n\n\n\nLet’s talk about renewable fibers, which are materials that come from nature and can be used to make various products. There are two main categories:\nNatural Plant Fibers: These fibers are directly sourced from plants. They include familiar ones like cotton, hemp, flax, jute, bamboo, ramie, kenaf, sisal, and even coconut fibers. These materials are as natural as they come, and they’ve been used for ages.\nCellulose-Based Fibers: Some fibers are made from cellulose, which is a natural substance found in plant cell walls. These include rayon (also known as viscose), lyocell (often called Tencel), modal, acetate, regenerated bamboo fiber, soy fiber, seacell (made from seaweed), and even nanocellulose, which is super tiny and used in some advanced applications."
  },
  {
    "objectID": "chapters/week11.html",
    "href": "chapters/week11.html",
    "title": "11  Secondary Metabolism in Plants",
    "section": "",
    "text": "Secondary metabolites in plants have important physiological functions that help the plants survive and thrive. These functions can be understood in various ways.\nOne key role of secondary metabolites is to protect plants against herbivores (animals that eat plants) and microbial infections (tiny organisms like bacteria and fungi that can harm the plant). Think of these metabolites as the plant’s defense system, like a shield that keeps them safe from harm.\nAnother way secondary metabolites benefit plants is by acting as allelopathic agents. This might sound complex, but it simply means that these chemicals give plants an advantage in competing with other nearby plants for resources like sunlight and nutrients. In other words, they help the plant be the strongest one in the neighborhood.\nPlants also use secondary metabolites to attract pollinators and animals that help disperse their seeds. Imagine these metabolites as a sweet fragrance or a colorful flower that says, “Hey, come visit me!” to bees, butterflies, and other creatures. In return, these visitors help the plant reproduce by carrying pollen or spreading its seeds."
  },
  {
    "objectID": "chapters/week11.html#terpenoids",
    "href": "chapters/week11.html#terpenoids",
    "title": "11  Secondary Metabolism in Plants",
    "section": "11.1 Terpenoids",
    "text": "11.1 Terpenoids\n\n\n\n\n\nImages of Some Terpenoids\n\n\n\n\nTerpenoids are a type of plant natural product, and they’re quite interesting because they come in many different shapes and sizes. They are the most diverse group of plant chemicals, and they play a crucial role in the plant world.\nThese terpenoids were first discovered in turpentine, which is a semi-fluid resin primarily obtained from pine trees. So, when you think of pine trees, you can also think of terpenoids.\nWhat’s really cool about terpenoids is that they are all made from smaller building blocks called C5 units, which are based on a structure called isopentane. These C5 units can combine in various ways, kind of like building blocks in a construction set. So, just like you can create different structures using the same set of Legos, plants can make a wide range of terpenoids by combining these C5 units in different ways.\n\n11.1.1 Classifying Terpenoids\nTerpenoids, those diverse plant chemicals, can be classified based on the number of five-carbon units they contain. This classification helps us understand how they work and what they do.\nFirst, there are hemiterpenes, which have just one isoprene unit. Isoprene is a small part of a terpenoid. An example of hemiterpenes is when some C3 plants emit isoprene at high temperatures. This can lead to the formation of NO2, a chemical that plays a role in various processes.\nNext, we have monoterpenes, which contain two isoprene units. Monoterpenes are often found in the fragrant essences of flowers and the essential oils of herbs and spices. Think of the delightful scents you get from flowers and herbs like lavender or mint – that’s thanks to monoterpenes.\nLastly, there are sesquiterpenes, which contain three isoprene units. These compounds can be found in essential oils, phytoalexins (substances that help plants defend against microbes), and antibiotic compounds that protect plants from microbial challenges. They can also act as antifeedants, which discourage animals from eating the plants.\n\n11.1.1.1 More Kinds of Terpenoids\nTerpenoids come in different types, and they are categorized based on the number of five-carbon units they contain. Here, we’ll explore a few more of these types to give you a better idea of their diversity.\nFirst, we have diterpenes, which have four of those five-carbon units. Diterpenes can be found in various plant compounds like phytol, which is a part of the chlorophyll molecule responsible for photosynthesis. They’re also present in substances like gibberellic acid (GA), phytoalexins (which help plants fight off microbes), and taxols. Norditerpenoids are a related group that lost one carbon along the way in their structure.\nTriterpenes, on the other hand, are made up of six of these five-carbon units. They often consist of two C15 chains head-to-head, and they can be found in different plant compounds, including brassinosteroids, certain phytoalexins, various toxins that deter animals from eating the plants, and components of surface waxes, such as oleanolic acid found in grapes.\nTetrapenes are a step up, as they’re made of a whopping eight of these five-carbon units (a total of 40 carbon atoms). You can find tetrapenes in carotenoids, which are responsible for the bright colors in fruits and vegetables, like the orange color in carrots.\nPolyterpenes, as the name suggests, are long chains of these five-carbon units and are responsible for rubber production. They are used in making things like tires.\nFinally, we have meroterpenes, which have mixed origins and are partially derived from terpenoids. They are involved in the synthesis of compounds like cytokinins and alkaloids, which have terpenoid fragments in their structure. These compounds have various roles in plant growth and defense.\n\n\n\n11.1.2 Creating Terpenoids\n\n\n\n\n\nMaking Terpenoids\n\n\n\n\nPlants have some highly specialized structures that are like secret factories for making, releasing, or storing terpenoids. These structures help the plants in various ways.\nOne of these special structures is called a “glandular trichome.” Think of it as a tiny, specialized cell or group of cells on the plant’s surface. These glandular trichomes are like the plant’s perfume factory, producing terpenoid essential oils. These oils often give flowers their unique scents and can attract pollinators, like bees and butterflies.\nAnother structure is the “secretory cavities,” which are like tiny storage spaces within the plant. They also play a role in producing terpenoid essential oils and are usually found in the flowers. So, they’re like the plant’s treasure chest of scents.\nConifers, like pine trees, have their own special structures for terpenoids called “resin ducts and blisters.” These are like the plant’s defense mechanisms. They produce a substance called resin, which contains terpenoids like terpentine. This resin can protect the plant from pests and diseases.\n\n11.1.2.1 Further Plant Structures\nPlants have some special structures that are like dedicated factories for making, releasing, or storing terpenoids. These structures are essential for various plant functions.\nThe plant’s outer layer, known as the epidermis, plays a role in making triterpenoid surface waxes. These waxes act like a protective shield, similar to how sunscreen protects our skin from the sun. They help the plant conserve water and prevent it from losing too much moisture.\nAnother structure called “laticifers” is like a terpenoid factory for certain triterpenes and polyterpenes, such as rubber. Laticifers are long, tube-like cells that store these valuable substances. Rubber, for example, is a well-known terpenoid produced by some plants.\nThese specialized structures are like secret vaults where the plant keeps its precious terpenoid products. By doing this, they prevent these chemicals from interfering with the plant’s important metabolic processes.\n\n\n11.1.2.2 Isoprene Rules\nUnderstanding how terpenoids are built is like following a set of rules, and two important scientists made significant contributions to these rules.\nThe first rule is called the “Isoprene rule.” This rule suggests that most terpenoids could be constructed by repeatedly joining small units called isoprene. Think of isoprene as a building block, and by putting many of them together, you can create a wide variety of terpenoids. Otto Wallach’s work on this concept earned him a Nobel Prize in 1910.\nThe second rule is known as the “Biogenetic isoprene rule.” This rule says that a compound is considered an isoprenoid if it is made biologically from an isoprenoid precursor, with or without rearrangements. It’s like saying a cake is still a cake, even if you mix up the ingredients a bit. Leopold Ruzicka was awarded a Nobel Prize in 1939 for his research related to this rule.\n\n\n11.1.2.3 Steps in Isoprene Biosynthesis\nThe process of making terpenoids can be broken down into four steps, kind of like following a recipe to create a delicious dish.\nThe first step involves making a fundamental precursor called IPP, which stands for Isopentenyl Pyrophosphate. Think of IPP as the basic ingredient you need for your dish.\nNext, we have the second step, which is like adding more ingredients to your dish. In this case, you repeatedly add IPP to create a series of prenyl diphosphate homologs. These homologs serve as the precursor molecules that form the building blocks for terpenoids. It’s like gathering the key components for your recipe.\nThe third step is where the magic happens. Specific enzymes called terpenoid synthases take these prenyl diphosphate molecules and turn them into the parent carbon skeletons of the terpenoids. These skeletons are like the structure of your dish, providing the basis for its flavor and texture.\nFinally, in the fourth step, secondary enzymes come into play. They make further modifications to these carbon skeletons, giving rise to the unique functional properties and incredible diversity of natural terpenoid products. This is where your dish gets its special flavors and characteristics, making it stand out from the rest.\n\n\n11.1.2.4 Synthesis Locations\nFirst, let’s talk about the cytoplasm and the endoplasmic reticulum (ER). In these areas, you’ll find the production of terpenoids like sesquiterpenes (which have 15 carbon atoms), triterpenes (30 carbon atoms), and polyterpenes. Think of it as the factory floor where these larger terpenoids are manufactured.\nOn the other hand, plastids are like another factory within the plant cell. They are in charge of making terpenoids with different sizes, such as isoprene (5 carbon atoms), monoterpenes (10 carbon atoms), diterpenes (20 carbon atoms), and tetraterpenes (40 carbon atoms). It’s like having a separate kitchen in your house for making specific types of dishes.\nWhat’s interesting is that the way these compounds are made can be a bit different in each of these locations. It’s like having different recipes for different rooms in your house. The plant uses these distinct compartments to create a wide variety of terpenoids, each with its own purpose and function.\n\n11.1.2.4.1 Mevalonate Pathway for forming IPP in Cytosol\n\n\n\n\n\nFormation of IPP via the Mevalonate Pathway\n\n\n\n\nThe mevalonate pathway is like a recipe for making something important in the plant cell – a compound called IPP (Isopentenyl Pyrophosphate). It happens in the cytosol, which is a part of the cell.\nFirst, this pathway involves a two-step process where three molecules of acetyl-CoA come together. It’s like combining a few key ingredients to start making a special sauce.\nThe next step is turning HMG-CoA, which is the result of the previous process, into mevalonic acid. This transformation involves processes like phosphorylation and decarboxylation, which might sound complex but are just ways of changing the structure of the molecule.\nInterestingly, the mevalonate pathway isn’t exclusive to plants. It’s also used by animals, including humans, to create cholesterol, a vital substance for our bodies.\n\n\n11.1.2.4.2 Mevalonate Pathway for Forming IPP in Plastid\n\n\n\n\n\nForming IPP in the Plastid via the Mevalonate Pathway\n\n\n\n\nThe MEP pathway is like another recipe, but this time, it’s used in the plastids of plant cells to make IPP (Isopentenyl Pyrophosphate).\nIn the first step of this pathway, two molecules containing three carbon atoms each (C3) come together to form a single molecule with five carbon atoms (C5). It’s a bit like taking two small puzzle pieces and fitting them together to make a bigger, more complex piece.\nCytidine triphosphate, which is another molecule, plays a role in creating a cyclic diphosphate. Think of it as a special ingredient that helps everything come together and take the right shape.\nThe final part of this pathway involves two reduction steps, which are like making some adjustments to the molecule. These steps result in the production of two isomers: IPP and DMPP. Isomers are like twins – they have the same ingredients, but their arrangement is slightly different.\n\n\n\n11.1.2.5 Forming Terpenoids from IPP\n\n\n\n\n\nMaking Terpenoids from IPP\n\n\n\n\nTo create different types of terpenoids from IPP (Isopentenyl Pyrophosphate), a repetitive process takes place. It’s like a simple pattern that’s followed to build various terpenoid structures.\nThis repetitive process involves adding units with five carbon atoms (C5 units) over and over again. These additions are made by special enzymes called prenyltransferases. Think of these enzymes as workers on an assembly line, adding one piece after another to construct the final terpenoid product.\n\n\n11.1.2.6 Forming Monoterpenes\n\n\n\n\n\nStructure of Some Monoterpenes\n\n\n\n\nThe structures of monoterpenes, which are a type of terpenoid, are quite simple to understand. They are mainly formed by joining isoprene units in a head-to-tail fashion. Think of isoprene units as small building blocks. When these units are linked together, one after the other, they create the structure of a monoterpene.\nHowever, there are also a few exceptions in the world of monoterpenes. Some monoterpenes don’t follow the usual “head-to-tail” pattern and have irregular structures. It’s like most of the cars on the road following traffic rules, but there are a few that go their own way.\n\n\n11.1.2.7 Forming Triterpenes\n\n\n\n\n\nForming Triterpenes\n\n\n\n\nFirst, two molecules of FPP (Farnesyl Pyrophosphate) are joined head-to-head. Think of this as taking two puzzle pieces and connecting them to create something new, which, in this case, is called squalene.\nAfter squalene is formed, it goes through an oxidation process. This is like adding some seasoning to your dish to enhance the flavor and make it even better.\nWhat’s interesting is that the production of triterpenes, which can have 15 carbon atoms (C15) or 30 carbon atoms (C30), is regulated in a reciprocal manner. It means that the amounts of these two types of triterpenes can influence each other. If you make more of one, it might affect the production of the other, like balancing the ingredients in a recipe to get the right taste.\n\n\n\n11.1.3 Rubber\nNatural rubber is a fascinating material made by plants, and it’s actually a type of polymer. Imagine a polymer as a long chain made up of lots of small units. In the case of rubber, these small units are called isoprene. When you put many isoprene units together, you get a long chain of rubber.\nBack in 1877, a bunch of tiny seedlings from a plant called Hevea brasiliensis arrived in the Singapore botanic garden. Some of these little plants were grown in Singapore, while others were sent to gardens in the Malay Peninsula. These plants turned out to be the starting point for the rubber industry in Southeast Asia (SEA) and China. Rubber production became a significant part of their economies.\nNow, let’s talk about what rubber does for the plant itself. It serves a few important functions:\nFirst, it can be like stored food for the plant. Just as we keep snacks in our pantry for later, the plant stores rubber as a potential energy source.\nSecond, rubber can also be a way for the plant to get rid of waste products. Imagine it as the plant’s version of taking out the trash.\nThird, rubber can act as a protective shield. If the plant gets injured, the rubber helps form a layer that dries and hardens, preventing harmful fungi and bacteria from entering the plant.\nLastly, it might also protect the plant from animals that like to munch on it. The toughness of rubber can deter browsing animals from eating the plant, almost like a natural armor.\n\n\n11.1.4 Sesquiterpenes\n\n\n\n\n\nStructurse of some Sesquiterpenes\n\n\n\n\nSesquiterpenes are a group of terpenoids that are known for their greater diversity in terms of skeleton structures. In simple terms, they have more variety in the ways their molecular structures are arranged compared to other terpenoids.\nOne of the important roles of sesquiterpenes in plants is their involvement in plant defense. They act like a protective shield, helping the plant defend itself against threats such as herbivores (animals that eat plants) and microbial infections. Think of them as the plant’s armor, offering extra protection in the world of nature.\n\n\n11.1.5 Monarch Butterfly\nOne of the most remarkable things about Monarch butterflies is that they are the only species known for long-distance migration among all butterflies. Just like birds, they embark on incredible journeys. In the autumn, they travel south to escape the cold, and in the spring, they journey back north to their breeding grounds.\nMonarchs are so iconic that they are designated as the national insect of the United States, sharing this honor with the honeybee. It’s like a symbol that represents the natural beauty and diversity of the country.\nHowever, Monarch butterflies have also become the subject of various controversies. These include concerns related to deforestation, the preservation of milkweed plants (which are essential for their survival), and debates about genetically modified (GM) food and its potential impact on these magnificent creatures.\n\n11.1.5.1 Monarch Butterfly and Plant Chemicals\nThe Monarch butterfly has a fascinating way of dealing with plant chemicals. It’s like a special adaptation that helps them thrive.\nMonarch butterflies have a unique diet, and they prefer to feed on milkweed plants, specifically the Asclepias species. These milkweed plants contain toxic compounds known as cardenolides. It’s like Monarchs have a taste for something others find unpalatable.\nWhen Monarch butterflies feed on milkweed, they not only consume these cardenolides but also accumulate them in their bodies. This is where the magic happens. These toxic compounds make the Monarchs themselves toxic to predators, such as birds. It’s like the Monarchs are arming themselves with a secret weapon.\nBut here’s the twist – even the predators have evolved in response to this. Some birds have adapted to tolerate these toxins, so they can still eat Monarchs without getting sick. It’s like an ongoing game of survival where both the prey and the predators keep adapting to one another.\n\n\n\n11.1.6 White Flies Hijacking Plant Defense Genes\nIn a fascinating turn of events, the white fly, which is a common pest in agriculture, managed to pull off something remarkable. This little insect, known as Bemisia tabaci, has found a way to hack into a plant’s defense system.\n\n\n\n\n\nA White Fly Hacking a Plant’s Defense System\n\n\n\n\nDuring this process, the white fly acquired a specific gene called PMaT1 from a plant. This transfer of genetic material from a plant to an insect is known as a “plant-to-insect horizontal gene transfer event.” It’s like the white fly sneaking a piece of the plant’s genetic code for its own benefit.\nWhat’s even more intriguing is that this acquired gene, PMaT1, gives the white fly a superpower. It enables the white fly to neutralize or detoxify certain plant defense compounds, specifically phenolic glucosides. These are like the natural defenses that plants use to protect themselves.\nAs a result, the white fly can continue to feed on its plant hosts without being harmed by the plant’s defenses. It’s almost as if the white fly found a way to outsmart the plant and enjoy a meal without any consequences."
  },
  {
    "objectID": "chapters/week11.html#alkaloids",
    "href": "chapters/week11.html#alkaloids",
    "title": "11  Secondary Metabolism in Plants",
    "section": "11.2 Alkaloids",
    "text": "11.2 Alkaloids\n\n\n\n\n\nExamples of Some Alkaloids\n\n\n\n\nAlkaloids are a group of natural compounds found in plants, and they have some special properties. These compounds are known for being pharmacologically active, which means they can have effects on living organisms. They contain nitrogen and have a basic chemical structure.\nAlkaloids have been part of human history for a long time. They’ve been used for various purposes, such as poisons, medicines, and as ingredients in concoctions and potions. So, you can think of them as the ancient ingredients in the recipes of traditional healers and herbalists.\nWhat’s really interesting is that a significant number of flowering plants, around 20%, produce alkaloids. Some plant species can produce more than 100 different alkaloids. It’s like having a treasure chest of compounds in the plant world, each with its unique properties and uses.\n\n11.2.1 Opium Wars\nThe Opium Wars are historical events that vividly illustrate how the trade and impact of a plant-derived substance can influence geopolitics, the relationships between countries.\nThese two wars, fought between Britain and China in the years 1840-42, were mainly over the trade of opium. In the early 19th century, there was a significant increase in the import of opium to China. The Chinese Emperor responded by ordering the ban of opium trade due to the negative social and health consequences it was causing in the country.\nHowever, the British Empire had a different perspective. They saw opium as a profitable commodity for commercial trade. The import of opium to China helped balance Britain’s substantial trade deficit with China, where they were buying a lot more Chinese goods than they were selling. So, opium trade was a way to address this imbalance.\nThe Opium Wars and the “unequal treaties” that were signed afterward had a significant impact on China. They played a part in the weakening and eventual downfall of the Chinese Empire.\nAs a side note, in January 1819, Sir Thomas Stamford Raffles of the English East India Company landed in Singapore, which eventually became a crucial trading port. This was also a part of the larger picture of colonial and commercial interests of the time.\n\n\n11.2.2 Alkaloids and Plant Defense\nAlkaloids play a crucial role in the chemical defense strategies of many plants. They have a wide range of effects on animals and insects, which help plants protect themselves.\nOne example is pyrrolizidine, which is toxic to mammals. It’s typically found in the inflorescences (flower clusters) of the Senecio genus. Interestingly, some pyrrolizidines are harmless until they encounter cytochrome P450 monooxygenases in the liver. These enzymes transform them into toxic substances. It’s like a secret defense mechanism that gets activated only when needed.\nQuinolizidine alkaloids, mainly produced by the Lupinus genus (commonly known as lupines), are found in high amounts in lupine seeds. These alkaloids are toxic to grazing animals. This plant-animal interaction is like a game of survival where animals learn to avoid lupine-containing plants.\nAlkaloids like nicotine and caffeine serve as defenses against insects. When a plant is wounded, it stimulates the synthesis of nicotine. This is a fast response that creates N-acyl nicotines, which are highly toxic to hornworms, a type of insect. After about 36 hours, there is an increase in alkaloid biosynthesis, providing extra protection. Jasmonate, a plant hormone, seems to be involved in upregulating alkaloid synthesis, essentially increasing the production of these defensive compounds when needed.\n\n\n11.2.3 Stealing Alkaloids\nIn the world of plants, the defensive chemicals they produce, like alkaloids, can be so valuable that others might want to steal them. Yes, even in the plant kingdom, there are thieves!\nOne example of this plant theft occurs between lupines and Indian paintbrush plants. These two types of plants often grow together in the same areas, or “sympatric” regions. Indian paintbrush plants are a bit like freeloaders because they are hemiparasites. They graft their roots onto the roots of lupine plants and essentially steal water, nutrients, and defensive alkaloids from them.\nThrough careful studies in experimental gardens, scientists have discovered that Indian paintbrush plants extract alkaloids from lupines. These stolen alkaloids serve as a kind of protective shield for the Indian paintbrush. When herbivores come around looking for a snack, they are discouraged from eating the Indian paintbrush due to the defensive alkaloids it acquired from the lupine.\n\n\n11.2.4 Manufacturing Alkaloids\nStudying alkaloid biosynthesis, or how plants make these special compounds, can be quite challenging due to several reasons.\nFirst, alkaloids have complex chemical structures. It’s like trying to understand a very intricate puzzle with many pieces. These structures can be tough to unravel.\nSecond, alkaloids often have multiple asymmetric centers. Imagine trying to balance a complex mobile with multiple moving parts. It’s not easy to keep everything in order.\nThird, the concentrations of the enzymes responsible for alkaloid biosynthesis are typically quite low. This is like having very few workers in a factory, making it harder to observe their activities.\nAdditionally, a large number of other compounds like tannins and phenolics can interfere with the extraction of these active enzymes. It’s as if you have many distractions while trying to focus on a specific task.\nLastly, the rate at which natural product metabolism occurs in plants can be slow. This is similar to a factory that produces goods at a sluggish pace, making it challenging to study the process in action.\n\n11.2.4.1 Methods for Studying Alkaloid Processing\nUsing a cell culture system for studying alkaloid biosynthesis is incredibly important for several reasons.\nFirst, this system allows researchers to produce a significant quantity of alkaloids. It’s like having a mini alkaloid factory in the lab, where you can generate a lot of these compounds for study.\nAnother advantage is that cell cultures provide a year-round supply of plant material. This means researchers can work with plants regardless of the season. It’s like having an all-season garden at your disposal.\nAdditionally, cell cultures offer a more consistent and uniform state of development in the cells being studied. It’s like having a group of synchronized dancers who all move in harmony, making it easier to observe and analyze the process.\nMoreover, cell cultures often have a compressed cell cycle, which means they go through their growth and division stages more quickly. This speeds up the research process, making it more efficient.\nIn addition to cell culture, researchers use other techniques for studying alkaloid biosynthesis. These techniques include precursor feeding experiments, which involve giving cells specific compounds to see how they transform them into alkaloids. Analytical techniques like mass spectrometry (MS) and nuclear magnetic resonance (NMR) are also used to analyze and identify the chemical compounds involved in alkaloid biosynthesis.\n\n\n\n11.2.5 Berberine Synthesis\n\n\n\n\n\nA Berberine Synthesis Setup\n\n\n\n\nBerberine biosynthesis is a fascinating process, and it’s notable for a few reasons.\nFirstly, it’s the first pathway of alkaloid biosynthesis that has been completely defined. Imagine it as solving a complex puzzle and finally figuring out all the pieces and how they fit together.\n\n\n\n\n\nSteps Involved in Berberine Synthesis\n\n\n\n\nBerberine is a well-known alkaloid with powerful antimicrobial properties. It’s like a natural antibiotic that plants produce.\nResearchers have made significant progress in understanding and studying berberine biosynthesis, thanks to highly efficient cell culture systems. These systems can yield impressive amounts of berberine, up to 7 grams per liter. It’s like having a specialized factory in the lab, cranking out this valuable alkaloid for various applications."
  },
  {
    "objectID": "chapters/week11.html#plant-phenolics",
    "href": "chapters/week11.html#plant-phenolics",
    "title": "11  Secondary Metabolism in Plants",
    "section": "11.3 Plant Phenolics",
    "text": "11.3 Plant Phenolics\n\n\n\n\n\nPlant Phenolics\n\n\n\n\nPlant phenolics are an interesting group of compounds that have played a significant role in plants’ adaptation from aquatic environments to life on land. Let’s break down their importance and functions.\nIn the evolutionary journey from water to land, plants needed to develop ways to support themselves and protect their cells. Phenolics have been crucial in this process, mostly by contributing to the structure of cell walls. Think of them as the bricks and mortar that make up the plant’s walls.\n\n\n\n\n\nPathway for Making Phenolics\n\n\n\n\nBut phenolics are not just about structural support. They also serve other important functions. They can act as a defense mechanism, deterring herbivores and pathogens from damaging the plant. Phenolics even play a part in the colors of flowers, making them attractive to pollinators, and they can add flavor to various plant parts, like fruits.\nWithin the category of plant phenolics, there are several major types. Lignin is one of the most important, forming the sturdy framework of plant cell walls. Flavonoids are another type, contributing to flower colors and serving as antioxidants. There are also many other types of phenolics, each with their own unique roles in plant biology.\n\n11.3.1 Manipulating Plant Phenolics\nThe manipulation of plant phenolic metabolism is a powerful tool that can lead to a range of beneficial outcomes.\nOne significant application is the creation of plants with enhanced resistance to pathogens. By modifying phenolic metabolism, scientists can help plants become better defenders against diseases and pests. It’s like giving the plant an upgraded immune system to protect itself.\nAnother area of interest is the improvement of wood quality and fiber products. By adjusting phenolic metabolism, researchers can enhance the strength and durability of wood, making it more valuable for various applications. It’s like turning ordinary wood into a super-strong building material.\nManipulating phenolic metabolism can also result in new or improved sources for pharmaceuticals. Certain plant compounds have medicinal properties, and tweaking phenolic metabolism can make these compounds more accessible for drug production. It’s like discovering a treasure trove of potential medicines hidden within plants.\nPhenolic metabolism manipulation has applications in the nutraceutical industry, where plants can be engineered to produce compounds that promote health and wellness. It’s like turning plants into natural health supplements.\nIn horticulture, this technology can be used to create plants with enhanced features, such as unique colors or improved resistance to environmental stresses. It’s like designing custom-made plants to suit specific preferences and conditions.\nAdditionally, phenolic metabolism manipulation can be used to improve the flavor, fragrances, and odor of plants. This can lead to the creation of more appealing and aromatic products, whether in the food or cosmetic industry. It’s like adding a touch of magic to the sensory experience."
  },
  {
    "objectID": "chapters/week11.html#lignin-synthesis",
    "href": "chapters/week11.html#lignin-synthesis",
    "title": "11  Secondary Metabolism in Plants",
    "section": "11.4 Lignin Synthesis",
    "text": "11.4 Lignin Synthesis\nLignin synthesis is an essential process in plants, especially in those with woody tissues like trees and in various vascular tissues. Here’s why it’s important:\nLignin is a type of noncellulosic material that serves as an encrusting substance in woody plant tissues. In fact, it’s one of the most abundant organic natural products found in plants, right after cellulose. It typically makes up about 20-30% of the total content in vascular tissues, which are like the plumbing system of plants.\nIn trees, lignin is responsible for the formation of secondary xylem tissues. These tissues help transport water and nutrients throughout the plant, providing support and structure. In herbaceous plants and grasses, lignin reinforces their vascular tissues.\nOne unique thing about lignin is that it can’t be isolated in its native state, meaning it’s challenging to extract and study directly. Instead, it’s formed from smaller building blocks known as monolignols. These monolignols include coniferyl alcohol, coumaryl alcohol, and sinapyl alcohol, which come together to create lignin.\n\n\n\n\n\nLigning Biosynthesis Pathway\n\n\n\n\nLignin synthesis occurs after the overall architecture of the plant cell wall is already established. It’s like adding a protective layer once the main structure of a building is in place.\nThis synthesis process happens at specific sites within the plant cell, particularly in the cell corners and middle lamella. These are like the critical spots where lignin is needed to provide strength and support.\nTo assist in this process, cell wall proteins play a role. One such protein is the proline-rich protein, which aids in the formation of lignin. It’s a bit like having specialized workers on a construction site, making sure everything comes together correctly.\nIt’s worth noting that the way lignin synthesis happens in non-woody herbaceous plants and grasses can be somewhat different. These plants have their own unique methods for building and strengthening their cell walls."
  },
  {
    "objectID": "chapters/week11.html#flavonoids",
    "href": "chapters/week11.html#flavonoids",
    "title": "11  Secondary Metabolism in Plants",
    "section": "11.5 Flavonoids",
    "text": "11.5 Flavonoids\n\n\n\n\n\nExamples of Flavonoids\n\n\n\n\nFlavonoids are a remarkable group of natural compounds found in plants, and they come in many varieties.\nIn fact, they make up an enormous class of phenolic natural products, with more than 4,500 different compounds falling under this category. Among them are anthocyanins, which are responsible for the vibrant pigments in many flowers and fruits, and proanthocyanidins, which are like condensed tannins, known for their astringent taste.\nFlavonoids are found in most plant tissues, often stored in vacuoles, which are like plant storage units. What’s interesting is that they can exist in different forms, whether as single molecules, paired as dimers, or even in longer chains as polymers.\nThese compounds have diverse functions in plants. Some play a role in plant-animal interactions. For example, they can attract pollinators like bees and butterflies, helping in the plant’s reproductive process. On the flip side, flavonoids like condensed tannins act as antifeedants, discouraging herbivores from munching on the plants.\nFlavonoids also have additional functions like protecting the plant from harmful UV radiation, much like sunscreen for us, and they can act as signaling molecules within the plant to trigger various responses.\n\n11.5.1 Coumarins\n\n\n\n\n\nExamples of Coumarins\n\n\n\n\nAmong the various plant phenolic compounds, coumarins are a notable group. They belong to a category called benzopyranones and are relatively numerous, with over 1,500 different members.\nCoumarins are primarily associated with the defense mechanisms of plants. They play a crucial role in protecting plants from various threats, such as herbivores and pathogens. It’s like having a team of guardians that stand ready to defend the plant when danger approaches.\n\n\n11.5.2 Stilbenes\n\n\n\n\n\nExamples of Stilbenes\n\n\n\n\nStilbenes are another interesting group of plant phenolic compounds, and there are more than 300 different types known today.\nThese compounds have several important functions in plants. One of their key roles is to act as antifungal agents, helping plants ward off fungal infections. It’s like the plant’s own natural defense against harmful fungi.\nStilbenes can also serve as antifeedants, making the plant less appealing to herbivores. It’s a bit like giving the plant a bitter taste that discourages animals from munching on it.\nThese compounds are involved in regulating processes like dormancy and growth inhibition in plants. They play a part in controlling when a plant rests and when it actively grows. It’s like the plant’s internal clock that helps it adapt to changing conditions.\nBeyond their role in plants, stilbenes are also important in pharmacology and human health. Some stilbenoids have been studied for their potential health benefits in humans, making them a subject of interest in the medical field."
  },
  {
    "objectID": "chapters/week12.html",
    "href": "chapters/week12.html",
    "title": "12  Plants as Medicine",
    "section": "",
    "text": "Ever since the early days of human civilization, people have used plants as a sort of medicine for their ailments.\nMateria medica, a term rooted in Latin, translates to “medical material” or “substance.” The historical use of medicinal substances dates back to ancient civilizations.\nAround 1000 B.C., ancient Egyptian medicine already employed various herbs like garlic, opium, castor oil, coriander, mint, and indigo for medicinal purposes. This indicates an early recognition of the healing properties of plants and other natural materials.\nOne of the earliest comprehensive compilations of medicinal substances is found in the Sushruta Samhita, an Indian Ayurvedic treatise from the 6th century B.C. This text detailed 700 medicinal plants, 64 mineral-based preparations, and 57 animal-based preparations, reflecting a rich tradition of herbal knowledge.\nIn Chinese medicine, the Shennong Emperor’s Classic of Materia Medica, dating back to the 1st century AD, stands out. This manual lists around 365 medicines, with 252 of them derived from herbs, showcasing the Chinese understanding of the therapeutic potential of various plant-based substances.\nThe Greek physician Dioscorides made a significant contribution with his work “De Materia Medica” in the first century AD, becoming the first European treatise on the properties and uses of medicinal plants. With descriptions of over 500 plants, this compilation remained an authoritative reference for centuries.\nIn the medieval Islamic world, Muslim botanists and physicians expanded on this knowledge. For instance, in the 9th century, al-Dinawari documented over 637 plant-based drugs, contributing to the growing wealth of information on materia medica."
  },
  {
    "objectID": "chapters/week12.html#traditional-medicine",
    "href": "chapters/week12.html#traditional-medicine",
    "title": "12  Plants as Medicine",
    "section": "12.1 Traditional Medicine",
    "text": "12.1 Traditional Medicine\nTraditional medicine, at its core, is a fusion of philosophy and medicine, drawing on ancient wisdom and practices. One prominent example is Ayurvedic medicine, a system native to India that intertwines philosophy and the science of life.\nThe term “Ayurveda” stems from the Sanskrit words “āyus,” meaning ‘life,’ and “veda,” meaning ‘science.’ This holistic approach is grounded in the belief in the existence of five fundamental elements—earth, water, fire, air, and space—that form not only the universe but also the human body.\nAccording to Ayurveda, the human body comprises seven primary constituent elements: blood, flesh, fat, bone, marrow, chyle, and semen. Each of these elements plays a vital role in the functioning of the body, reflecting a deep understanding of the interconnectedness of life.\nCentral to Ayurvedic philosophy is the emphasis on balance among three fundamental substances: wind or spirit (representing air), phlegm, and bile. These are seen as divine forces governing different aspects of life. Maintaining equilibrium among these forces is believed to contribute to overall health and well-being.\nIn essence, Ayurvedic medicine reflects a profound understanding of the elements shaping the universe and the human body. Its philosophy intertwines seamlessly with medicinal practices, emphasizing the importance of balance and harmony in the divine forces governing life. This holistic approach has endured through the ages, offering a unique perspective on health and healing.\nTraditional Chinese Medicine (TCM) represents a sophisticated integration of philosophy and medical theory, encompassing intricate concepts such as Yin-yang, the Five Phases, the human body Channel, Zang Fu organ theory, and Qi.\nIn TCM, the theory is rich and complex, with each herb assigned specific characteristics. Herbs are classified based on temperature, ranging from extreme yin (cold) to extreme yang (hot), and they are further categorized by taste—pungent, sweet, sour, bitter, and salty. This classification forms the basis for understanding the herb’s therapeutic properties and how it interacts with the body.\nThe core principle of TCM herbal treatment is to restore the internal balance of Yin and Yang within the patient. Yin and Yang represent opposing forces that, when in harmony, contribute to a person’s well-being. The goal of herbal treatment is to rebalance these forces, addressing the root cause of health issues.\nWhat makes TCM particularly unique is its approach to individualized medicine. Each prescription is essentially a carefully crafted cocktail of multiple herbs, each serving a distinct purpose. This tailoring allows practitioners to create personalized treatments, acknowledging the individual patient’s unique constitution and health needs.\nIn summary, Traditional Chinese Medicine offers a comprehensive approach to health, intertwining philosophy and intricate medical theories. The emphasis on balance, personalized prescriptions, and the integration of diverse concepts makes TCM a distinctive and holistic system that has been practiced and refined over centuries.\n\n12.1.1 History of Using Plants as Medicines\nFrom the 1800s to the present day, the pursuit of active compounds from plants has undergone significant changes and evolutions.\nIn the earlier centuries, there was a prevailing focus on the concept of “one molecule, one medicine.” Scientists sought to identify individual molecules within plants that could serve as effective medicines against various diseases. This reductionist approach aimed at isolating specific compounds for medicinal purposes.\nAs research advanced, a multitude of active compounds were successfully identified, each showing potential in addressing different health conditions. This marked a crucial phase in understanding the diverse therapeutic properties hidden within plants.\nTo ensure a sustainable supply of these plant-derived active compounds, scientists employed multiple approaches. These included methods for cultivating and harvesting plants, as well as developing techniques for extracting and synthesizing the desired molecules.\nHowever, during a certain period, there was a shift in focus. Formulated medicine, which involves combining multiple compounds or herbs, was somewhat overlooked, with many active compounds being marketed and consumed as individual supplements rather than as part of a holistic medicine approach.\nIn recent times, there has been a renewed interest in formulated medicine. Researchers and practitioners are revisiting the concept of combining multiple compounds in specific formulations, acknowledging the potential synergies that can arise. This renewed interest suggests a shift back towards recognizing the value of traditional philosophies that considered the holistic nature of plant-based medicines.\nIn summary, the journey from the 1800s to the present in the quest for active compounds has seen shifts in focus, from isolating individual molecules to acknowledging the potential synergies in formulated medicines. The current resurgence of interest in formulated medicine reflects a recognition of the holistic approaches embedded in traditional philosophies and the importance of considering the complex interactions among various plant compounds.\n\n\n12.1.2 Artemisin\n\n\n\n\n\nA Closeup of Artemisia annua\n\n\n\n\nArtemisinin, a significant terpenoid, was originally extracted from the Chinese medicinal herb Artemisia annua, which had been used for over a millennium to treat skin diseases and malaria.\nToday, artemisinin is a vital drug employed in the treatment of multi-drug resistant strains of Falciparum malaria, a particularly challenging form of the disease. One notable aspect is its rapid turnover time, which may contribute to the parasite’s struggle to develop resistance. The World Health Organization (WHO) has recommended a switch to Artemisinin-based Combination Therapy (ACT) for malaria treatment.\nThe mechanism of action of artemisinin against malaria is fascinating. During a malaria infection, hemoglobin is consumed, releasing free heme—an iron-porphyrin complex. Artemisinin interacts with this free heme, creating high-valent iron-oxo species. This sets off a chain reaction, producing reactive oxygen radicals that inflict damage upon the parasite, ultimately leading to its demise.\nArtemisinin production is primarily sourced from plantations, with ongoing efforts in breeding to enhance productivity. While chemical synthesis is feasible, it remains costly. Genetic Modification (GM) presents a promising avenue to increase artemisinin production, and breakthroughs include the use of yeast to produce artemisinic acid, a precursor to artemisinin, through synthetic biology.\nThe Bill Gates Foundation is actively supporting research aimed at large-scale production of artemisinin, with the goal of making it more accessible to developing countries. This highlights the global efforts to combat malaria and underscores the importance of innovative approaches, including genetic modification and synthetic biology, in addressing health challenges on a broader scale.\n\n12.1.2.1 Discovery of Artemisinin\n\n\n\n\n\nProduction of Artemisinin via Yeast\n\n\n\n\nThe discovery of artemisinin is a fascinating story that unfolded during the Vietnam War (1955-75). In 1969, the Chinese army initiated Project 523 to address the severe problem of malaria. The breakthrough came in 1972 when Tu Youyou’s research group identified artemisinin in the leaves of Artemisia annua, a medicinal herb. The drug derived from artemisinin was named Qinghaosu in Chinese.\nRemarkably, artemisinin was just one among nearly 5000 traditional Chinese medicines. When tested against 2000 formulated medicines, it didn’t initially stand out. However, a literature review revealed that the traditional preparation of artemisinin, without heating, as documented in Ge Hong’s “Emergency Prescriptions Kept Up One’s Sleeve,” was a crucial detail. Further experimentation determined that solvent extraction was the most effective method.\nThis medicine played a pivotal role in the outcome of the Vietnam War, yet its significance remained relatively unknown outside of China until the 1980s. The discovery of artemisinin not only marked a turning point in the fight against malaria but also highlighted the potential treasures hidden within traditional herbal remedies. Tu Youyou’s dedication and the innovative approach to exploring ancient texts demonstrate the valuable intersection of traditional knowledge and modern scientific discovery.\n\n\n\n12.1.3 Paclitaxel\nPaclitaxel, a potent anti-cancer drug, originates from the terpenoids found in the bark of the Pacific yew tree (Taxus brevifolia). Discovered by the National Cancer Institute (NCI) in 1967, it is commercially known as ‘taxol’ or ‘abraxane’ and has been instrumental in treating various cancers, including lung, ovarian, breast, and head cancers. Its annual sales peaked at an impressive US$1.6 billion in 2000.\nThe mechanism of action of paclitaxel is intriguing—it binds to microtubules, preventing their breakdown and thereby halting cell division. This unique property makes it a valuable asset in the fight against cancer.\nHowever, controversies surround paclitaxel, including ecological concerns due to the large demand for raw materials. Additionally, debates arise from academic research and commercial rights, with Bristol-Myers Squibb facing accusations of maintaining a ‘cancer monopoly.’ The generic name versus the commercial trademark also contributes to the discourse.\nOver the years, the production of paclitaxel has undergone transformations. Initially sourced solely from the bark of the Pacific yew from 1967 to 1993, it later expanded to include needles of the tree and other Taxus species. A semisynthetic pathway, utilizing 10-deacetylbaccatin isolated from the European Yew’s needles, became an alternative. Presently, plant cell fermentation (PCF) is a common method for Taxol production, with PhytoBiotech being a major player. Looking ahead, there are prospects for paclitaxel production from fungi or even Escherichia coli (E. coli) through metabolic engineering—an exciting frontier in cancer drug development.\n\n\n12.1.4 Ginsengs\nGinsengs, belonging to a genus of 11 slow-growing perennial plants with fleshy roots in the Araliaceae family, have gained prominence in traditional medicine. Notably, American ginseng (Panax quinquefolium) and Asian ginseng (P. ginseng) are consumed for their adaptogenic properties, serving as stress resistors, aphrodisiacs, nourishing stimulants, and treatments for sexual dysfunction in men. Notoginseng (P. notoginseng) is renowned for its hemostatic qualities, invigorating and blood-building effects.\nModern medical research has unveiled several beneficial properties of ginsengs. They exhibit antioxidant activity and demonstrate anti-carcinogenic effects. Laboratory studies on animals, encompassing both Asian and American ginseng, indicate enhanced libido and improved copulatory performance.\nIn a randomized, double-blind study, an extract of American ginseng showcased its effectiveness in reducing influenza cases among the elderly when compared to a placebo. However, it’s crucial to note that herbal-drug interactions have been reported, emphasizing the need for cautious use.\nGinsengs stand as a fascinating intersection of traditional wisdom and modern scientific validation, offering a spectrum of health benefits. From stress management to potential anti-cancer properties, ginsengs continue to capture the interest of researchers and health enthusiasts alike.\n\n\n12.1.5 Digitoxigenin\nDigitoxigenin, derived from Foxglove (Digitalis species), holds historical significance in the treatment of heart diseases. Discovered by the Scottish doctor William Withering in 1775 and released for medical use in 1785, digitalis has played a crucial role in cardiac care.\nThe mechanism of action of digitoxigenin is intriguing. This terpenoid blocks the sodium-potassium pump and enhances calcium release, leading to increased contraction of the heart muscle. This unique mechanism makes it a valuable asset in managing heart conditions.\nHowever, it’s important to note that digitoxigenin, specifically in the form of digitoxin, can exhibit toxic effects. These may include anorexia, nausea, vomiting, diarrhea, confusion, visual disturbances, and abnormal heart rhythms. Additionally, caution is warranted as mixing digitoxigenin with other herbs could potentially lead to significant problems.\nThe story of digitoxigenin reflects the delicate balance between its therapeutic benefits and potential risks. As a foundational component in the history of cardiac medicine, it underscores the ongoing need for careful administration and monitoring when using potent herbal compounds for medical purposes.\n\n\n12.1.6 Berberine\nBerberine, prominently present in Huang Lian, has been recognized for its therapeutic applications in traditional medicine. Known for its efficacy against damp-heat syndromes, especially for intestinal and lung infections, Huang Lian is also applied topically for various skin diseases.\nIn the realm of cardiovascular health, berberine exhibits interesting effects. In low doses, it acts as a cardiac stimulant, enhancing coronary perfusion, while at higher doses in animal studies, it inhibits cardiac activity. Notably, it has shown promise in reducing high blood pressure.\nBerberine’s antimicrobial properties make it a valuable asset in topical dressings and the treatment of diarrhea. Extensive testing has demonstrated its effectiveness against bacteria, yeasts, viruses, and amoebas, with varying levels of potency.\nBeyond these applications, berberine serves as an anthelmintic, aiding in the expulsion of parasitic worms from the body. Recent findings have also highlighted its role in lowering cholesterol, employing a mechanism distinct from that of statin drugs.\n\n12.1.6.1 Berberine in Singapore\nBerberine, once a traditional remedy for newly born jaundice, faced a ban in Singapore in October 1978. This decision was influenced by the observation that immigrants from Southern China, who had a high incidence of G6PD deficiency, experienced more severe jaundice and kernicterus (brain damage due to jaundice) when berberine was used for infants with this deficiency.\nThe ban on berberine-containing products persisted until January 1st, 2013, when the Singapore government decided to permit the usage of Chinese Proprietary Medicines (CPMs) containing berberine. Subsequently, the importation of herbs containing berberine was allowed from 2016.\n\n\n12.1.6.2 Applications of Berberine to Diabetes\nBerberine has emerged as a promising element in the management of diabetes, particularly type 2 diabetes (T2DM). Through its impact on insulin receptors (InsR), BBR has shown the ability to enhance insulin signaling in human cell lines and animals.\nStudies have revealed that BBR not only increases InsR mRNA transcription but also elevates protein expression, and these effects are observed in a dose- and time-dependent manner. Multiple trials have been conducted to explore BBR’s impact on blood glucose levels and InsR expression in individuals with T2DM.\nIn a notable trial involving 97 patients reported by Zhang et al. in 2010, BBR demonstrated substantial positive outcomes. The results showed a significant decrease in fasting blood sugar by 26%, HbA1c by 18%, triglycerides by 18%, and serum insulin by 28% after BBR therapy. Additionally, liver enzymes exhibited a notable decline following BBR treatment.\n\n\n\n12.1.7 Psoriasis and PUVA Treatments\n\n\n\n\n\nPsoriasis Treatments\n\n\n\n\nPsoriasis, a skin disorder characterized by inflammatory patches covered in silvery-white scales, particularly the common plaque psoriasis, is known for its immune-mediated nature. This condition triggers an accelerated growth of skin cells, with new cells maturing in just 3 to 6 days instead of the usual 28 to 30 days.\nOne of the treatments employed for psoriasis is PUVA (Psoralen plus Ultraviolet A) therapy. PUVA involves the use of Methoxypsoralen, a photosensitizing medication, in combination with ultraviolet A (UVA) radiation. The treatment induces inflammation and redness in the skin. Interestingly, this deliberate damage hinders the proliferation of skin cells, effectively reducing the formation of psoriasis plaques.\n\n\n12.1.8 Sustainable production of Plant Compounds\n\n\n\n\n\nArguments For and Against Natural and Pure Drugs\n\n\n\n\nAchieving sustainable production of specific compounds derived from plants involves a multi-faceted approach. Firstly, traditional breeding methods play a crucial role in enhancing productivity. Through careful selection and cultivation of plants with improved traits, researchers aim to develop varieties that yield higher quantities of the desired compounds. Additionally, genetic modification (GM) techniques are employed to boost biosynthesis, introducing genetic alterations that enhance the production of specific compounds.\nPlant tissue culture or cell culture represents another avenue for sustainable production. By cultivating plant tissues or cells in controlled environments, researchers can create a consistent and reproducible source of the targeted compounds. Meanwhile, chemical synthesis is considered if it proves cost-effective while maintaining the desired quality and efficacy of the plant-derived compounds.\nSemi-synthetic pathways offer a hybrid solution, utilizing sustainably produced precursors to create compounds through a combination of natural and synthetic processes. Lastly, the transfer of biosynthetic pathways to bacteria or yeast, optimized through synthetic biology approaches, represents a cutting-edge strategy for achieving efficient and scalable production systems.\nOne more thing to note is that there’s really not any sort of supervision when it comes to over the counter herbal medicines."
  },
  {
    "objectID": "chapters/week12.html#herbal-medicine-preparation",
    "href": "chapters/week12.html#herbal-medicine-preparation",
    "title": "12  Plants as Medicine",
    "section": "12.2 Herbal Medicine Preparation",
    "text": "12.2 Herbal Medicine Preparation\nSeveral arguments support the use of herbal preparations, particularly in the form of formulated medicines:\nFirstly, herbal preparations often exhibit multiple functions due to the presence of different components within a single herb. Unlike isolated compounds, these preparations leverage the synergistic effects of diverse compounds, allowing for a more holistic approach to health.\nAdditionally, combining multiple compounds from various herbs in a formulated medicine may enhance their effectiveness. The synergistic interactions among different herbal ingredients can contribute to a more potent therapeutic effect, addressing health concerns from various angles.\nMoreover, the process of preparing herbal formulations can lead to secondary reactions, resulting in the formation of additional bioactive compounds. While these compounds may be challenging to characterize and quantify, they can contribute to the overall therapeutic efficacy of the herbal preparation. This complexity in composition adds layers of potential benefits that extend beyond the individual components.\n\n12.2.1 Most Diseases Have Various Origins\nAddressing complex and chronic conditions often requires a nuanced approach, as not all ailments can be effectively treated by single compounds. Conditions such as AIDS, diabetes, metabolic syndrome, obesity, and Alzheimer’s exhibit pleiotropic characteristics, involving multiple interconnected factors. Attempting to address these multifaceted conditions with a single compound may prove insufficient, given the intricate nature of their underlying mechanisms.\nIn contrast, many traditional medicines are crafted from a combination of several plants, suggesting that their effectiveness may stem from the synergy of multiple factors working in concert. The intricate balance of various compounds within these herbal formulations may offer a more comprehensive and holistic solution to the complexity of chronic diseases.\n\n\n12.2.2 Regulations for Herbal Medicine\nThe regulatory landscape for formulated medicines, particularly herbal drugs, has undergone significant changes, exemplified by modifications introduced by the U.S. Food and Drug Administration (FDA) in 2004. One notable adjustment was the removal of the requirement for disclosing a single active component in herbal drug approval processes. Instead, the FDA emphasized the importance of quality control and ensuring therapeutic consistency in these formulations.\nA landmark moment in this evolving regulatory framework occurred in 2006 when the FDA approved the topical use of a green tea extract for combating the human papillomavirus (HPV). This approval marked a significant milestone as the first instance of an herbal drug receiving FDA recognition for its efficacy in treating a specific condition.\nAs of now, the FDA has received approximately 450 Investigational New Drug (IND) and pre-IND applications for botanicals. This influx of applications underscores the growing interest and recognition of herbal medicines within the regulatory sphere. The emphasis on quality control and therapeutic consistency aligns with a broader acknowledgment of the potential benefits and complexities associated with herbal formulations.\n\n12.2.2.1 Example: Danshen Dripping Pill\n\n\n\n\n\nIngredients in the Danshen Dripping Pill\n\n\n\n\nThe movement towards FDA approval for formulated herbal medicines is exemplified by the case of the Danshen Dripping Pill, developed by Tianjin Tasly Pharmaceutical. This cardiotonic pill is composed of three herbal ingredients and one synthetic phytochemical, traditionally utilized for the treatment of angina and coronary heart diseases.\nThe regulatory journey of the Danshen Dripping Pill began with the acquisition of an Investigational New Drug (IND) designation in the United States in 1997. Subsequent phases of clinical development followed this initial step. Phase I trials focused on establishing the safety of the pill in healthy human subjects. In 2010, Phase II trials provided evidence of its efficacy in treating chronic stable angina.\nMoving forward, the Phase III clinical trial commenced in 2015 and is currently ongoing. This phase aims to further evaluate the safety and effectiveness of the Danshen Dripping Pill in a larger and more diverse patient population. Notably, the rights to this herbal medicine have been licensed to Arbor Pharmaceuticals, a development that signifies external investment and support for its continued development.\n\n\n12.2.2.2 Example: Huang Qin Tang\n\n\n\n\n\nIngredients in Huang Qin Tang\n\n\n\n\nHuang Qin Tang, with a history of nearly 2000 years in treating gastrointestinal symptoms, is a herbal formulation that consists of four plants, each contributing to its therapeutic effects. Although traditionally known for its gastrointestinal benefits, Huang Qin Tang has demonstrated a weakness in directly inhibiting tumors. However, it exhibits a remarkable ability to enhance the anti-tumor activity of various chemotherapies with a broad spectrum through multiple mechanisms of action, concurrently reducing toxicity.\nThe formulation’s potential in cancer therapy has been substantiated by positive results in a Phase II clinical trial conducted by Yale Medical School, specifically for the treatment of liver cancer. This marks a significant step in validating the efficacy and safety of Huang Qin Tang as an adjunctive therapeutic approach in combination with conventional chemotherapies."
  },
  {
    "objectID": "chapters/week12.html#traditional-chinese-medicine-and-mainstream-medicine",
    "href": "chapters/week12.html#traditional-chinese-medicine-and-mainstream-medicine",
    "title": "12  Plants as Medicine",
    "section": "12.3 Traditional Chinese Medicine and Mainstream Medicine",
    "text": "12.3 Traditional Chinese Medicine and Mainstream Medicine\nThe integration of traditional medicine into mainstream healthcare is a nuanced process driven by several key factors. One pivotal aspect is the accumulation of scientific evidence that supports the efficacy of traditional remedies and sheds light on the underlying mechanisms of their therapeutic actions. Rigorous research, including clinical trials, plays a vital role in substantiating the effectiveness of traditional medicine, contributing to its acceptance in mainstream healthcare practices.\nQuality control measures are another critical element in facilitating the transition of traditional medicine. The implementation of the 6Ps—Good Agricultural Practice (GAP), Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Good Storage Practice (GSP), Standard Operating Procedure (SOP), and Good Manufacturing Practice (GMP)—ensures standardized processes from cultivation to production. These practices not only enhance the consistency and reliability of herbal products but also align traditional medicine with the rigorous standards expected in mainstream healthcare.\nAddressing concerns related to the safety of traditional medicine is paramount for its acceptance. This involves a thorough assessment of potential toxicity and interactions with conventional drugs. By conducting comprehensive research and establishing testing protocols, the aim is to identify and mitigate any risks associated with the use of herbal remedies, thereby ensuring their safe integration into mainstream healthcare.\nFurthermore, fostering collaboration between traditional healers and modern healthcare professionals is instrumental in creating a holistic approach to patient care. This interdisciplinary collaboration allows for the exchange of knowledge and expertise, leveraging the strengths of both traditional and modern medicine to provide patients with a diverse and comprehensive set of treatment options.\n\n12.3.1 Toxicity from Herb Contamination\nThe case study involving toxicity due to herb contamination highlights the potential risks associated with herbal supplements and the importance of stringent quality control measures. In this instance, two women presented at a hospital with symptoms such as nausea, vomiting, and irregular heartbeats after using a dietary supplement intended for “systematic cleaning of the body.” Laboratory tests confirmed digitalis toxicity, prompting an investigation by the U.S. Food and Drug Administration (FDA).\nThe FDA’s inquiry led to the identification of the source of contamination – raw herbs imported from Germany. The bulk plantain used in the supplement was found to be contaminated by Digitalis lanata, a plant known for its cardiac glycoside content, including compounds like digitoxin. The discovery had widespread implications, affecting more than 150 companies that had utilized approximately 2.7 tons of the contaminated plantain in various herbal products.\n\n\n12.3.2 Importance of Regulation\nThe importance of quality control (QC) for medical herbs cannot be overstated, considering the various factors that can significantly impact the composition and efficacy of herbal products. Genetic variation within plant species can lead to differences in the presence and concentration of bioactive compounds. An illustrative example is Stephania tetrandra, where only a specific variant among more than ten may contain the desired compound tetrandrine. This underscores the need for precise identification and selection of plant sources to ensure consistency in herbal formulations.\nMisidentification of herbs poses a serious risk to consumers. An infamous case involved Aristolochia fangchi, which contains aristolochic acid, a nephrotoxic compound. The inadvertent use of this herb, instead of the intended Stephania tetrandra, resulted in severe kidney failure in some cases. This highlights the critical role of accurate plant identification in preventing harmful consequences.\nThe complexity of nomenclature in traditional medicine further complicates matters. Chinese medical herbs, for instance, may have one name referring to several species, as seen with GuanZhong, which encompasses 31 different species. Additionally, a single species might be referred to by different names, exemplified by TianQi. This linguistic variability emphasizes the necessity for standardized and precise botanical taxonomy to avoid confusion in the formulation and prescription of herbal medicines.\nAdulteration, the intentional or unintentional inclusion of incorrect or inferior substances, is another challenge in the herbal industry. Rigorous QC practices, including authentication of raw materials and regular testing, are crucial for detecting and preventing adulteration. Companies that prioritize and implement robust QC measures not only safeguard consumer health but also position themselves favorably in the market by establishing trust and reliability."
  },
  {
    "objectID": "chapters/week12.html#standardizations-and-quality-control-of-herbal-medications",
    "href": "chapters/week12.html#standardizations-and-quality-control-of-herbal-medications",
    "title": "12  Plants as Medicine",
    "section": "12.4 Standardizations and Quality Control of Herbal Medications",
    "text": "12.4 Standardizations and Quality Control of Herbal Medications\n\n\n\n\n\nQuality Assurance Part 1\n\n\n\n\n\n\n\n\n\nMetabolic Engineering\n\n\n\n\nThe above process - metabolic engineering - has some consequences as a whole. We don’t know how under or over-expressing certain proteins (e.g., transcription factors) will affect other processes in the cell. Likewise, if we do things inside a yeast cell, we must often make a new pathway."
  }
]